Basic Information

Faculty

• Faculty of Medicine

Professional Memberships

• Cord Blood Connect
• Asia Pacific Blood and Marrow Transplantation Group
• American Society for Transplantation and Cellular Therapy
• American Society of Hematology
• Japanese Society of Myeloma
• Japanese Society for Histocompatibility and Immunogenetics
• The Japan Society of Transfusion Medicine and Cell Therapy
• Japanese Society for Transplantation and Cellular Therapy
• The Japanese Society of Internal Medicine
• The Japanese Society of Hematology

Academic Degree

• Ph. D (medical)(Kyoto University )

Academic Resume (Graduate Schools)

• Kyoto University, University of Medicine, PhD in medical research, 博士課程医学専攻, 修了

Academic Resume (Undergraduate School/Majors)

• Kyoto University , Medical Department, Medical science, 卒業

Research History

• From Jul. 2021, To Mar. 2022

  Kyoto University Hospital, Hematology and Oncology Medical lecturer
• From 01 Aug. 2016

  Kyoto University Hospital, Hematology and Oncology Research Associate
• From 01 Apr. 2016

  Kyoto University Hospital, Hematology and Oncology Hospital Assistant
• From Apr. 2012, To Mar. 2016

  Saitama Medical Center Jichi Medical University, Hematology Instructor
• From 01 Apr. 2010

  Duke University medical center, Research Scholar
• From 01 Apr. 2010

  Japan Society for the Promotion of Science, Special Researcher PD
• From Apr. 2022, To Present

  Graduate School of Medicine, Kyoto University, Department of Hematology and Oncology, Associate Professor

ID,URL

• J-Global ID

  201401034506034337

• External link

  http://kaken.nii.ac.jp/d/r/30636311.ja.html

researchmap URL

• https://researchmap.jp/yjk

Research

Research Topics, Overview of the research

• Research Topics

  Searching for prognostic factors and developing new therapyin allogeneic hematopoietic stem cell transplantation

• Overview of the research

  Allogeneic hematopoietic stem cell transplantation is a curative treatment for relapsed and refractory hematologic diseases. We are searching for new prognostic factors using patient data and samples, and developing new treatment based on their results.

Research Interests

• Retrospective analysis
• Clinical trial
• HLA
• Cord blood transplantation
• Allogeneic hematopoietic stem cell transplantation

Research Areas

• Life sciences, Hematology and oncology

Papers

• Impact of myelodysplasia-related gene mutations and residual mutations at remission in venetoclax/azacitidine for AML.

  Yoshikazu Ikoma; Nobuhiko Nakamura; Yuto Kaneda; Hiroyuki Takamori; Tomokazu Seki; Nobuhiro Hiramoto; Junichi Kitagawa; Junya Kanda; Kei Fujita; Tetsuji Morishita; Yotaro Ochi; Shigeru Chiba; Nana Sasaki; Michiko Ichii; Kazunori Imada; Mizuki Watanabe; Masakatsu Hishizawa; Yasuko Miyahara; Yoshitomo Maesako; Yasuhiro Tanaka; Satoko Oka; Masaaki Tsuji; Satoshi Yoshihara; Kinuko Mitani; Yasunori Ueda; Toshiyuki Kitano; Mitsumasa Watanabe; Nobuo Sezaki; Tadakazu Kondo; Senji Kasahara; Akifumi Takaori-Kondo; Nobuhiro Kanemura; Seishi Ogawa; Yasuhito Nannya

  Leukemia, 21 Apr. 2025

  
• A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation.

  Kanda Y; Kobayashi T; Mori T; Tanaka M; Nakaseko C; Yokota A; Watanabe R; Kako S; Kakihana K; Kato J; Tanihara A; Doki N; Ashizawa M; Kimura SI; Kikuchi M; Kanamori H; Okamoto S; Kanto Study; Group; for Cell Therapy

  Bone marrow transplantation, Jan. 2016, Peer-reviewed

  
• Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia with t(6;9)(p23;q34) dramatically improves the patient prognosis: a matched-pair analysis

  Ishiyama K; Takami A; Kanda Y; Nakao S; Hidaka M; Maeda T; Naoe T; Taniguchi S; Kawa K; Nagamura T; Atsuta Y; Sakamaki H

  LEUKEMIA, 2012, Peer-reviewed

  
• Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation.

  Nakaseko C; Ozawa S; Sakaida E; Sakai M; Kanda Y; Oshima K; Kurokawa M; Takahashi S; Ooi J; Shimizu T; Yokota A; Yoshiba F; Fujimaki K; Kanamori H; Sakai R; Saitoh T; Sakura T; Maruta A; Sakamaki H; Okamoto S

  International journal of hematology, Mar. 2011, Peer-reviewed

  
• A practice-oriented genome-profiling study for acute myeloid leukemia using the novel HANDLE system: HM-screen-JAPAN02.

  Hironori Arai; Naoko Hosono; SungGi Chi; Kentaro Fukushima; Daisuke Ikeda; Satoshi Iyama; Akihiko Gotoh; Takayuki Ikezoe; Chikashi Yoshida; Goichi Yoshimoto; Junya Kanda; Naoto Takahashi; Emiko Sakaida; Kensuke Usuki; Takahiro Yamauchi; Yosuke Minami

  International journal of hematology, 16 Dec. 2024

  
• クロマチンアクセシビリティ解析による急性骨髄性白血病の新規分子サブグループの同定

  越智 陽太郎; Markus Liew; 南谷 泰仁; 笠原 千嗣; 平本 展大; 兼村 信宏; 瀬崎 伸夫; 櫻田 麻希; 岩崎 惇; 諫田 淳也; 上田 恭典; 吉原 哲; Albin Osterroos; 本村 公則; 中川 正宏; 佐伯 龍之介; 福島 英人; 岡崎 幸治; 依田 成玄; 奥田 瑠璃花; Lanying Zhao; 白石 友一; 石川 隆之; 宮野 悟; 鈴木 洋; 高折 晃史; Soren Lehmann; 小川 誠司

  日本血液学会学術集会, Oct. 2024

  
• Real-World Outcomes of Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Japan: Retrospective Analysis of Transplant Registry Unified Management Program Registry: GVHD outcomes after allo-HSCT.

  Junya Kanda; Takaya Mitsuyoshi; Masatoshi Sakurai; Hisakazu Nishimori; Makoto Murata; Naoyuki Uchida; Noriko Doki; Yoshihiro Inamoto; Tetsuya Nishida; Masatsugu Tanaka; Yuta Katayama; Tetsuya Eto; Ken-Ichi Matsuoka; Satoshi Yoshihara; Masashi Sawa; Toshiro Kawakita; Gyungjin Jun; Mio Kurata; Tatsuo Ichinohe; Takahiro Fukuda; Takanori Teshima; Yoshiko Atsuta; Seitaro Terakura

  Transplantation and cellular therapy, 01 Jul. 2024

  
• Population Pharmacokinetic Modeling of Posaconazole in Japanese Patients Receiving Fungal Prophylaxis.

  Mitsuhiro Sugimoto; Atsushi Yonezawa; Junya Kanda; Kotaro Itohara; Daiki Hira; Takeo Yamagiwa; Risa Taniguchi; Yuta Hanyu; Mizuki Watanabe; Yasuyuki Arai; Chisaki Mizumoto; Toshio Kitawaki; Tadakazu Kondo; Kouhei Yamashita; Akifumi Takaori-Kondo; Tomohiro Terada

  Therapeutic drug monitoring, 04 Apr. 2024

  
• 急性骨髄性白血病におけるTET2遺伝子変異 HM-SCREEN-Japan 02

  井山 諭; 池 成基; 池添 隆之; 福島 健太郎; 宇津 欣和; 諫田 淳也; 吉本 五一; 池田 大輔; 森下 喬允; 小林 敬宏; 山内 高弘; 臼杵 憲祐; 近藤 健; 中邑 幸伸; 小島 研介; 吉田 近思; 後藤 明彦; 山本 一仁; 黒田 純也; 石塚 賢治; 堺田 惠美子; 堀口 拓人; 小船 雅義; 南 陽介

  日本血液学会学術集会, Oct. 2023

  
• AML診療におけるターゲットシーケンス解析の有用性 HM-SCREEN-Japan02試験

  細野 奈穂子; 山内 高弘; 池 成基; 新井 宏典; 福島 健太郎; 井山 諭; 後藤 明彦; 池添 隆之; 吉田 近思; 吉本 五一; 諫田 淳也; 高橋 直人; 堺田 惠美子; 臼杵 憲祐; 南 陽介

  日本血液学会学術集会, Oct. 2023

  
• クロマチンアクセシビリティ解析による急性骨髄性白血病のエピジェネティクス不均一性の解明

  越智 陽太郎; 南谷 泰仁; Liew-Littorin Markus; 笠原 千嗣; 平本 展大; 兼村 信宏; 瀬崎 伸夫; 櫻田 麻希; 岩崎 惇; 諫田 淳也; 上田 恭典; 吉原 哲; Osterroos Albin; 本村 公則; 中川 正宏; 佐伯 龍之介; 依田 成玄; 奥田 瑠璃花; 白石 友一; 石川 隆之; 宮野 悟; 高折 晃史; Lehmann Soren; 小川 誠司

  日本血液学会学術集会, Oct. 2023

  
• Donor selection in T-cell-replete haploidentical donor peripheral blood stem cell transplantation.

  Fumiya Wada; Makoto Iwasaki; Masahiro Hirayama; Koji Kawamura; Katsuji Kaida; Noriko Doki; Hirohisa Nakamae; Yuta Hasegawa; Takahiro Fukuda; Tetsuya Eto; Nobuhiro Hiramoto; Yumiko Maruyama; Koji Nagafuji; Shuichi Ota; Jun Ishikawa; Toshihiko Ando; Tatsuo Ichinohe; Yoshiko Atsuta; Hideki Nakasone; Junya Kanda

  Leukemia, Apr. 2025

  
• HLA-matched related peripheral blood stem cell and bone marrow transplantation with RIC regimens yield comparable outcomes for adult AML.

  Takaya Mitsuyoshi; Yasuyuki Arai; Tadakazu Kondo; Takahito Kawata; Shigeki Hirabayashi; Masatsugu Tanaka; Yasuo Mori; Noriko Doki; Tetsuya Nishida; Takeharu Kotani; Masao Ogata; Takayuki Tabayashi; Tetsuya Eto; Masashi Sawa; Kazunori Imada; Junya Kanda; Tatsuo Ichinohe; Yoshiko Atsuta; Masamitsu Yanada

  EJHaem, Feb. 2025

  
• Association between early anti-cytomegalovirus therapy and the incidence of chronic graft-versus-host disease

  Kotaro Miyao; Makoto Murata; Tetsuya Nishida; Yukiyasu Ozawa; Naoyuki Uchida; Takahiro Fukuda; Noriko Doki; Tetsuya Eto; Toshiro Kawakita; Yasuo Mori; Satoru Takada; Hiroyuki Ohigashi; Masatsugu Tanaka; Yoshinobu Kanda; Ken-ichi Matsuoka; Fumihiko Ishimaru; Yoshiko Atsuta; Junya Kanda; Seitaro Terakura

  International Journal of Hematology, 14 Nov. 2024

  
• 非定型慢性骨髄性白血病に対する同種移植成績の年次推移

  糸永 英弘; 宮崎 泰司; 近藤 健; 島津 裕; 青木 淳; 黒澤 修兵; 池田 宇次; 衛藤 徹也; 内田 直之; 中澤 英之; 河村 浩二; 諫田 淳也; 熱田 由子; 立花 崇孝

  日本血液学会学術集会, Oct. 2024

  
• Impact of center volume on outcomes in allogeneic hematopoietic cell transplantation for children.

  Motohiro Kato; Hideki Nakashone; Keitaro Matsuo; Yuri Ito; Atsumi Yanagisawa; Marie Ohbiki; Ken Tabuchi; Tatsuo Ichinohe; Yoshiko Hashii; Junya Kanda; Hideki Goto; Koji Kato; Makoto Yoshimitsu; Atsushi Sato; Moeko Hino; Kimikazu Matsumoto; Kimikazu Yakushijin; Yoshiko Atsuta; Takahiro Fukuda

  Bone marrow transplantation, 10 Apr. 2025

  
• Low Survival Due to Higher Risk of Relapse and Nonrelapse Mortality After Allogeneic HSCT in ATL Compared with AML and ALL.

  Shohei Tomori; Satoko Morishima; Koji Kato; Hideki Nakasone; Nobuaki Nakano; Tetsuya Eto; Toshiro Kawakita; Youko Suehiro; Yasuhiko Miyazaki; Naoyuki Uchida; Yasushi Sawayama; Yasuo Mori; Hirohisa Nakamae; Koji Nagafuji; Yasufumi Uehara; Noriko Doki; Junya Kanda; Takahiro Fukuda; Yoshiko Atsuta; Makoto Yoshimitsu

  Transplantation and cellular therapy, Apr. 2025

  
• 移植前呼吸機能低下を伴うHLA適合同種造血細胞移植における至適ドナーソースの検討

  川村 俊人; 玉置 雅治; 小沼 貴晶; 鬼塚 真仁; 堺田 恵美子; 林 裕美; 土岐 典子; 小澤 幸泰; 澤 正史; 荒 隆英; 福田 隆浩; 一戸 辰夫; 熱田 由子; 神田 善伸; 藥師神 公和; 諫田 淳也; 仲宗根 秀樹

  日本血液学会学術集会, Oct. 2023

  
• Cord blood is a suitable donor source of allogeneic hematopoietic cell transplantation for adult T-cell leukemia-lymphoma: a nationwide retrospective study.

  Masahito Tokunaga; Nobuaki Nakano; Shigeo Fuji; Atsushi Wake; Atae Utsunomiya; Ayumu Ito; Tetsuya Eto; Toshiro Kawakita; Yasuo Mori; Yukiyoshi Moriuchi; Youko Suehiro; Yasuhiko Miyazaki; Naoyuki Uchida; Yasushi Sawayama; Kenji Ishitsuka; Junya Kanda; Takafumi Kimura; Tatsuo Ichinohe; Yoshiko Atsuta; Takahiro Fukuda; Makoto Yoshimitsu; Koji Kato

  Bone marrow transplantation, Apr. 2023

  
• Center effect on outcomes of second allogeneic hematopoietic stem cell transplantation for B-cell acute lymphoblastic leukemia: a nationwide retrospective study.

  Shuhei Kurosawa; Takahiro Fukuda; Tatsuo Ichinohe; Yoshiko Hashii; Junya Kanda; Hideki Goto; Koji Kato; Fumihiko Ishimaru; Makoto Yoshimitsu; Moeko Hino; Keitaro Matsuo; Yuri Ito; Atsumi Yanagisawa; Marie Ohbiki; Ken Tabuchi; Yoshiko Atsuta; Yasuyuki Arai

  Cytotherapy, 12 Mar. 2025

  
• Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT.

  Shunto Kawamura; Daishi Nakagawa; Takashi Nagayama; Yuta Katayama; Noriko Doki; Wataru Takeda; Tetsuya Nishida; Ken-Ichi Matsuoka; Takashi Ikeda; Hiroyuki Ohigashi; Masashi Sawa; Kentaro Fukushima; Junya Kanda; Kentaro Serizawa; Makoto Onizuka; Takahiro Fukuda; Yoshiko Atsuta; Yoshinobu Kanda; Hideki Nakasone

  Blood advances, 14 Jan. 2025

  
• Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study.

  Satoshi Iyama; SungGi Chi; Masashi Idogawa; Takayuki Ikezoe; Kentaro Fukushima; Yoshikazu Utsu; Junya Kanda; Goichi Yoshimoto; Takahiro Kobayashi; Naoko Hosono; Takahiro Yamauchi; Takeshi Kondo; Yukinori Nakamura; Kensuke Kojima; Chikashi Yoshida; Akihiko Gotoh; Kazuhito Yamamoto; Junya Kuroda; Kenji Ishitsuka; Emiko Sakaida; Hiroto Horiguchi; Kohichi Takada; Hirofumi Ohnishi; Masayoshi Kobune; Yosuke Minami

  Annals of hematology, Jan. 2025

  
• Long-Term Survival After Allogeneic Hematopoietic Stem Cell Transplantation for BCR::ABL1-Negative Atypical Chronic Myeloid Leukemia: A Nationwide Retrospective Study by Adult CML/MPN and MDS Working Groups of the Japanese Society for Transplantation and Cellular Therapy.

  Hidehiro Itonaga; Yasushi Miyazaki; Takeshi Kondo; Yutaka Shimazu; Jun Aoki; Shuhei Kurosawa; Takashi Ikeda; Tetsuya Eto; Naoyuki Uchida; Hideyuki Nakazawa; Koji Kawamura; Junya Kanda; Yoshiko Atsuta; Takayoshi Tachibana

  American journal of hematology, 11 Feb. 2025

  
• Increased relative eosinophil counts portend neck oedema after chimeric antigen receptor-T therapy.

  Naokazu Nakamura; Tomoyasu Jo; Yasuyuki Arai; Toshio Kitawaki; Momoko Nishikori; Chisaki Mizumoto; Junya Kanda; Kouhei Yamashita; Miki Nagao; Akifumi Takaori-Kondo

  British journal of haematology, 06 Jan. 2025

  
• Severe cases of local cytokine release syndrome (CRS); craniocervical edema soon after chimeric antigen T-cell (CAR-T) therapy.

  Naokazu Nakamura; Tomoyasu Jo; Yasuyuki Arai; Toshio Kitawaki; Momoko Nishikori; Chisaki Mizumoto; Junya Kanda; Kouhei Yamashita; Miki Nagao; Akifumi Takaori-Kondo

  Oxford medical case reports, Jan. 2025

  Access this paper :

  
• Fluctuation of physical function during chimeric antigen receptor T-cell therapy during rehabilitation intervention: Real-world data and risk factor analyses.

  Ryota Hamada; Yasuyuki Arai; Toshio Kitawaki; Naokazu Nakamura; Masanobu Murao; Michiko Matsushita; Junsuke Miyasaka; Tsugumi Asano; Tomoyasu Jo; Momoko Nishikori; Junya Kanda; Chisaki Mizumoto; Kouhei Yamashita; Ryosuke Ikeguchi; Akifumi Takaori-Kondo

  EJHaem, Dec. 2024

  Access this paper :

  
• Comparison of Nonrelapse Mortality After Haploidentical Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation in Hematologic Disease.

  Kaito Harada; Junya Kanda; Masahiro Hirayama; Fumiya Wada; Naoyuki Uchida; Masatsugu Tanaka; Hirohisa Nakamae; Masahito Tokunaga; Kazuya Ishiwata; Makoto Onizuka; Yuta Hasegawa; Takahiro Fukuda; Tetsuya Eto; Naoki Kurita; Toshiro Kawakita; Atsushi Jinguji; Fumihiko Ishimaru; Yoshiko Atsuta; Hideki Nakasone

  Transplantation and cellular therapy, 26 Nov. 2024

  
• Effect of peptide-binding motif on survival of HLA-haploidentical transplantation with post-transplant cyclophosphamide.

  Kentaro Ido; Hirohisa Nakamae; Norimichi Hattori; Minoru Kanaya; Kaoru Morita; Masayuki Hino; Hiroyuki Ohigashi; Takahiro Fukuda; Tetsuya Eto; Koji Nagafuji; Nobuhiro Hiramoto; Yumiko Maruyama; Shuichi Ota; Ken-Ichi Matsuoka; Toshihiko Ando; Takashi Akasaka; Yasuo Mori; Tomohiko Kamimura; Toshiro Kawakita; Koji Kawamura; Junya Kanda; Makoto Onizuka; Yoshiko Atsuta; Makoto Murata

  British journal of haematology, 07 Jul. 2024

  
• Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma

  Yosuke Nakaya; Hirohisa Nakamae; Masashi Nishikubo; Eisei Kondo; Takahiro Fukuda; Nobuhiro Hiramoto; Yasuo Mori; Koji Nagafuji; Tetsuya Eto; Yasushi Onishi; Naoyuki Uchida; Jun Ishikawa; Ken-ichi Matsuoka; Shunsuke Yui; Ken Takase; Toshiro Kawakita; Junya Kanda; Tatsuo Ichinohe; Yoshiko Atsuta; Shinichi Kako

  Bone Marrow Transplantation, May 2024

  
• 急性骨髄性白血病における同種移植前処置強度スコアの外部検証

  柳田 正光; 下村 良充; 水野 昌平; 松田 健佑; 近藤 忠一; 土岐 典子; 田中 正嗣; 福田 隆浩; 荒 隆英; 内田 直之; 鬼塚 真仁; 澤 正史; 小澤 幸泰; 平本 展大; 太田 秀一; 諫田 淳也; 神田 善伸; 一戸 辰夫; 岡本 真一郎; 熱田 由子; 小沼 貴晶

  日本血液学会学術集会, Oct. 2023

  
• ベネトクラクスのトラフ血中濃度とAUCの相関性についての解析

  川上 智也; 山際 岳朗; 米澤 淳; 諫田 淳也; 中川 俊作; 谷口 理沙; 林 裕美; 阪本 貴士; 水本 智咲; 近藤 忠一; 高折 晃史; 寺田 智祐

  日本臨床薬理学会学術総会抄録集, Jan. 2024

  
• 急性白血病における新規RNA分子及び治療標的の同定

  和田 典也; 加藤 匠矢; シュルティー・バーガット; 平林 茂樹; 孫 楽; 小口 綾貴子; 竹内 一博; 関戸 翔; 平井 公也; チャン・ジーウェイ; 岩崎 惇; 諫田 淳也; 阪本 貴士; 白川 康太郎; 高折 晃史; 村川 泰裕

  日本血液学会学術集会, Oct. 2023

  
• AML治療におけるvenetoclax血中濃度測定の意義

  林 裕美; 山際 岳朗; 諫田 淳也; 石川 隆之; 渡邊 光正; 宮原 裕子; 宮尾 康太郎; 堤 康彦; 立花 崇孝; 平田 大二; 藤原 慎一郎; 上田 恭典; 片岡 良久; 川端 浩; 北野 俊行; 木村 俊一; 横山 洋紀; 吉藤 康太; 太田 健介; 脇田 知志; 阪本 貴士; 水本 智咲; 北脇 年雄; 米澤 淳; 川上 智也; 中川 俊作; 谷口 理沙; 寺田 智祐; 高折 晃史

  日本血液学会学術集会, Oct. 2023

  
• CAR-T細胞療法後に肺動脈内のT細胞塊を認めたtriple-hit DLBCLの1例

  中村 直和; 錦織 桃子; 水本 智咲; 阪本 貴士; 諫田 淳也; 白川 康太郎; 北脇 年雄; 近藤 忠一; 山下 浩平; 高折 晃史

  臨床血液, Aug. 2022

  
• 嚥下障害を伴う治療関連急性骨髄性白血病に対してベネトクラクスを導入した1例

  中村 名欧; 和田 典也; 阪本 貴士; 諫田 淳也; 山際 岳朗; 米澤 淳; 寺田 智祐; 水本 智咲; 北脇 年雄; 近藤 忠一; 山下 浩平; 高折 晃史

  臨床血液, Feb. 2022

  
• Allogeneic hematopoietic stem cell transplantation using reduced intensity conditioning regimen for patients with acute myeloid leukemia not in complete remission.

  Yoshimitsu Shimomura; Tetsuhisa Kitamura; Masamitsu Yanada; Shohei Mizuno; Tadakazu Kondo; Satoshi Yoshihara; Masatsugu Tanaka; Kazuki Inai; Yuta Katayama; Makoto Onizuka; Takahiro Fukuda; Hirohisa Nakamae; Mineo Kurokawa; Shingo Yano; Miho Nara; Masayoshi Masuko; Shigesaburo Miyakoshi; Tetsuya Eto; Makoto Yoshimitsu; Fumihiko Ishimaru; Junya Kanda; Yoshiko Atsuta; Takaaki Konuma

  Cytotherapy, 17 Nov. 2024

  
• Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy.

  Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Ugai T; Kusuda M; Kameda K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Tanihara A; Kanda Y

  Infectious diseases (London, England), Jun. 2017, Peer-reviewed

  
• Association between human herpesvirus-6 encephalitis and antiviral prophylaxis after allogeneic hematopoietic stem cell transplantation in the letermovir era

  Toshiki Terao; Ken-ichi Matsuoka; Shigeo Fuji; Shunto Kawamura; Takashi Toya; Noriko Doki; Naoyuki Uchida; Masatsugu Tanaka; Takahiro Fukuda; Masashi Sawa; Jun Ishikawa; Tetsuya Nishida; Hiroyuki Ohigashi; Yumiko Maruyama; Shin-ichiro Fujiwara; Yoshinobu Kanda; Shuichi Ota; Fumihiko Ishimaru; Yoshiko Atsuta; Junya Kanda; Masao Ogata; Kimikazu Yakushijin; Hideki Nakasone

  Bone Marrow Transplantation, 25 May 2024

  
• 多発性骨髄腫に対するエロツズマブ・レナリドミド・デキサメタゾン療法の効果 KMFデータベースによる解析(Efficacy of elotuzumab plus lenalidomide and dexamethasone for MM: A retrospective analysis from KMF)

  淵田 真一; 伊藤 量基; 小杉 智; 太田 健介; 内山 人二; 島津 裕; 恩田 佳幸; 金子 仁臣; 足立 陽子; 高桑 輝人; 諫田 淳也; 魚嶋 伸彦; 柴山 浩彦; 福島 健太郎; 田中 宏和; 志村 勇司; 今田 和典; 八木 秀男; 吉原 哲; 日野 雅之; 保仙 直毅; 高折 晃史; 松村 到; 野村 昌作; 島崎 千尋; 黒田 純也

  日本血液学会学術集会, Sep. 2021

  
• Impact of donor type on the outcomes of acute graft versus host disease to systemic corticosteroid therapy.

  Yoshimitsu Shimomura; Tetsuhisa Kitamura; Junichi Sugita; Toshiki Terao; Atsushi Satake; Tsuneaki Hirakawa; Naoyuki Uchida; Masashi Shimabukuro; Masatsugu Tanaka; Tetsuya Eto; Nobuhiro Hiramoto; Keisuke Kataoka; Hirohisa Nakamae; Ken Takase; Toshiro Kawakita; Yasuyuki Arai; Wataru Takeda; Fumihiko Ishimaru; Takahiro Fukuda; Yoshiko Atsuta; Hideki Nakasone; Junya Kanda

  Bone marrow transplantation, 30 Sep. 2024

  
• Haploidentical transplantation with post-transplant cyclophosphamide versus single cord blood transplantation in adults with relapsed/refractory non-Hodgkin lymphoma.

  Masashi Nishikubo; Yoshimitsu Shimomura; Yosuke Nakaya; Akihito Shinohara; Naoyuki Uchida; Nobuyuki Takayama; Hikaru Kobayashi; Yasufumi Uehara; Jun Ishikawa; Kazuya Ishiwata; Nobuhiro Hiramoto; Hideyuki Nakazawa; Keisuke Kataoka; Junya Kanda; Koji Nagafuji; Yasuji Kozai; Yoshiko Matsuhashi; Fumihiko Ishimaru; Sung-Won Kim; Takahiro Fukuda; Yoshinobu Kanda; Yoshiko Atsuta; Eisei Kondo; Shinichi Kako

  Bone marrow transplantation, 25 Sep. 2024

  
• The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patients.

  Yutaka Shimazu; Junya Kanda; Teruhito Takakuwa; Yoshiyuki Onda; Kentaro Fukushima; Masaaki Hotta; Shin-Ichi Fuchida; Nobuhiko Uoshima; Yuji Shimura; Hirokazu Tanaka; Kensuke Ohta; Hirohiko Shibayama; Satoru Kosugi; Hideo Yagi; Satoshi Yoshihara; Naoki Hosen; Tomoki Ito; Chihiro Shimazaki; Itaru Matsumura; Junya Kuroda; Akifumi Takaori-Kondo; Masayuki Hino

  Annals of hematology, 21 Aug. 2024

  
• Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome

  Naokazu Nakamura; Nao Yamamoto; Tadakazu Kondo; Mayumi Matsumoto; Ryo Ikunari; Tomomi Sakai; Yasuhiro Tanaka; Hiroko Tsunemine; June Takeda; Junya Kanda; Yasuhito Nannya; Seishi Ogawa; Akifumi Takaori-Kondo; Nobuyoshi Arima

  International Journal of Hematology, 25 Mar. 2024

  
• Impact of cytogenetic abnormalities in symptomatic multiple myeloma; a Japanese real-world analysis from Kansai Myeloma Forum.

  Aya Nakaya; Hirohiko Shibayama; Nobuhiko Uoshima; Ryosuke Yamamura; Satoshi Yoshioka; Kazunori Imada; Yuji Shimura; Masaaki Hotta; Toshimitsu Matsui; Satoru Kosugi; Hitoshi Hanamoto; Hitoji Uchiyama; Satoshi Yoshihara; Shin-Ichi Fuchida; Yoshiyuki Onda; Yasuhiro Tanaka; Kensuke Ohta; Mitsuhiro Matsuda; Junya Kanda; Adachi Yoko; Miki Kiyota; Eri Kawata; Ryoichi Takahashi; Kentaro Fukushima; Hirokazu Tanaka; Hideo Yagi; Teruhito Takakuwa; Naoki Hosen; Tomoki Ito; Chihiro Shimazaki; Akifumi Takaori-Kondo; Junya Kuroda; Itaru Matsumura; Masayuki Hino

  Leukemia research reports, 2023

  
• Associations between acute and chronic graft-versus-host disease.

  Masaharu Tamaki; Yu Akahoshi; Yoshihiro Inamoto; Kaoru Morita; Naoyuki Uchida; Noriko Doki; Masatsugu Tanaka; Tetsuya Nishida; Hiroyuki Ohigashi; Hirohisa Nakamae; Makoto Onizuka; Yuta Katayama; Ken-Ichi Matsuoka; Masashi Sawa; Fumihiko Ishimaru; Yoshinobu Kanda; Takahiro Fukuda; Yoshiko Atsuta; Seitaro Terakura; Junya Kanda

  Blood advances, 27 Aug. 2024

  
• Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period.

  Takaaki Konuma; Kotaro Miyao; Hideki Nakasone; Fumihiko Ouchi; Takahiro Fukuda; Masatsugu Tanaka; Yukiyasu Ozawa; Shuichi Ota; Toshiro Kawakita; Naoyuki Uchida; Masashi Sawa; Yuta Katayama; Nobuhiro Hiramoto; Tetsuya Eto; Tatsuo Ichinohe; Yoshiko Atsuta; Junya Kanda

  Cytotherapy, Aug. 2024

  
• Superiority of BM over PBSC for recipients with pre-transplant lung dysfunction in HLA-matched allogeneic HCT.

  Shunto Kawamura; Masaharu Tamaki; Takaaki Konuma; Makoto Onizuka; Emiko Sakaida; Hiromi Hayashi; Noriko Doki; Tetsuya Nishida; Masashi Sawa; Hiroyuki Ohigashi; Takahiro Fukuda; Jun Ishikawa; Ken-Ichi Matsuoka; Toshiro Kawakita; Masatsugu Tanaka; Fumihiko Ishimaru; Tatsuo Ichinohe; Yoshiko Atsuta; Yoshinobu Kanda; Kimikazu Yakushijin; Junya Kanda; Hideki Nakasone

  Cytotherapy, 12 Jun. 2024

  
• Impact of Different Fludarabine Doses in the Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow Transplantation.

  Kodai Kuriyama; Shigeo Fuji; Ayumu Ito; Noriko Doki; Yuta Katayama; Hiroyuki Ohigashi; Tetsuya Nishida; Kentaro Serizawa; Tetsuya Eto; Naoyuki Uchida; Yoshinobu Kanda; Masatsugu Tanaka; Ken-Ichi Matsuoka; Hideyuki Nakazawa; Junya Kanda; Takahiro Fukuda; Yoshiko Atsuta; Masao Ogata

  Transplantation and cellular therapy, May 2024

  
• 臍帯血移植とfemale-to-male骨髄移植における予後の比較検討

  玉置 雅治; 赤星 佑; 岡田 陽介; 内田 直之; 田中 正嗣; 土岐 典子; 澤 正史; 丸山 ゆみ子; 上田 恭典; 宮腰 重三郎; 片山 雄太; 河北 敏郎; 木村 貴文; 鬼塚 真仁; 福田 隆浩; 熱田 良子; 柳沢 龍; 薬師神 公和; 諫田 淳也; 仲宗根 秀樹

  日本血液学会学術集会, Oct. 2023

  
• 移植前肝臓合併症患者における同種移植の予後と合併症

  三崎 柚季子; 玉置 雅治; 柳沢 龍; 土岐 典子; 福田 隆浩; 内田 直之; 田中 正嗣; 小澤 幸泰; 澤 正史; 荒 隆英; 諫田 淳也; 熱田 由子; 神田 善伸; 仲宗根 秀樹

  日本血液学会学術集会, Oct. 2023

  
• Impact of conditioning intensity and regimen on transplant outcomes in patients with adult T-cell leukemia-lymphoma

  Yoshitaka Inoue; Nobuaki Nakano; Shigeo Fuji; Tetsuya Eto; Toshiro Kawakita; Youko Suehiro; Toshihiro Miyamoto; Yasushi Sawayama; Naoyuki Uchida; Tadakazu Kondo; Junya Kanda; Yoshiko Atsuta; Takahiro Fukuda; Makoto Yoshimitsu; Koji Kato; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation

  Bone Marrow Transplantation, 2021

  
• Trends in allogeneic hematopoietic cell transplantation survival using population-based descriptive epidemiology method: analysis of national transplant registry data.

  Yachiyo Kuwatsuka; Hidemi Ito; Ken Tabuchi; Takaaki Konuma; Naoyuki Uchida; Yoshihiro Inamoto; Kazuki Inai; Tetsuya Nishida; Kazuhiro Ikegame; Tetsuya Eto; Yuta Katayama; Keisuke Kataoka; Masatsugu Tanaka; Satoshi Takahashi; Takahiro Fukuda; Tatsuo Ichinohe; Fumihiko Kimura; Junya Kanda; Yoshiko Atsuta; Keitaro Matsuo

  Bone marrow transplantation, 19 Jun. 2024

  
• 維持透析中の多発性骨髄腫患者に対する,キメラ抗原受容体T細胞(CAR-T)用リンパ球採取の経験

  河原 宏紀; 佐野 瞳; 城 友泰; 水本 智咲; 新井 康之; 諫田 淳也; 山下 浩平; 高折 晃史; 松原 雄; 柳田 素子

  日本輸血細胞治療学会誌, Feb. 2024

  
• Individual HLAs affect survival after allogeneic stem cell transplantation in adult T-cell leukaemia/lymphoma.

  Satoko Morishima; Makoto Yoshimitsu; Takero Shindo; Atae Utsunomiya; Takashi Ishida; Ayumu Ito; Nobuaki Nakano; Toshiro Kawakita; Tetsuya Eto; Youko Suehiro; Hidehiro Itonaga; Yasuo Mori; Yasuhiko Miyazaki; Junya Kanda; Naoyuki Uchida; Yasushi Sawayama; Shouhei Tomori; Tatsuo Ichinohe; Yoshiko Atsuta; Takahiro Fukuda; Koji Kato

  HLA, Jun. 2024

  
• 造血器疾患患者で同定される生殖細胞系列変異の取り扱いにおける課題

  渡邊 瑞希; 岡 知美; 諫田 淳也; 岩崎 惇; 竹田 淳恵; 岡 智子; 野吾 和宏; 山崎 寛章; 三好 隆史; 平田 大二; 前迫 善智; 浅越 康助; 菱澤 方勝; 北野 俊行; 田中 康博; 渡邊 光正; 辻 將公; 中坊 幸晴; 今田 和典; 伊藤 満; 川端 浩; 川崎 秀徳; 越智 陽太郎; 南谷 泰仁; 小川 誠司; 高折 晃史

  日本血液学会学術集会, Oct. 2023

  
• Center effect on allogeneic hematopoietic stem cell transplantation outcomes for B-cell acute lymphoblastic leukemia.

  Shuhei Kurosawa; Takahiro Fukuda; Tatsuo Ichinohe; Yoshiko Hashii; Junya Kanda; Hideki Goto; Koji Kato; Makoto Yoshimitsu; Fumihiko Ishimaru; Atsushi Sato; Makoto Onizuka; Keitaro Matsuo; Yuri Ito; Atsumi Yanagisawa; Marie Ohbiki; Ken Tabuch; Yoshiko Atsuta; Yasuyuki Arai

  Cytotherapy, 09 May 2024

  
• Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy

  Naokazu Nakamura; Tomoyasu Jo; Yasuyuki Arai; Toshio Kitawaki; Momoko Nishikori; Chisaki Mizumoto; Junya Kanda; Kouhei Yamashita; Miki Nagao; Akifumi Takaori-Kondo

  Clinical and Experimental Medicine, 21 May 2024

  
• HLA haploidentical stem cell transplantation from HLA homozygous donors to HLA heterozygous donors may have lower survival rates than haploidentical transplantation from HLA heterozygous donors to HLA heterozygous donors: a retrospective nationwide analysis.

  Keiko Fukunaga; Kazuhiro Ikegame; Hirohisa Nakamae; Noriko Doki; Takahiro Fukuda; Yukio Kondo; Takahide Ara; Tetsuya Eto; Yasuo Mori; Ken-Ichi Matsuoka; Yoshinobu Kanda; Makoto Onizuka; Yoshiko Atsuta; Tatsuo Ichinohe; Satoko Morishima; Junya Kanda

  International journal of hematology, Feb. 2024

  
• Impact of GVHD on lymphoma progression: Nationwide study from Japanese Society for Transplantation and Cellular Therapy.

  Mizuki Watanabe; Junya Kanda; Takahiro Fukuda; Naoyuki Uchida; Kazuhiro Ikegame; Keisuke Kataoka; Hikaru Kobayashi; Takahide Ara; Jun Ishikawa; Ken-Ichi Matsuoka; Yasuhiro Sugio; Hideyuki Nakazawa; Takashi Ikeda; Yoshiko Atsuta; Eisei Kondo; Ritsuro Suzuki

  British journal of haematology, Nov. 2023

  
• Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national survey.

  Nobuaki Nakano; Hideki Nakasone; Shigeo Fuji; Akihito Shinohara; Ritsuro Suzuki; Atae Utsunomiya; Tetsuya Eto; Satoko Morishima; Kazuhiro Ikegame; Yasutaka Kakinoki; Ken-Ichi Matsuoka; Yasuo Mori; Youko Suehiro; Naoyuki Uchida; Ayumu Ito; Noriko Doki; Yukiyasu Ozawa; Junya Kanda; Yoshinobu Kanda; Takahiro Fukuda; Yoshiko Atsuta; Masao Ogata

  The Lancet regional health. Western Pacific, Nov. 2023

  
• The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.

  Yutaka Shimazu; Junya Kanda; Yoshiyuki Onda; Shin-Ichi Fuchida; Kensuke Ohta; Yuji Shimura; Satoru Kosugi; Ryosuke Yamamura; Mitsuhiro Matsuda; Hitoshi Hanamoto; Yoko Adachi; Naoyuki Anzai; Masaaki Hotta; Kentaro Fukushima; Hideo Yagi; Satoshi Yoshihara; Yasuhiro Tanaka; Teruhito Takakuwa; Hirokazu Tanaka; Hirohiko Shibayama; Nobuhiko Uoshima; Naoki Hosen; Tomoki Ito; Chihiro Shimazaki; Itaru Matsumura; Junya Kuroda; Akifumi Takaori-Kondo; Masayuki Hino

  Cancer immunology, immunotherapy : CII, 17 May 2024

  
• The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation.

  Yutaka Shimazu; Junya Kanda; Kazuhito Suzuki; Akinori Wada; Taku Kikuchi; Takashi Ikeda; Nobuhiro Tsukada; Akiyoshi Miwa; Mitsuhiro Itagaki; Shinichi Kako; Kaichi Nishiwaki; Shuichi Ota; Shin-Ichiro Fujiwara; Keisuke Kataoka; Noriko Doki; Masashi Sawa; Nobuhiro Hiramoto; Akinori Nishikawa; Toshi Imai; Tatsuo Ichinohe; Yoshinobu Kanda; Yoshiko Atsuta; Koji Kawamura

  Cancer science, 16 May 2024

  
• Bortezomib-cyclophosphamide-dexamethasone induction/consolidation and bortezomib maintenance for transplant-eligible newly diagnosed multiple myeloma: phase 2 multicenter trial

  Hiroyuki Muranushi; Junya Kanda; Masayuki Kobayashi; Takeshi Maeda; Toshiyuki Kitano; Masaaki Tsuji; Yasunori Ueda; Takayuki Ishikawa; Masaharu Nohgawa; Mitsumasa Watanabe; Kazunori Imada; Toshinori Moriguchi; Mitsuru Itoh; Hitoshi Ohno; Akihito Yonezawa; Hirokazu Hirata; Nobuyoshi Arima; Kohsuke Asagoe; Naoyuki Anzai; Kayoko Nagata; Shinji Yasuno; Yoshihiro Kuwabara; Hiromi Kitao; Ihhwa Kim; Kiyomi Kawagishi; Kenji Ueshima; Shinjiro Tominari; Takeo Nakayama; Kouhei Yamashita; Akifumi Takaori-Kondo

  Hematology, 13 Feb. 2022

  Access this paper :

  
• SRSF2変異はAML患者においてFLT3-ITDと排他的であり、生存に寄与するユニークなインパクトをもつ

  岩切 美歌; 永田 安伸; 盛 佳旦; 丸毛 淳史; 阪口 正洋; 荒井 邦仁; 北野 智章; 脇田 知志; 黒田 純也; 永尾 侑平; 田所 治朗; 内山 人二; 木村 晋也; 本村 小百合; 佐藤 恵理子; 緒方 正男; 三橋 健次郎; 安藤 純; 諫田 淳也; 河田 英里; 土岐 典子; 森 慎一郎; 魚嶋 伸彦; 賀古 真一; 鐘野 勝洋; 佐竹 敦志; 神田 善伸; 山口 博樹

  日本血液学会学術集会, Oct. 2023

  
• 急性骨髄性白血病を対象としたミトコンドリアコピー数解析

  下平 統英; 小島 祐依; 脇田 知志; 丸毛 淳史; 森田 薫; 賀古 真一; 土岐 典子; 諫田 淳也; 黒田 純也; 森 慎一郎; 佐竹 敦志; 臼杵 憲祐; 植木 俊充; 魚嶋 伸彦; 河田 英里; 中山 一隆; 永尾 侑平; 鐘野 勝洋; 澁澤 基治; 木村 晋也; 一戸 辰夫; 本村 小百合; 橋本 朗子; 佐藤 恵理子; 緒方 正男; 安藤 純; 田代 晴子; 阪口 正洋; 神田 善伸; 山口 博樹

  日本血液学会学術集会, Oct. 2023

  
• ミトコンドリアコピー数はNPM1/FLT3変異陽性急性骨髄性白血病の予後を層別化する

  小島 祐依; 下平 統英; 脇田 知志; 丸毛 淳史; 森田 薫; 賀古 真一; 土岐 典子; 諫田 淳也; 黒田 純也; 森 慎一郎; 佐竹 敦志; 臼杵 憲祐; 植木 俊充; 魚嶋 伸彦; 河田 英里; 中山 一隆; 永尾 侑平; 鐘野 勝洋; 澁澤 基治; 木村 晋也; 一戸 辰夫; 本村 小百合; 橋本 朗子; 佐藤 恵理子; 緒方 正男; 安藤 純; 田代 晴子; 阪口 正洋; 神田 善伸; 山口 博樹

  日本血液学会学術集会, Oct. 2023

  
• KMT2A遺伝子の異常を伴う急性骨髄性白血病(AML)患者の臨床的特徴と予後への影響

  土蔵 太一朗; 脇田 知志; 丸毛 淳史; 森田 薫; 賀古 真一; 土岐 典子; 諫田 淳也; 黒田 純也; 森 慎一郎; 佐竹 敦志; 臼杵 憲祐; 植木 俊充; 魚嶋 伸彦; 河田 英里; 中山 一隆; 永尾 侑平; 鐘野 勝洋; 澁澤 基治; 木村 晋也; 一戸 辰夫; 本村 小百合; 橋本 朗子; 佐藤 恵理子; 緒方 正男; 安藤 純; 田代 晴子; 阪口 正洋; 神田 善伸; 山口 博樹

  日本血液学会学術集会, Oct. 2023

  
• ベネトクラクス奏効患者の特徴

  Sheng Jiadan; 永田 安伸; 丸毛 淳史; 阪口 正洋; 荒井 邦仁; 宮田 美保; 脇田 知志; 土岐 典子; 橋本 朗子; 木村 晋也; 緒方 正男; 魚嶋 伸彦; 三橋 健次郎; 安藤 純; 萩原 政夫; 佐藤 恵理子; 永尾 侑平; 諫田 淳也; 賀古 真一; 関口 康宣; 福永 景子; 枝廣 太郎; 田代 晴子; 佐竹 敦志; 内山 人二; 高田 覚; 西山 大地; 鐘野 勝洋; 神田 善伸; 山口 博樹

  日本血液学会学術集会, Oct. 2023

  
• AML with unsuccessful cytogenetics and unclassified cytogeneticsの予後

  下山 達; 脇田 知志; 丸毛 淳史; 森田 薫; 賀古 真一; 土岐 典子; 諫田 淳也; 黒田 純也; 森 慎一郎; 佐竹 敦志; 臼杵 憲祐; 植木 俊充; 魚嶋 伸彦; 河田 英里; 中山 一隆; 永尾 侑平; 鐘野 勝洋; 澁澤 基治; 木村 晋也; 一戸 辰夫; 本村 小百合; 橋本 朗子; 佐藤 恵理子; 緒方 正男; 安藤 純; 田代 晴子; 阪口 正洋; 神田 善伸; 山口 博樹

  日本血液学会学術集会, Oct. 2023

  
• Pre-transplant phase angle as a potential marker for predicting the development of infection after allogeneic hematopoietic stem cell transplantation

  Ryota Hamada; Masanobu Murao; Tsugumi Asano; Junsuke Miyasaka; Michiko Matsushita; Taishi Kajimoto; Ayumi Otagaki; Manabu Nankaku; Ami Kobayashi; Tadakazu Kondo; Yasuyuki Arai; Junya Kanda; Akifumi Takaori-Kondo; Ryosuke Ikeguchi; Shuichi Matsuda

  Clinical Nutrition ESPEN, Sep. 2023, Peer-reviewed

  
• Impact of Early Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation on Relapse in Patients with Myelodysplastic Syndrome: A Nationwide Retrospective Study from Adult Myelodysplastic Syndrome Working Group of the JSTCT.

  Tatsuya Konishi; Kensuke Matsuda; Hidehiro Itonaga; Noriko Doki; Tetsuya Nishida; Ken-Ichi Matsuoka; Takashi Ikeda; Yoshinobu Kanda; Takahiro Fukuda; Junya Kanda; Hirohisa Nakamae; Kazunori Imada; Yasunori Ueda; Tatsuo Ichinohe; Yoshiko Atsuta; Ken Ishiyama

  Transplantation and cellular therapy, 30 Apr. 2024

  
• Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registry.

  Tomoya Maeda; Akira Matsuda; Junya Kanda; Hiroshi Kawabata; Takayuki Ishikawa; Kaoru Tohyama; Akira Kitanaka; Kayano Araseki; Kei Shimbo; Tomoko Hata; Takahiro Suzuki; Hidekazu Kayano; Kensuke Usuki; Maki Shindo-Ueda; Nobuyoshi Arima; Masaharu Nohgawa; Akiko Ohta; Shigeru Chiba; Yasushi Miyazaki; Shinji Nakao; Keiya Ozawa; Shunya Arai; Mineo Kurokawa; Akifumi Takaori-Kondo; Kinuko Mitani

  British journal of haematology, 31 Jan. 2024

  
• 腎機能が低下した患者におけるベネクレクスタ・アザシチジン併用療法の臨床成績

  仲 亮祐; 近藤 忠一; 西久保 雅司; 村主 啓行; 上田 恭典; 岡 知美; 和田 典也; 諫田 淳也; 山本 昌平; 渡邊 光正; 岡田 慎理; 今田 和典; 中坊 幸晴; 水谷 優; 南谷 泰仁; 小川 誠司; 石川 隆之

  日本血液学会学術集会, Oct. 2023

  
• Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study.

  Naokazu Nakamura; Nobuyoshi Arima; Teruhito Takakuwa; Satoshi Yoshioka; Kazunori Imada; Kentaro Fukushima; Masaaki Hotta; Shin-Ichi Fuchida; Junya Kanda; Nobuhiko Uoshima; Yuji Shimura; Hirokazu Tanaka; Kensuke Ohta; Satoru Kosugi; Hideo Yagi; Satoshi Yoshihara; Ryosuke Yamamura; Yoko Adachi; Hitoshi Hanamoto; Hirohiko Shibayama; Naoki Hosen; Tomoki Ito; Chihiro Shimazaki; Akifumi Takaori-Kondo; Junya Kuroda; Itaru Matsumura; Masayuki Hino

  Annals of hematology, 16 Mar. 2024

  
• 抗CMV早期治療と慢性GVHD発症の関連

  宮尾 康太郎; 村田 誠; 西田 徹也; 小澤 幸泰; 内田 直之; 福田 隆浩; 土岐 典子; 衛藤 徹也; 河北 敏郎; 石丸 文彦; 熱田 由子; 諫田 淳也; 寺倉 精太郎

  日本血液学会学術集会, Oct. 2023

  
• Conserved Extended Haplotype(CEH)を有するHLAホモ接合ドナーからの非血縁さい帯血移植における移植免疫反応

  森島 泰雄; 森島 聡子; 村田 誠; 有馬 靖佳; 内田 直之; 熱田 由子; 一戸 辰夫; 加藤 俊一; 諌田 淳也

  MHC: Major Histocompatibility Complex, Sep. 2019

  
• 臍帯血移植前の血液がん患者の認知機能の特徴

  馬場 千夏; 山脇 理恵; 濱田 涼太; 新井 康之; 諫田 淳也; 池口 良輔; 松田 秀一; 村井 俊哉

  高次脳機能研究, Mar. 2023

  
• Outcomes of cessation of the administration of nucleos(t)ide analogues on HBV reactivation after allogeneic hematopoietic stem cell transplantation: A nationwide retrospective study.

  Masahiro Onozawa; Shigeru Kusumoto; Yuho Najima; Hiroya Hashimoto; Kohei Okada; Masaharu Tamaki; Masatsugu Tanaka; Takayuki Sato; Tsutomu Takahashi; Kaoru Hatano; Koichi Onodera; Yukiyoshi Moriuchi; Kimikazu Yakushijin; Junya Kanda; Koji Nagafuji; Masao Ogata; Nobuaki Nakano; Akihiro Tamori; Masashi Mizokami

  Transplantation and cellular therapy, 17 Jan. 2024

  
• Comparative Analysis of Allogeneic Bone Marrow Transplantation Outcomes Between Japanese and Non-Japanese Populations.

  Ryu Yanagisawa; Michiho Shindo; Akihito Shinohara; Yachiyo Kuwatsuka; Koichi Nakase; Fumihiko Kimura; Naoki Shingai; Tetsuya Nishida; Takahiro Fukuda; Masatoshi Sakurai; Mineo Kurokawa; Takashi Koike; Shuichi Ota; Satoru Takada; Makoto Onizuka; Naoyuki Uchida; Masatsugu Tanaka; Maiko Noguchi; Yumiko Maruyama; Maki Hagihara; Tatsuo Ichinohe; Yoshiko Atsuta; Junya Kanda; Hideki Nakasone; Tomomi Toubai

  Transplantation proceedings, 08 Feb. 2024

  
• Clinical impact of CRS on prolonged hematotoxicity after CAR-T cell therapy: KyoTox a-score, a novel prediction model.

  Naokazu Nakamura; Tomoyasu Jo; Yasuyuki Arai; Toshio Kitawaki; Momoko Nishikori; Chisaki Mizumoto; Junya Kanda; Kouhei Yamashita; Miki Nagao; Akifumi Takaori-Kondo

  Transplantation and cellular therapy, 26 Jan. 2024

  
• Comparison of melphalan dose in patients with myelodysplastic syndrome undergoing allogeneic transplantation with reduced-intensity conditioning.

  Shuhei Kurosawa; Yoshimitsu Shimomura; Hidehiro Itonaga; Yuta Katayama; Makoto Onizuka; Masatsugu Tanaka; Hikaru Kobayashi; Yukiyasu Ozawa; Masashi Sawa; Junya Kanda; Noriko Doki; Shin Fujisawa; Naoyuki Uchida; Takahiro Fukuda; Yoshiko Atsuta; Ken Ishiyama

  Transplantation and cellular therapy, 06 Feb. 2024

  
• The effect of center experience on allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia.

  Masamitsu Yanada; Shingo Yano; Yachiyo Kuwatsuka; Koji Kawamura; Takahiro Fukuda; Tatsuo Ichinohe; Yoshiko Hashii; Hideki Goto; Koji Kato; Fumihiko Ishimaru; Atsushi Sato; Makoto Onizuka; Keitaro Matsuo; Yuri Ito; Atsumi Yanagisawa; Marie Ohbiki; Ken Tabuchi; Yoshiko Atsuta; Junya Kanda; Takaaki Konuma

  Bone marrow transplantation, 06 Feb. 2024

  
• 臍帯血移植とfemale-to-male骨髄移植における予後の比較検討

  玉置 雅治; 赤星 佑; 岡田 陽介; 内田 直之; 田中 正嗣; 土岐 典子; 澤 正史; 丸山 ゆみ子; 上田 恭典; 宮腰 重三郎; 片山 雄太; 河北 敏郎; 木村 貴文; 鬼塚 真仁; 福田 隆浩; 熱田 良子; 柳沢 龍; 薬師神 公和; 諫田 淳也; 仲宗根 秀樹

  日本血液学会学術集会, Oct. 2022

  
• 高齢者移植における至適な前処置強度選択のためのスコアリングシステム

  赤星 佑; 多田 雄真; 堺田 惠美子; 楠田 待子; 土岐 典子; 内田 直之; 福田 隆浩; 田中 正嗣; 澤 正史; 片山 雄太; 松岡 賢市; 小澤 幸泰; 鬼塚 真仁; 諫田 淳也; 神田 善伸; 熱田 由子; 仲宗根 秀樹

  日本血液学会学術集会, Oct. 2022

  
• Development of an umbilical cord blood transplantation-specific non-relapse mortality risk assessment score.

  Yosuke Okada; Yoshiaki Usui; Hiromi Hayashi; Masashi Nishikubo; Tomomi Toubai; Naoyuki Uchida; Masatsugu Tanaka; Makoto Onizuka; Satoshi Takahashi; Noriko Doki; Yasufumi Uehara; Yumiko Maruyama; Kazuya Ishiwata; Toshiro Kawakita; Masashi Sawa; Tetsuya Eto; Fumihiko Ishimaru; Koji Kato; Takahiro Fukuda; Yoshiko Atsuta; Junya Kanda; Kimikazu Yakushijin; Hideki Nakasone

  Blood advances, 01 Jan. 2024

  
• Association of individual comorbidities with outcomes in allogeneic hematopoietic cell transplantation from unrelated adult donors versus unrelated cord blood: A study on behalf of the Donor/Source and Transplant Complications Working Groups of the Japanese Society for Transplantation and Cellular Therapy.

  Takaaki Konuma; Kaito Harada; Akihito Shinohara; Naoyuki Uchida; Naoki Shingai; Ayumu Ito; Yukiyasu Ozawa; Masatsugu Tanaka; Masashi Sawa; Makoto Onizuka; Yuta Katayama; Nobuhiro Hiramoto; Nobuaki Nakano; Takafumi Kimura; Yoshinobu Kanda; Takahiro Fukuda; Yoshiko Atsuta; Hideki Nakasone; Junya Kanda

  American journal of hematology, Feb. 2024

  
• Scoring system for optimal cord blood unit selection for single cord blood transplantation.

  Mizuki Watanabe; Takaaki Konuma; Nobuhiko Imahashi; Seitaro Terakura; Sachiko Seo; Satoko Morishima; Naoyuki Uchida; Noriko Doki; Masatsugu Tanaka; Tetsuya Nishida; Toshiro Kawakita; Tetsuya Eto; Satoshi Takahashi; Masashi Sawa; Yasufumi Uehara; Sung-Won Kim; Fumihiko Ishimaru; Tatsuo Ichinohe; Takahiro Fukuda; Yoshiko Atsuta; Junya Kanda

  Cytotherapy, 27 Dec. 2023

  
• Effect of Conditioning Regimens and Graft-versus-Host Disease Prophylaxis on the Outcomes of Umbilical Cord Blood Transplantation Performed with Cyclophosphamide/Total Body Irradiation-Based Regimens.

  Nobuhiko Imahashi; Naoki Kurita; Takaaki Konuma; Satoshi Takahashi; Tetsuya Nishida; Masatsugu Tanaka; Hirohisa Nakamae; Toshiro Kawakita; Shuichi Ota; Noriko Doki; Yasushi Onishi; Masashi Sawa; Kazutaka Ozeki; Nobuhiro Hiramoto; Makoto Onizuka; Fumihiko Ishimaru; Tatsuo Ichinohe; Yoshiko Atsuta; Junya Kanda

  Transplantation and cellular therapy, 09 Dec. 2023

  
• Impact of center volume on chronic graft versus host disease in patients with allogeneic stem cell transplantation.

  Yoshimitsu Shimomura; Tetsuhisa Kitamura; Makoto Murata; Keitaro Matsuo; Yuri Ito; Tatsuo Ichinohe; Yoshiko Hashii; Hideki Goto; Koji Kato; Fumihiko Ishimaru; Atsushi Sato; Makoto Onizuka; Atsumi Yanagisawa; Marie Ohbiki; Ken Tabuchi; Yoshiko Atsuta; Takahiro Fukuda; Junya Kanda; Seitaro Terakura

  Transplantation and cellular therapy, 11 Jan. 2024

  
• KyoTox-e score; prediction of post-CAR-T prolonged thrombocytopenia using peripheral blood data before apheresis

  Tomoyasu Jo; Yasuyuki Arai; Toshio Kitawaki; Naokazu Nakamura; Momoko Nishikori; Chisaki Mizumoto; Junya Kanda; Kouhei Yamashita; Miki Nagao; Akifumi Takaori-Kondo

  Bone Marrow Transplantation, 19 Dec. 2023

  
• Risk analysis of fluctuating hypercalcemia after leukapheresis in cellular therapy

  Tomoyasu Jo; Yasuyuki Arai; Toshio Kitawaki; Momoko Nishikori; Chisaki Mizumoto; Junya Kanda; Kouhei Yamashita; Miki Nagao; Akifumi Takaori-Kondo

  Scientific Reports, 11 Sep. 2023

  Access this paper :

  
• Impact of stem cell selection between bone marrow and peripheral blood stem cells for unrelated hematopoietic stem cell transplantation for hematologic malignancies: on behalf of the Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy.

  Hiromi Hayashi; Makoto Iwasaki; Hideki Nakasone; Reo Tanoshima; Masashi Shimabukuro; Wataru Takeda; Tetsuya Nishida; Shinichi Kako; Shin-Ichiro Fujiwara; Yuta Katayama; Masashi Sawa; Kentaro Serizawa; Ken-Ichi Matsuoka; Naoyuki Uchida; Takashi Ikeda; Hiroyuki Ohigashi; Kentaro Fukushima; Moeko Hino; Yoshinobu Kanda; Takahiro Fukuda; Yoshiko Atsuta; Junya Kanda

  Cytotherapy, 16 Dec. 2023

  
• Hematopoietic stem cell transplantation from haploidentical offspring donors using post-transplant cyclophosphamide versus human leukocyte antigen-matched siblings in older patients with myelodysplastic syndrome.

  Yoshimitsu Shimomura; Tetsuhisa Kitamura; Takaaki Konuma; Yosuke Nakaya; Noriko Doki; Masashi Sawa; Hirohisa Nakamae; Tetsuya Eto; Tetsuya Nishida; Hiroyuki Ohigashi; Shuichi Ota; Makoto Onizuka; Nobuhiro Hiramoto; Toshiro Kawakita; Junya Kanda; Tatsuo Ichinohe; Yoshiko Atsuta; Hidehiro Itonaga

  American journal of hematology, 15 Nov. 2023

  
• Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL.

  Kazuaki Kameda; Shinichi Kako; Sung-Won Kim; Yoshiaki Usui; Koji Kato; Takahiro Fukuda; Naoyuki Uchida; Hikaru Kobayashi; Toshio Wakayama; Emiko Sakaida; Shingo Yano; Kazunori Imada; Miho Nara; Takashi Ikeda; Shin-Ichi Fuchida; Jun Ishikawa; Hiroyuki Sugahara; Junya Kanda; Takafumi Kimura; Tatsuo Ichinohe; Yoshiko Atsuta; Eisei Kondo

  Leukemia, May 2022

  
• The prognosis and risk factors for patients with complex karyotype myelodysplastic syndrome undergoing allogeneic haematopoietic stem cell transplantation.

  Yoshimitsu Shimomura; Sho Komukai; Tetsuhisa Kitamura; Takayoshi Tachibana; Shuhei Kurosawa; Hidehiro Itonaga; Shokichi Tsukamoto; Noriko Doki; Yuta Katayama; Ayumu Ito; Masashi Sawa; Yasunori Ueda; Hirohisa Nakamae; Yuichiro Nawa; Masatsugu Tanaka; Yasuyuki Arai; Shuichi Ota; Keisuke Kataoka; Tetsuya Nishida; Junya Kanda; Takahiro Fukuda; Yoshiko Atsuta; Ken Ishiyama

  British journal of haematology, 19 Oct. 2023, Peer-reviewed

  
• Effect of graft-versus-host disease on outcomes of HLA-haploidentical peripheral blood transplantation using post-transplant cyclophophamide.

  Yoshimitsu Shimomura; Sho Komukai; Tetsuhisa Kitamura; Tomotaka Sobue; Yu Akahoshi; Junya Kanda; Hiroyuki Ohigashi; Hirohisa Nakamae; Nobuhiro Hiramoto; Koji Nagafuji; Takashi Tanaka; Tetsuya Eto; Shuichi Ota; Yumiko Maruyama; Takashi Akasaka; Ken-Ichi Matsuoka; Yasuo Mori; Takahiro Fukuda; Yoshiko Atsuta; Seitaro Terakura

  Bone marrow transplantation, 28 Oct. 2023

  
• Impact of Antimicrobial Drug-Drug Interactions on Acute Kidney Injury after Allogeneic Hematopoietic Cell Transplantation

  Fumiya Wada; Yasuyuki Arai; Tomoyasu Jo; Chisaki Mizumoto; Junya Kanda; Toshio Kitawaki; Momoko Nishikori; Kouhei Yamashita; Akifumi Takaori-Kondo

  Transplantation and Cellular Therapy, Jul. 2023

  
• Comparison of haploidentical stem cell transplantation with post-transplant cyclophosphamide versus umbilical cord blood transplantation in adult patients with aplastic anemia.

  Yasushi Onishi; Takehiko Mori; Hirohito Yamazaki; Nobuhiro Hiramoto; Yoshitaka Zaimoku; Minoru Kanaya; Kosei Matsue; Makoto Onizuka; Nobuyuki Aotsuka; Naoyuki Uchida; Koichi Onodera; Junya Kanda; Hirohisa Nakamae; Ryusuke Yamamoto; Takuro Kuriyama; Takafumi Kimura; Tatsuo Ichinohe; Yoshiko Atsuta

  Transplantation and cellular therapy, 18 Sep. 2023

  
• Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum.

  Yuji Shimura; Hirohiko Shibayama; Aya Nakaya; Ryosuke Yamamura; Kazunori Imada; Hitomi Kaneko; Hitoshi Hanamoto; Shin-Ichi Fuchida; Hirokazu Tanaka; Satoru Kosugi; Miki Kiyota; Toshimitsu Matsui; Junya Kanda; Masato Iida; Mitsuhiro Matsuda; Nobuhiko Uoshima; Masaru Shibano; Takahiro Karasuno; Tsuneyoshi Hamada; Kensuke Ohta; Tomoki Ito; Hideo Yagi; Satoshi Yoshihara; Chihiro Shimazaki; Shosaku Nomura; Masayuki Hino; Akifumi Takaori-Kondo; Itaru Matsumura; Yuzuru Kanakura; Junya Kuroda

  International journal of hematology, 05 Sep. 2023

  
• Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics.

  Satoshi Yamasaki; Shohei Mizuno; Makoto Iwasaki; Sachiko Seo; Naoyuki Uchida; Miyakoshi Shigesaburo; Nobuaki Nakano; Kazuya Ishiwata; Yasufumi Uehara; Tetsuya Eto; Ken Takase; Toshiro Kawakita; Masatsugu Tanaka; Masashi Sawa; Yuta Katayama; Yuichiro Nawa; Onizuka Makoto; Tatsuo Ichinohe; Yoshiko Atsuta; Junya Kanda; Masamitsu Yanada

  Annals of hematology, Jun. 2023

  
• 成人急性骨髄性白血病に対する非血縁者間末梢血幹細胞移植と非血縁者間骨髄移植の比較(Peripheral-blood stem cells versus bone marrow from unrelated donors for adult AML patients)

  城 友泰; 新井 康之; 近藤 忠一; 水野 昌平; 平林 茂樹; 稲本 賢弘; 諫田 淳也; 土岐 典子; 福田 隆浩; 小澤 幸泰; 片山 雄太; 神田 善伸; 鬼塚 真仁; 一戸 辰夫; 熱田 由子; 柳田 正光

  日本血液学会学術集会, Sep. 2021

  
• Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma.

  Yosuke Okada; Fumihiko Kimura; Naoki Kurita; Hiroyuki Takahashi; Yutaka Shimazu; Shohei Mizuno; Naoyuki Uchida; Keisuke Kataoka; Nobuhiro Hiramoto; Shuichi Ota; Shinichi Kako; Nobuhiro Tsukada; Yoshinobu Kanda; Shingo Kurahashi; Noriko Doki; Akinori Nishikawa; Sung-Won Kim; Akira Hangaishi; Junya Kanda; Takahiro Fukuda; Yoshiko Atsuta; Eisei Kondo; Koji Kawamura; Hideki Nakasone

  Cytotherapy, 23 Jun. 2023

  
• Mild Acute Graft-Versus-Host Disease Improves Outcomes After HLA-Haploidentical-Related Donor Transplantation Using Posttransplant Cyclophosphamide and Cord Blood Transplantation.

  Fumiya Wada; Junya Kanda; Kimimori Kamijo; Masashi Nishikubo; Satoshi Yoshioka; Takayuki Ishikawa; Yasunori Ueda; Takashi Akasaka; Yasuyuki Arai; Kiyotaka Izumi; Hirokazu Hirata; Takashi Ikeda; Akihito Yonezawa; Naoyuki Anzai; Mitsumasa Watanabe; Kazunori Imada; Kazuhiro Yago; Naoki Tamura; Mitsuru Itoh; Yuki Masuo; Akane Kunitomi; Tomoharu Takeoka; Toshiyuki Kitano; Nobuyoshi Arima; Masakatsu Hishizawa; Kohsuke Asagoe; Tadakazu Kondo; Akifumi Takaori-Kondo

  Cell transplantation, 2023

  Access this paper :

  
• External validation and extended application of the transplant conditioning intensity score in acute myeloid leukemia.

  Masamitsu Yanada; Yoshimitsu Shimomura; Shohei Mizuno; Kensuke Matsuda; Tadakazu Kondo; Noriko Doki; Masatsugu Tanaka; Takahiro Fukuda; Takahide Ara; Naoyuki Uchida; Makoto Onizuka; Masashi Sawa; Yukiyasu Ozawa; Nobuhiro Hiramoto; Shuichi Ota; Junya Kanda; Yoshinobu Kanda; Tatsuo Ichinohe; Shinichiro Okamoto; Yoshiko Atsuta; Takaaki Konuma

  Bone marrow transplantation, 13 Jul. 2023

  
• Single-unit unrelated cord blood transplantation versus HLA-matched sibling transplantation in adults with advanced myelodysplastic syndrome: A registry-based study from the adult MDS working group of the Japanese society for transplantation and cellular therapy.

  Takaaki Konuma; Hidehiro Itonaga; Yoshimitsu Shimomura; Machiko Fujioka; Kazunari Aoki; Naoyuki Uchida; Makoto Onizuka; Atsushi Jinguji; Masatsugu Tanaka; Yasunori Ueda; Yuta Katayama; Masashi Sawa; Haruyuki Tanaka; Hirohisa Nakamae; Toshiro Kawakita; Yumiko Maruyama; Satoshi Takahashi; Fumihiko Ishimaru; Junya Kanda; Tatsuo Ichinohe; Yoshiko Atsuta

  Hematological oncology, 18 Aug. 2023

  
• Minimal important difference of the 6-minute walk test after allogenic hematopoietic stem cell transplantation.

  Masanobu Murao; Tadakazu Kondo; Ryota Hamada; Junsuke Miyasaka; Michiko Matsushita; Ayumi Otagaki; Taishi Kajimoto; Yasuyuki Arai; Junya Kanda; Manabu Nankaku; Ryosuke Ikeguchi; Akifumi Takaori-Kondo; Shuichi Matsuda

  Disability and rehabilitation, 13 Aug. 2023

  
• Impact of HLA disparity on overall mortality risk in patients with extensive chronic GVHD: The HLA Working Group of Japanese Society for Transplantation and Cellular Therapy.

  Shigeo Fuji; Akitoshi Hakoda; Junya Kanda; Takahiro Fukuda; Noriko Doki; Yuta Katayama; Naoyuki Uchida; Yukiyasu Ozawa; Yoshinobu Kanda; Masatsugu Tanaka; Keisuke Kataoka; Takahide Ara; Masashi Sawa; Makoto Onizuka; Yasushi Onishi; Takafumi Kimura; Tatsuo Ichinohe; Yoshiko Atsuta; Ayumi Shintani; Satoko Morishima

  Bone marrow transplantation, 07 Aug. 2023

  
• Epitope Mismatch at HLA-DRB1 Associates with Reduced Relapse Risk in Cord Blood Transplantation for Standard-Risk Hematologic Malignancy

  Mari Morita-Fujita; Takero Shindo; Tomoki Iemura; Yasuyuki Arai; Junya Kanda; Kazuya Okada; Yasunori Ueda; Onda Yoshiyuki; Naoyuki Anzai; Takuto Mori; Takayuki Ishikawa; Yasuyuki Otsuka; Akihito Yonezawa; Naoki Yuhi; Kazunori Imada; Akifumi Oba; Mitsuru Itoh; Yoshio Okamoto; Toshiyuki Kitano; Takashi Ikeda; Shinichi Kotani; Takashi Akasaka; Kazuhiro Yago; Mitsumasa Watanabe; Masaharu Nohgawa; Masaaki Tsuji; Tomoharu Takeoka; Ryusuke Yamamoto; Nobuyoshi Arima; Noriyoshi Yoshinaga; Masakatsu Hishizawa; Kouhei Yamashita; Tadakazu Kondo; Akifumi Takaori-Kondo

  Transplantation and Cellular Therapy, Jun. 2023

  
• Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome.

  Asami Kataoka; Chisaki Mizumoto; Junya Kanda; Makoto Iwasaki; Maki Sakurada; Tomomi Oka; Masakazu Fujimoto; Yosuke Yamamoto; Kohei Yamashita; Yasuhito Nannya; Seishi Ogawa; Akifumi Takaori-Kondo

  International journal of hematology, Jun. 2023

  Access this paper :

  
• An adult case of refractory autoimmune neutropenia after liver transplantation.

  Huye Sun; Fumiya Wada; Junya Kanda; Chisaki Mizumoto; Takashi Ito; Yuuki Masano; Yoichiro Uchida; Etsurou Hatano; Kimiko Yurugi; Rie Hishida; Kouhei Yamashita; Akifumi Takaori-Kondo

  International journal of hematology, 21 Feb. 2023

  
• 肝移植後に難治性自己免疫性好中球減少症を発症した成人の1例

  孫 胡曄; 和田 典也; 諫田 淳也; 水本 智咲; 山下 浩平; 高折 晃史; 伊藤 孝司; 政野 裕紀; 内田 洋一朗; 波多野 悦朗; 万木 紀美子; 菱田 理恵

  臨床血液, Feb. 2023

  
• Venetoclax and azacitidine therapy in acute myeloid leukemia patients with severe renal impairment.

  Ryosuke Naka; Tadakazu Kondo; Masashi Nishikubo; Hiroyuki Muranushi; Yasunori Ueda; Tomomi Oka; Fumiya Wada; Junya Kanda; Shohei Yamamoto; Mitsumasa Watanabe; Shinri Okada; Kazunori Imada; Yukiharu Nakabo; Yu Mizutani; Yasuhito Nannya; Seishi Ogawa; Takayuki Ishikawa

  American journal of hematology, 28 Jun. 2023

  
• Unrelated female-to-male bone marrow transplantation would be preferred over cord blood transplantation in male patients.

  Masaharu Tamaki; Yu Akahoshi; Yosuke Okada; Naoyuki Uchida; Masatsugu Tanaka; Noriko Doki; Masashi Sawa; Yumiko Maruyama; Yasunori Ueda; Shigesaburo Miyakoshi; Yuta Katayama; Toshiro Kawakita; Takafumi Kimura; Makoto Onizuka; Takahiro Fukuda; Yoshiko Atsuta; Ryu Yanagisawa; Kimikazu Yakushijin; Junya Kanda; Hideki Nakasone

  Cytotherapy, 20 Jun. 2023

  
• A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

  Tomoyasu Jo; Yasuyuki Arai; Junya Kanda; Tadakazu Kondo; Kazuhiro Ikegame; Naoyuki Uchida; Noriko Doki; Takahiro Fukuda; Yukiyasu Ozawa; Masatsugu Tanaka; Takahide Ara; Takuro Kuriyama; Yuta Katayama; Toshiro Kawakita; Yoshinobu Kanda; Makoto Onizuka; Tatsuo Ichinohe; Yoshiko Atsuta; Seitaro Terakura

  Communications Medicine, 16 May 2023

  Access this paper :

  
• Identification of an asymptomatic Shwachman-Bodian-Diamond syndrome mutation in a patient with acute myeloid leukemia.

  Sho Shibata; Shojiro Inano; Mizuki Watanabe; Kensuke Fujiwara; Hiroo Ueno; Yasuhito Nannya; Junya Kanda; Naoto Kawasaki; Yoshio Okamoto; Yoko Takiuchi; Akiko Fukunaga; Sumie Tabata; Seishi Ogawa; Akifumi Takaori-Kondo; Toshiyuki Kitano

  International journal of hematology, Mar. 2022

  
• Successful treatment with cyclosporine of pure red cell aplasia induced by obinutuzumab bendamustine therapy.

  Yutaka Shimazu; Chisaki Mizumoto; Kazuhisa Chonabayashi; Yuta Hanyu; Junya Kanda; Akifumi Takaori-Kondo

  Annals of hematology, 27 Apr. 2023

  Access this paper :

  
• Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin.

  Yutaka Shimazu; Junya Kanda; Satoru Kosugi; Tomoki Ito; Hitomi Kaneko; Kazunori Imada; Yuji Shimura; Shin-Ichi Fuchida; Kentaro Fukushima; Hirokazu Tanaka; Satoshi Yoshihara; Kensuke Ohta; Nobuhiko Uoshima; Hideo Yagi; Hirohiko Shibayama; Ryosuke Yamamura; Yasuhiro Tanaka; Hitoji Uchiyama; Yoshiyuki Onda; Yoko Adachi; Hitoshi Hanamoto; Ryoichi Takahashi; Mitsuhiro Matsuda; Takashi Miyoshi; Teruhito Takakuwa; Masayuki Hino; Naoki Hosen; Shosaku Nomura; Chihiro Shimazaki; Itaru Matsumura; Akifumi Takaori-Kondo; Junya Kuroda

  Scientific reports, 29 Mar. 2023

  Access this paper :

  
• Impact of HLA-mismatched unrelated transplantation in patients with adult T-cell leukemia/lymphoma.

  Yoshitaka Inoue; Satoko Morishima; Koji Kato; Ayumu Ito; Nobuaki Nakano; Takuro Kuriyama; Toshiro Kawakita; Yasuo Mori; Youko Suehiro; Hidehiro Itonaga; Yasuhiko Miyazaki; Kazunori Imada; Shouhei Tomori; Junya Kanda; Tatsuo Ichinohe; Yoshiko Atsuta; Takahiro Fukuda; Makoto Yoshimitsu

  Bone marrow transplantation, 12 May 2023

  
• T-cell counts in peripheral blood at leukapheresis predict responses to subsequent CAR-T cell therapy

  Fumiya Wada; Tomoyasu Jo; Yasuyuki Arai; Toshio Kitawaki; Chisaki Mizumoto; Junya Kanda; Momoko Nishikori; Kouhei Yamashita; Miki Nagao; Akifumi Takaori-Kondo

  Scientific Reports, 04 Nov. 2022

  Access this paper :

  
• Favorable Outcome with Conditioning Regimen of Flu/Bu4/Mel in Acute Myeloid Leukemia Patients in Remission Undergoing Cord Blood Transplantation

  Shohei Mizuno; Akiyoshi Takami; Koji Kawamura; Yoshimitsu Shimomura; Yasuyuki Arai; Takaaki Konuma; Yukiyasu Ozawa; Masashi Sawa; Shuichi Ota; Satoshi Takahashi; Naoyuki Anzai; Nobuhiro Hiramoto; Makoto Onizuka; Hirohisa Nakamae; Masatsugu Tanaka; Makoto Murata; Takafumi Kimura; Junya Kanda; Takahiro Fukuda; Yoshiko Atsuta; Masamitsu Yanada

  Transplantation and Cellular Therapy, Nov. 2022

  
• Different effects of thymoglobulin on acute leukemia with pre-transplant residual blasts in HLA mismatch transplantation.

  Manabu Wakamatsu; Makoto Murata; Junya Kanda; Kentaro Fukushima; Takahiro Fukuda; Yuho Najima; Yuta Katayama; Yukiyasu Ozawa; Masatsugu Tanaka; Yoshinobu Kanda; Tetsuya Eto; Satoru Takada; Shinichi Kako; Naoyuki Uchida; Toshiro Kawakita; Hashii Yoshiko; Tatsuo Ichinohe; Yoshiko Atsuta; Seitaro Terakura

  International journal of hematology, 22 Feb. 2023

  
• Effect of graft-versus-host disease on posttransplant outcomes following single cord blood transplantation in comparison to haploidentical transplantation with posttransplant cyclophosphamide for adult acute myeloid leukemia.

  Takaaki Konuma; Kensuke Matsuda; Yoshimitsu Shimomura; Susumu Tanoue; Junichi Sugita; Yoshihiro Inamoto; Masahiro Hirayama; Takahide Ara; Hirohisa Nakamae; Shuichi Ota; Yumiko Maruyama; Tetsuya Eto; Naoyuki Uchida; Masatsugu Tanaka; Kazuya Ishiwata; Satoshi Koi; Satoshi Takahashi; Yukiyasu Ozawa; Makoto Onizuka; Yoshinobu Kanda; Takafumi Kimura; Tatsuo Ichinohe; Yoshiko Atsuta; Junya Kanda; Masamitsu Yanada

  Transplantation and cellular therapy, 06 Mar. 2023

  
• Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical relatives in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukemia: a propensity score analysis of a nationwide database.

  Hidehiro Itonaga; Yasushi Miyazaki; Kazunari Aoki; Naoki Shingai; Yukiyasu Ozawa; Takahiro Fukuda; Keisuke Kataoka; Toshiro Kawakita; Yasunori Ueda; Takahide Ara; Masatsugu Tanaka; Yuta Katayama; Masashi Sawa; Tetsuya Eto; Junya Kanda; Yoshiko Atsuta; Ken Ishiyama

  Annals of hematology, 15 Mar. 2023

  
• Progress in survival following three decades of allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: a real-world registry study in Japan.

  Takaaki Konuma; Hidehiro Itonaga; Ken Ishiyama; Atsushi Hamamura; Naoyuki Uchida; Yukiyasu Ozawa; Yuta Katayama; Masatoshi Sakurai; Yasunori Ueda; Ken-Ichi Matsuoka; Toshiro Kawakita; Tetsuya Eto; Takahide Ara; Junya Kanda; Onizuka Makoto; Takahiro Fukuda; Yoshiko Atsuta

  American journal of hematology, 12 Jan. 2023

  
• Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia.

  Satoshi Wakita; Atsushi Marumo; Kaoru Morita; Shinichi Kako; Takashi Toya; Yuho Najima; Noriko Doki; Junya Kanda; Junya Kuroda; Shinichiro Mori; Atsushi Satake; Kensuke Usuki; Toshimitsu Ueki; Nobuhiko Uoshima; Yutaka Kobayashi; Eri Kawata; Kazutaka Nakayama; Yuhei Nagao; Katsuhiro Shono; Motoharu Shibusawa; Jiro Tadokoro; Masao Hagihara; Hitoji Uchiyama; Naoyuki Uchida; Yasushi Kubota; Shinya Kimura; Hisao Nagoshi; Tatsuo Ichinohe; Saiko Kurosawa; Sayuri Motomura; Akiko Hashimoto; Hideharu Muto; Eriko Sato; Masao Ogata; Kenjiro Mitsuhashi; Jun Ando; Haruko Tashiro; Masahiro Sakaguchi; Shunsuke Yui; Kunihito Arai; Tomoaki Kitano; Miho Miyata; Haruka Arai; Masayuki Kanda; Kako Itabashi; Takahiro Fukuda; Yoshinobu Kanda; Hiroki Yamaguchi

  Cancer science, 07 Jan. 2023

  
• Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.

  Kaito Harada; Mari Morita-Fujita; Takahiro Fukuda; Yukiyasu Ozawa; Noriko Doki; Masako Toyosaki; Yumiko Maruyama; Yoshinobu Kanda; Takashi Ashida; Tetsuya Eto; Satoru Takada; Naoyuki Uchida; Tatsuo Ichinohe; Junya Kanda; Makoto Onizuka; Yoshiko Atsuta; Shinichi Kako; Yasuyuki Arai

  Cytotherapy, Sep. 2022

  Access this paper :

  
• Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide.

  Yutaka Shimazu; Junya Kanda; Hitomi Kaneko; Kazunori Imada; Ryosuke Yamamura; Satoru Kosugi; Yuji Shimura; Tomoki Ito; Shin-Ichi Fuchida; Hitoji Uchiyama; Kentaro Fukushima; Satoshi Yoshihara; Hitoshi Hanamoto; Hirokazu Tanaka; Nobuhiko Uoshima; Kensuke Ohta; Hideo Yagi; Hirohiko Shibayama; Yoshiyuki Onda; Yasuhiro Tanaka; Yoko Adachi; Mitsuhiro Matsuda; Masato Iida; Takashi Miyoshi; Toshimitsu Matsui; Ryoichi Takahashi; Teruhito Takakuwa; Masayuki Hino; Naoki Hosen; Shosaku Nomura; Chihiro Shimazaki; Itaru Matsumura; Akifumi Takaori-Kondo; Junya Kuroda

  Therapeutic advances in hematology, 2022

  Access this paper :

  
• Novel risk assessment for the intensity of conditioning regimen in elderly patients.

  Yu Akahoshi; Yuma Tada; Emiko Sakaida; Machiko Kusuda; Noriko Doki; Naoyuki Uchida; Takahiro Fukuda; Masatsugu Tanaka; Masashi Sawa; Yuta Katayama; Ken-Ichi Matsuoka; Yukiyasu Ozawa; Makoto Onizuka; Junya Kanda; Yoshinobu Kanda; Yoshiko Atsuta; Hideki Nakasone

  Blood advances, 12 Dec. 2022

  
• Comparable survival outcomes with haploidentical stem cell transplantation and unrelated bone marrow transplantation.

  Yoshiko Atsuta; Junichi Sugita; Hirohisa Nakamae; Yumiko Maruyama; Ken Ishiyama; Souichi Shiratori; Takahiro Fukuda; Mio Kurata; Naoki Shingai; Yukiyasu Ozawa; Masayoshi Masuko; Koji Nagafuji; Satoru Takada; Shinichi Kako; Yoshinobu Kanda; Junya Kanda; Tatsuo Ichinohe; Takanori Teshima

  Bone marrow transplantation, Dec. 2022

  
• Identifying the optimal conditioning intensity for stem cell transplantation in patients with myelodysplastic syndrome: a machine learning analysis.

  Yoshimitsu Shimomura; Sho Komukai; Tetsuhisa Kitamura; Tomotaka Sobue; Shuhei Kurosawa; Noriko Doki; Yuta Katayama; Yukiyasu Ozawa; Ken-Ichi Matsuoka; Takashi Tanaka; Shinichi Kako; Masashi Sawa; Yoshinobu Kanda; Hirohisa Nakamae; Hideyuki Nakazawa; Yasunori Ueda; Junya Kanda; Takahiro Fukuda; Yoshiko Atsuta; Ken Ishiyama

  Bone marrow transplantation, 14 Nov. 2022

  
• さい帯血移植におけるHLAホモ接合ハプロタイプを有するさい帯血の生着と急性GVHDへのリスク 同種iPSC移植・バンキングへの示唆

  森島 泰雄; 森島 聡子; 村田 誠; 有馬 靖佳; 内田 直之; 杉尾 康浩; 高橋 聡; 松橋 佳子; 鬼塚 真仁; 衛藤 徹也; 熱田 由子; 福田 隆浩; 一戸 辰夫; 加藤 俊一; 諌田 淳也

  MHC: Major Histocompatibility Complex, Aug. 2019

  
• Comparable survival outcomes with haploidentical stem cell transplantation and cord blood transplantation.

  Junichi Sugita; Yoshiko Atsuta; Hirohisa Nakamae; Yumiko Maruyama; Ken Ishiyama; Souichi Shiratori; Takahiro Fukuda; Mio Kurata; Naoki Shingai; Yukiyasu Ozawa; Masayoshi Masuko; Koji Nagafuji; Naoyuki Uchida; Masatsugu Tanaka; Makoto Onizuka; Junya Kanda; Takafumi Kimura; Tatsuo Ichinohe; Takanori Teshima

  Bone marrow transplantation, Nov. 2022

  
• Ph陰性B-ALLに対するブリナツモマブ治療中の採卵の実施可能性(Feasibility of fertility preservation during blinatumomab treatment for Ph-negative B-ALL)

  田代 裕介; 諫田 淳也; 家村 知樹; 近藤 忠一; 山下 浩平; 砂田 真澄; 堀江 昭史; 高折 晃史

  日本血液学会学術集会, Sep. 2021

  
• Comparison of transplant outcomes between haploidentical transplantation and single cord blood transplantation in non‐remission acute myeloid leukaemia: A nationwide retrospective study

  Kensuke Matsuda; Takaaki Konuma; Kyoko Fuse; Masayoshi Masuko; Koji Kawamura; Masahiro Hirayama; Naoyuki Uchida; Kazuhiro Ikegame; Atsushi Wake; Tetsuya Eto; Noriko Doki; Shigesaburo Miyakoshi; Masatsugu Tanaka; Satoshi Takahashi; Makoto Onizuka; Koji Kato; Takafumi Kimura; Tatsuo Ichinohe; Nobuyuki Takayama; Hikaru Kobayashi; Hirohisa Nakamae; Yoshiko Atsuta; Junya Kanda; Masamitsu Yanada

  British Journal of Haematology, 25 Oct. 2022

  
• Intensified conditioning regimens improved disease-free survival and engraftment after unrelated single-unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation.

  Takaaki Konuma; Junya Kanda; Naoyuki Uchida; Akihiko Nishijima; Masatsugu Tanaka; Yukiyasu Ozawa; MasashiSawa; MakotoOnizuka; Shuichi Ota; Yumiko Maruyama; Yoshinobu Kanda; Toshiro Kawakita; Takahide Ara; Tetsuya Eto; Hirohisa Nakamae; Takafumi Kimura; Takahiro Fukuda; Yoshiko Atsuta; For The Donor/Source Working Group Of The Japanese Society For Transplantation; Cellular Therapy

  Hematological oncology, 21 Oct. 2022

  
• Altered effect of killer immunoglobulin-like receptor-ligand mismatch by graft versus host disease prophylaxis in cord blood transplantation.

  Hisayuki Yokoyama; Masahiro Hirayama; Yoshiyuki Takahashi; Naoyuki Uchida; Masatsugu Tanaka; Makoto Onizuka; Yukiyasu Ozawa; Daishi Onai; Yuna Katsuoka; Atsushi Wake; Masashi Sawa; Hikaru Kobayashi; Yumiko Maruyama; Kazutaka Ozeki; Takafumi Kimura; Junya Kanda; Takahiro Fukuda; Yoshiko Atsuta; Seitaro Terakura; Satoko Morishima

  Bone marrow transplantation, 24 Sep. 2021

  
• Belt electrode-skeletal muscle electrical stimulation during early hematopoietic post-transplantation to prevent skeletal muscle atrophy and weakness.

  Ryota Hamada; Susumu Sato; Junsuke Miyasaka; Masanobu Murao; Michiko Matsushita; Taishi Kajimoto; Ayumi Otagaki; Tsugumi Asano; Manabu Nankaku; Tadakazu Kondo; Yasuyuki Arai; Junya Kanda; Akifumi Takaori-Kondo; Ryosuke Ikeguchi; Shuichi Matsuda

  Transplantation and cellular therapy, 07 Oct. 2022

  
• Production and nonclinical evaluation of an autologous iPSC–derived platelet product for the iPLAT1 clinical trial

  Naoshi Sugimoto; Sou Nakamura; Shin Shimizu; Akiko Shigemasa; Junya Kanda; Nobuki Matsuyama; Mitsunobu Tanaka; Tomoya Hayashi; Akihiro Fuchizaki; Masayuki Nogawa; Naohide Watanabe; Shinichiro Okamoto; Makoto Handa; Akira Sawaguchi; Dai Momose; Ki-Ryang Koh; Yoshihiko Tani; Akifumi Takaori-Kondo; Koji Eto

  Blood Advances, 13 Dec. 2022

  Access this paper :

  
• iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study

  Naoshi Sugimoto; Junya Kanda; Sou Nakamura; Toshiyuki Kitano; Masakatsu Hishizawa; Tadakazu Kondo; Shin Shimizu; Akiko Shigemasa; Hideyo Hirai; Yasuyuki Arai; Manabu Minami; Harue Tada; Dai Momose; Ki-Ryang Koh; Masayuki Nogawa; Naohide Watanabe; Shinichiro Okamoto; Makoto Handa; Akira Sawaguchi; Nobuki Matsuyama; Mitsunobu Tanaka; Tomoya Hayashi; Akihiro Fuchizaki; Yoshihiko Tani; Akifumi Takaori-Kondo; Koji Eto

  Blood, 01 Dec. 2022

  
• Significance of Omitting Day 11 Mini-Dose Methotrexate for GVHD Prophylaxis After Unrelated Bone Marrow Transplantation

  Naokazu Nakamura; Fumiya Wada; Tadakazu Kondo; Kazunari Aoki; Yasuyuki Arai; Chisaki Mizumoto; Junya Kanda; Toshio Kitawaki; Kouhei Yamashita; Akifumi Takaori-Kondo

  Transplantation and Cellular Therapy, Nov. 2022

  
• Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T ‐cell therapy

  Naokazu Nakamura; Yasuyuki Arai; Toshio Kitawaki; Tomoyasu Jo; Chisaki Mizumoto; Junya Kanda; Momoko Nishikori; Kouhei Yamashita; Akifumi Takaori‐Kondo

  British Journal of Haematology, 11 Oct. 2022

  
• Feasibility of ovarian stimulation for fertility preservation during and after blinatumomab treatment for Ph-negative B-cell acute lymphoblastic leukemia

  Yusuke Tashiro; Junya Kanda; Tomoki Iemura; Tadakazu Kondo; Kouhei Yamashita; Masumi Sunada; Akihito Horie; Akifumi Takaori-Kondo

  International Journal of Hematology, Sep. 2022

  Access this paper :

  
• Effects of combined test-dose and therapeutic drug monitoring strategy in exposure-directed busulfan

  Tomoki Iemura; Tadakazu Kondo; Atsushi Ueda; Takeshi Maeda; Toshio Kitawaki; Yasuyuki Arai; Junya Kanda; Takashi Ikeda; Kazunori Imada; Takayuki Ishikawa; Naoyuki Anzai; Mitsuru Itoh; Tomoharu Takeoka; Takashi Akasaka; Kazuhiro Yago; Akihito Yonezawa; Nobuyoshi Arima; Toshiyuki Kitano; Masaharu Nohgawa; Mitsumasa Watanabe; Toshinori Moriguchi; Kouhei Yamashita; Yasunori Ueda; Kana Matsumoto; Akifumi Takaori-Kondo

  05 Jul. 2022

  
• Addition and drug monitoring of mycophenolate mofetil for GVHD prophylaxis in unrelated bone marrow transplantation

  Fumiya Wada; Tadakazu Kondo; Ryusuke Yamamoto; Takero Yamagiwa; Yasuyuki Arai; Chisato Mizumoto; Junya Kanda; Toshio Kitawaki; Kouhei Yamashita; Akifumi Takaori-Kondo

  Bone Marrow Transplantation, Jul. 2022

  
• Coexistence of HLA and KIR ligand mismatches as a risk factor for viral infection early after cord blood transplantation

  Tomoki Iemura; Yasuyuki Arai; Toshio Kitawaki; Junya Kanda; Tadakazu Kondo; Yasunori Ueda; Takuto Mori; Kazunori Imada; Akihito Yonezawa; Kazuhiro Yago; Naoyuki Anzai; Shinichi Kotani; Masaharu Nohgawa; Toshiyuki Kitano; Mitsuru Itoh; Nobuyoshi Arima; Toshinori Moriguchi; Mitsumasa Watanabe; Masaaki Tsuji; Kouhei Yamashita; Akifumi Takaori-Kondo

  Bone Marrow Transplantation, May 2022

  
• 単一臍帯血と低用量サイモグロブリンを用いたHLA不適合血縁からの移植成績の比較(Comparison of cord blood and HLA mismatched related transplantation using antithymocyte globulin)

  和田 典也; 渡邊 瑞希; 小沼 貴晶; 岡部 基人; 小林 真一; 内田 直之; 池亀 和博; 田中 正嗣; 太田 貴徳; 土岐 典子; 鬼塚 真仁; 河北 敏郎; 衛藤 徹也; 高橋 聡; 木村 貴文; 一戸 辰夫; 熱田 由子; 諫田 淳也

  日本血液学会学術集会, Sep. 2021

  
• Impact of human leukocyte antigen mismatch on outcomes after unrelated bone marrow transplantation in paediatric patients: A retrospective analysis by the JSTCT HLA working group.

  Itaru Kato; Hirotoshi Sakaguchi; Shunichi Kato; Maho Sato; Maiko Noguchi; Nao Yoshida; Katsuyoshi Koh; Takashi Koike; Masakatsu Yanagimachi; Keisuke Kato; Yoshiyuki Takahashi; Naoto Fujita; Atsushi Sato; Yoshiko Hashii; Ken Tabuchi; Yoshiko Atsuta; Satoko Morishima; Junya Kanda

  British journal of haematology, 27 Aug. 2022

  
• Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation.

  Shinichi Kobayashi; Yoshinobu Kanda; Takaaki Konuma; Yoshihiro Inamoto; Kimikazu Matsumoto; Naoyuki Uchida; Kazuhiro Ikegame; Toshihiro Miyamoto; Noriko Doki; Hirohisa Nakamae; Yuta Katayama; Satoshi Takahashi; Souichi Shiratori; Shoji Saito; Toshiro Kawakita; Junya Kanda; Takahiro Fukuda; Yoshiko Atsuta; Fumihiko Kimura

  Bone marrow transplantation, 08 Oct. 2021

  
• 急性骨髄性白血病におけるRUNX1遺伝子変異の臨床的・遺伝子的特徴(The clinical features of RUNX1 mutation positive acute myeloid leukemia in a Japanese cohort)

  丸毛 淳史; 脇田 知志; 翁 家国; 賀古 真一; 土岐 典子; 諫田 淳也; 森 慎一郎; 佐竹 敦志; 臼杵 憲祐; 植木 俊充; 魚嶋 伸彦; 田近 賢二; 鐘野 勝洋; 田所 治朗; 萩原 政夫; 内山 人二; 久保田 寧; 黒田 純也; 黒澤 彩子; 橋本 朗子; 本村 小百合; 河田 英里; 佐藤 恵理子; 緒方 正男; 三橋 健次郎; 安藤 純; 福田 隆浩; 神田 善信; 山口 博樹

  日本血液学会学術集会, Sep. 2021

  
• Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients

  Tomoyasu Jo; Yasuyuki Arai; Tadakazu Kondo; Shohei Mizuno; Shigeki Hirabayashi; Yoshihiro Inamoto; Noriko Doki; Takahiro Fukuda; Yukiyasu Ozawa; Yuta Katayama; Yoshinobu Kanda; Kentaro Fukushima; Ken-ichi Matsuoka; Satoru Takada; Masashi Sawa; Takashi Ashida; Makoto Onizuka; Tatsuo Ichinohe; Yoshiko Atsuta; Junya Kanda; Masamitsu Yanada

  Cytotherapy, Jun. 2022

  Access this paper :

  
• Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma.

  Makiko Yamasaki-Morita; Yasuyuki Arai; Takashi Ishihara; Tomoko Onishi; Hanako Shimo; Kayoko Nakanishi; Yukiko Nishiyama; Tomoyasu Jo; Hidefumi Hiramatsu; Takaya Mitsuyoshi; Chisaki Mizumoto; Junya Kanda; Momoko Nishikori; Toshio Kitawaki; Keiji Nogami; Akifumi Takaori-Kondo; Miki Nagao; Souichi Adachi

  Blood advances, 26 Jul. 2022

  Access this paper :

  
• A Clinically Applicable Prediction Model to Improve T Cell Collection in Chimeric Antigen Receptor T Cell Therapy.

  Tomoyasu Jo; Satoshi Yoshihara; Asuka Hada; Yasuyuki Arai; Toshio Kitawaki; Junko Ikemoto; Hitomi Onomoto; Hiroki Sugiyama; Kyoko Yoshihara; Natsuno Obi; Keiko Matsui; Norimi Niwa; Yoko Nakagawa; Junya Kanda; Tadakazu Kondo; Satoshi Saida; Itaru Kato; Hidefumi Hiramatsu; Souichi Adachi; Junko Takita; Akifumi Takaori-Kondo; Miki Nagao

  Transplantation and cellular therapy, Jul. 2022

  Access this paper :

  
• Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma Forum.

  Aya Nakaya; Hirohiko Shibayama; Eiji Nakatani; Yuji Shimura; Satoru Kosugi; Hirokazu Tanaka; Shin-Ichi Fuchida; Junya Kanda; Nobuhiko Uoshima; Hitomi Kaneko; Kazunori Imada; Kensuke Ohta; Tomoki Ito; Hideo Yagi; Satoshi Yoshihara; Masayuki Hino; Chihiro Shimazaki; Akifumi Takaori-Kondo; Junya Kuroda; Itaru Matsumura; Yuzuru Kanakura; Shosaku Nomura

  EJHaem, Nov. 2021

  Access this paper :

  
• Coffee and green tea consumption and subsequent risk of acute myeloid leukemia and myelodysplastic syndromes in Japan.

  Ugai T; Matsuo K; Sawada N; Iwasaki M; Yamaji T; Shimazu T; Goto A; Inoue M; Kanda Y; Tsugane S; Japan; Public Health Center-based Prospective Study Group

  International journal of cancer, Mar. 2018, Peer-reviewed

  
• Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis.

  Yoshiyuki Onda; Junya Kanda; Hitomi Kaneko; Yuji Shimura; Shin-Ichi Fuchida; Aya Nakaya; Tomoki Itou; Ryosuke Yamamura; Hirokazu Tanaka; Hirohiko Shibayama; Yutaka Shimazu; Hitoji Uchiyama; Satoshi Yoshihara; Yoko Adachi; Mitsuhiro Matsuda; Hitoshi Hanamoto; Nobuhiko Uoshima; Satoru Kosugi; Kensuke Ohta; Hideo Yagi; Yuzuru Kanakura; Itaru Matsumura; Masayuki Hino; Shosaku Nomura; Chihiro Shimazaki; Akifumi Takaori-Kondo; Junya Kuroda

  Therapeutic advances in hematology, 2022

  Access this paper :

  
• Intramuscular adipose tissue content predicts patient outcomes after allogeneic hematopoietic stem cell transplantation.

  Ryota Hamada; Tsugumi Asano; Masanobu Murao; Junsuke Miyasaka; Michiko Matsushita; Taishi Kajimoto; Ayumi Otagaki; Manabu Nankaku; Yasuyuki Arai; Junya Kanda; Tadakazu Kondo; Akifumi Takaori-Kondo; Ryosuke Ikeguchi; Shuichi Matsuda

  Transplantation and cellular therapy, 19 Jun. 2022

  Access this paper :

  
• Ideal Body Weight Is Useful For Predicting Neutrophil Engraftment and Platelet Recovery for Overweight and Obese Recipients in Single-Unit Cord Blood Transplantation.

  Yosuke Okada; Hideki Nakasone; Takaaki Konuma; Naoyuki Uchida; Masatsugu Tanaka; Yasuhiro Sugio; Nobuyuki Aotsuka; Akihiko Nishijima; Yuna Katsuoka; Takahide Ara; Shuichi Ota; Makoto Onizuka; Masashi Sawa; Takafumi Kimura; Takahiro Fukuda; Yoshiko Atsuta; Junya Kanda; Fumihiko Kimura

  Transplantation and cellular therapy, 13 May 2022

  
• Effect of multiple HLA-locus mismatches on outcomes after single cord blood transplantation.

  Junya Kanda; Shigeki Hirabayashi; Hisayuki Yokoyama; Takakazu Kawase; Hidenori Tanaka; Naoyuki Uchida; Shuichi Taniguchi; Satoshi Takahashi; Makoto Onizuka; Masatsugu Tanaka; Yasuhiro Sugio; Tetsuya Eto; Yoshinobu Kanda; Takafumi Kimura; Tatsuo Ichinohe; Yoshiko Atsuta; Satoko Morishima

  Transplantation and cellular therapy, 13 May 2022

  
• Myeloablative Versus Reduced-Intensity Conditioning With Fludarabine/Busulfan for Myelodysplastic Syndrome: A Propensity Score-Matched Analysis.

  Shuhei Kurosawa; Yoshimitsu Shimomura; Hidehiro Itonaga; Yuho Najima; Takeshi Kobayashi; Yukiyasu Ozawa; Yoshinobu Kanda; Shinichi Kako; Toshiro Kawakita; Ken-Ichi Matsuoka; Yumiko Maruyama; Shuichi Ota; Hideyuki Nakazawa; Kazunori Imada; Takafumi Kimura; Junya Kanda; Takahiro Fukuda; Yoshiko Atsuta; Ken Ishiyama

  Transplantation and cellular therapy, 13 Mar. 2022

  
• Very elderly patients with myeloma: a multicenter retrospective analysis from Kansai Myeloma Forum(和訳中)

  岡山 裕介; 高桑 輝人; 志村 勇司; 金子 仁臣; 今田 和典; 小杉 智; 伊藤 量基; 淵田 真一; 田中 宏和; 魚嶋 伸彦; 吉原 哲; 諫田 淳也; 柴山 浩彦; 福島 健太郎; 太田 健介; 八木 秀男; 野村 昌作; 島崎 千尋; 松村 到; 高折 晃史; 保仙 直毅; 日野 雅之; 黒田 純也

  日本血液学会学術集会, Sep. 2021

  
• Comparison of the impact of two post-remission therapy regimens on cardiac events in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.

  Jin Hayakawa; Hideki Nakasone; Daisuke Minakata; Shin-Ichiro Fujiwara; Ayumi Gomyo; Yu Akahoshi; Yusuke Komiya; Naonori Harada; Tomotaka Ugai; Kazuaki Kameda; Hidenori Wada; Yuko Ishihara; Koji Kawamura; Kana Sakamoto; Miki Sato; Kiriko Terasako-Saito; Misato Kikuchi; Shun-Ichi Kimura; Junya Kanda; Shinichi Kako; Yoshinobu Kanda

  International journal of hematology, 16 Apr. 2022

  
• NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia.

  Atsushi Marumo; Satoshi Wakita; Kaoru Morita; Iekuni Oh; Shinichi Kako; Takashi Toya; Yuho Najima; Noriko Doki; Junya Kanda; Junya Kuroda; Shinichiro Mori; Atsushi Satake; Kensuke Usuki; Nobuhiko Uoshima; Yutaka Kobayashi; Eri Kawata; Yuhei Nagao; Katsuhiro Shono; Motoharu Shibusawa; Jiro Tadokoro; Masao Hagihara; Hitoji Uchiyama; Yasushi Kubota; Shinya Kimura; Sayuri Motomura; Akiko Hashimoto; Hideharu Muto; Eriko Sato; Masao Ogata; Kenjiro Mitsuhashi; Jun Ando; Kenta Date; Yusuke Fujiwara; Kazuki Terada; Shunsuke Yui; Kunihito Arai; Tomoaki Kitano; Miho Miyata; Kazuteru Ohashi; Yoshinobu Kanda; Hiroki Yamaguchi

  International journal of hematology, 04 Apr. 2022

  
• Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors.

  Masaharu Tamaki; Kazuaki Kameda; Shun-Ichi Kimura; Naonori Harada; Naoyuki Uchida; Noriko Doki; Masatsugu Tanaka; Kazuhiro Ikegame; Masashi Sawa; Yuta Katayama; Shigesaburo Miyakoshi; Takahide Ara; Junya Kanda; Makoto Onizuka; Takahiro Fukuda; Yoshiko Atsuta; Yoshinobu Kanda; Kimikazu Yakushijin; Hideki Nakasone

  Blood advances, 22 Mar. 2022

  
• Outcome of therapy-related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysis.

  Hidehiro Itonaga; Michiko Kida; Atsushi Hamamura; Naoyuki Uchida; Yukiyasu Ozawa; Takahiro Fukuda; Yasunori Ueda; Keisuke Kataoka; Yuta Katayama; Shuichi Ota; Ken-Ichi Matsuoka; Tadakazu Kondo; Tetsuya Eto; Junya Kanda; Tatsuo Ichinohe; Yoshiko Atsuta; Yasushi Miyazaki; Ken Ishiyama

  Hematological oncology, 17 Mar. 2022

  
• Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation

  Makoto Iwasaki; Junya Kanda; Hidenori Tanaka; Takero Shindo; Takahiko Sato; Noriko Doki; Takahiro Fukuda; Yukiyasu Ozawa; Tetsuya Eto; Naoyuki Uchida; Yuta Katayama; Keisuke Kataoka; Takahide Ara; Shuichi Ota; Makoto Onizuka; Yoshinobu Kanda; Tatsuo Ichinohe; Yoshiko Atsuta; Satoko Morishima

  Frontiers in Immunology, 03 Mar. 2022

  
• Decision Analysis for Unrelated Bone Marrow Transplantation or Immediate Cord Blood Transplantation for Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission.

  Shinichi Kako; Fumihiko Hayakawa; Koichi Miyamura; Junji Tanaka; Kiyotoshi Imai; Junya Kanda; Satoko Morishima; Naoyuki Uchida; Noriko Doki; Kazuhiro Ikegame; Yukiyasu Ozawa; Satoru Takada; Noriko Usui; Shigeki Ohtake; Hitoshi Kiyoi; Itaru Matsumura; Yasushi Miyazaki; Tatsuo Ichinohe; Takahiro Fukuda; Yoshiko Atsuta; Yoshinobu Kanda

  Transplantation and cellular therapy, Mar. 2022

  
• Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation.

  Kotaro Miyao; Yachiyo Kuwatsuka; Makoto Murata; Koji Nagafuji; Takanori Teshima; Yuki Takeuchi; Souichi Shiratori; Yuho Najima; Naoyuki Uchida; Masatsugu Tanaka; Masashi Sawa; Shuichi Ota; Takahiro Fukuda; Yukiyasu Ozawa; Shinichi Kako; Toshiro Kawakita; Takahide Ara; Junji Tanaka; Yoshinobu Kanda; Yoshiko Atsuta; Junya Kanda; Seitaro Terakura

  Transplantation and cellular therapy, Mar. 2022

  
• Human leukocyte antigen (HLA) haplotype matching in unrelated single HLA allele mismatch bone marrow transplantation.

  Akihisa Kawajiri; Takakazu Kawase; Hidenori Tanaka; Takahiro Fukuda; Junichi Mukae; Yukiyasu Ozawa; Tetsuya Eto; Naoyuki Uchida; Takehiko Mori; Takashi Ashida; Tadakazu Kondo; Makoto Onizuka; Tatsuo Ichinohe; Yoshiko Atsuta; Satoko Morishima; Junya Kanda

  Bone marrow transplantation, Mar. 2022

  
• The impact of GVHD on outcomes after adult single cord blood transplantation in European and Japanese populations.

  Junya Kanda; Hiromi Hayashi; Annalisa Ruggeri; Fumihiko Kimura; Fernanda Volt; Satoshi Takahashi; Shinichi Kako; Karina Tozatto-Maio; Masamitsu Yanada; Guillermo Sanz; Naoyuki Uchida; Emanuele Angelucci; Seiko Kato; Mohamad Mohty; Edouard Forcade; Masatsugu Tanaka; Jorge Sierra; Takanori Ohta; Riccardo Saccardi; Takahiro Fukuda; Tatsuo Ichinohe; Takafumi Kimura; Vanderson Rocha; Shinichiro Okamoto; Arnon Nagler; Yoshiko Atsuta; Eliane Gluckman

  Bone marrow transplantation, Jan. 2022

  Access this paper :

  
• Establishment of a Predictive Model for GvHD-free, Relapse-free Survival after Allogeneic HSCT using Ensemble Learning.

  Makoto Iwasaki; Junya Kanda; Yasuyuki Arai; Tadakazu Kondo; Takayuki Ishikawa; Yasunori Ueda; Kazunori Imada; Takashi Akasaka; Akihito Yonezawa; Kazuhiro Yago; Masaharu Nohgawa; Naoyuki Anzai; Toshinori Moriguchi; Toshiyuki Kitano; Mitsuru Itoh; Nobuyoshi Arima; Tomoharu Takeoka; Mitsumasa Watanabe; Hirokazu Hirata; Kosuke Asagoe; Isao Miyatsuka; Le My An; Masanori Miyanishi; Akifumi Takaori-Kondo

  Blood advances, 21 Dec. 2021

  
• A successfully managed refractory DLBCL case with CAR-T therapy and subsequent allo-SCT(和訳中)

  宮下 明大; 上辻 由里; 中山 藍; 小森 友紀子; 山口 順子; 堤 康彦; 佐々木 奈々; 小林 裕; 島津 裕; 諫田 淳也; 魚嶋 伸彦

  日本血液学会学術集会, Sep. 2021

  
• Novel web application predicting patient-specific prognosis in MM from KMF using machine learning(和訳中)

  高桑 輝人; 岡村 浩史; 島津 裕; 金子 仁臣; 今田 和典; 伊藤 量基; 山村 亮介; 太田 健介; 小杉 智; 田中 宏和; 淵田 真一; 志村 勇司; 諫田 淳也; 魚嶋 伸彦; 柴山 浩彦; 吉原 哲; 八木 秀男; 日野 雅之; 金倉 譲; 黒田 純也; 高折 晃史; 島崎 千尋; 松村 到; 野村 昌作

  日本血液学会学術集会, Sep. 2021

  
• Efficacy of elotuzumab plus lenalidomide and dexamethasone for MM: A retrospective analysis from KMF(和訳中)

  淵田 真一; 伊藤 量基; 小杉 智; 太田 健介; 内山 人二; 島津 裕; 恩田 佳幸; 金子 仁臣; 足立 陽子; 高桑 輝人; 諫田 淳也; 魚嶋 伸彦; 柴山 浩彦; 福島 健太郎; 田中 宏和; 志村 勇司; 今田 和典; 八木 秀男; 吉原 哲; 日野 雅之; 保仙 直毅; 高折 晃史; 松村 到; 野村 昌作; 島崎 千尋; 黒田 純也

  日本血液学会学術集会, Sep. 2021

  
• Comprehensive analysis of risk factors for HHV-6 encephalitis/myelitis after CBT(和訳中)

  森 拓人; 平本 展大; 緒方 正男; 原田 介斗; 内田 直之; 田中 正嗣; 太田 貴徳; 鬼塚 真仁; 中野 伸亮; 小林 光; 河北 敏郎; 和氣 敦; 衛藤 徹也; 高橋 聡; 木村 貴文; 諫田 淳也; 福田 隆浩; 熱田 由子; 仲宗根 秀樹

  日本血液学会学術集会, Sep. 2021

  
• CD19-CAR-T療法後に汎血球減少を認めたびまん性大細胞型B細胞リンパ腫の1例

  天ヶ瀬 寛記; 岩崎 惇; 諫田 淳也; 島津 裕; 水本 智咲; 近藤 忠一; 山下 浩平; 高折 晃史

  臨床血液, Mar. 2021

  
• HLA 1-3 antigen-mismatched related peripheral blood stem cells transplantation using low-dose antithymocyte globulin versus unrelated cord blood transplantation.

  Fumiya Wada; Mizuki Watanabe; Takaaki Konuma; Motohito Okabe; Shinichi Kobayashi; Naoyuki Uchida; Kazuhiro Ikegame; Masatsugu Tanaka; Yasuhiro Sugio; Junichi Mukae; Makoto Onizuka; Toshiro Kawakita; Takuro Kuriyama; Satoshi Takahashi; Takahiro Fukuda; Nobuaki Nakano; Masashi Sawa; Takafumi Kimura; Tatsuo Ichinohe; Yoshiko Atsuta; Junya Kanda

  American journal of hematology, 01 Mar. 2022

  
• Evaluation of indices for predicting recovery of exercise tolerance in patients surviving allogenic hematopoietic stem cell transplantation.

  Ryota Hamada; Tadakazu Kondo; Kazuhiro Harada; Masanobu Murao; Junsuke Miyasaka; Michiko Yoshida; Honami Yonezawa; Manabu Nankaku; Yasuyuki Arai; Junya Kanda; Akifumi Takaori-Kondo; Ryosuke Ikeguchi; Shuichi Matsuda

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 22 Jan. 2022

  Access this paper :

  
• Development of a quantitative prediction model for peripheral blood stem cell collection yield in the plerixafor era

  Akira Ishii; Tomoyasu Jo; Yasuyuki Arai; Shinichiro Oshima; Junya Kanda; Toshio Kitawaki; Keiko Matsui; Norimi Niwa; Yoko Nakagawa; Akifumi Takaori-Kondo; Miki Nagao

  Cytotherapy, Jan. 2022

  Access this paper :

  
• Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies.

  Nobuhiko Imahashi; Seitaro Terakura; Eisei Kondo; Koji Kato; Sung-Won Kim; Akihito Shinohara; Mizuki Watanabe; Takahiro Fukuda; Naoyuki Uchida; Hikaru Kobayashi; Jun Ishikawa; Keisuke Kataoka; Souichi Shiratori; Takashi Ikeda; Ken-Ichi Matsuoka; Shuro Yoshida; Tadakazu Kondo; Takafumi Kimura; Makoto Onizuka; Tatsuo Ichinohe; Yoshiko Atsuta; Junya Kanda

  Bone marrow transplantation, 24 Nov. 2021

  
• Comparison of cord blood and HLA mismatched related transplantation using antithymocyte globulin(和訳中)

  和田 典也; 渡邊 瑞希; 小沼 貴晶; 岡部 基人; 小林 真一; 内田 直之; 池亀 和博; 田中 正嗣; 太田 貴徳; 土岐 典子; 鬼塚 真仁; 河北 敏郎; 衛藤 徹也; 高橋 聡; 木村 貴文; 一戸 辰夫; 熱田 由子; 諫田 淳也

  日本血液学会学術集会, Sep. 2021

  
• 複数のHLA座不適合が単一臍帯血移植後の成績に与える影響 JSTCT HLA WG研究

  諫田 淳也; 平林 茂樹; 横山 寿行; 川瀬 孝和; 田中 秀則; 内田 直之; 谷口 修一; 高橋 聡; 鬼塚 真仁; 田中 正嗣; 杉尾 康浩; 衛藤 徹也; 神田 善伸; 木村 貴文; 一戸 辰夫; 熱田 由子; 森島 聡子

  MHC: Major Histocompatibility Complex, Sep. 2021

  
• サルコイドーシスの経過観察中に発症した肺門部の非ホジキンリンパ腫

  天ヶ瀬 寛記; 岩崎 惇; 進藤 岳郎; 諫田 淳也; 錦織 桃子; 近藤 忠一; 山下 浩平; 高折 晃史; 谷澤 公伸; 藤本 正数

  臨床血液, Sep. 2021

  
• Comparing cord blood transplantation and matched related donor transplantation in non-remission acute myeloid leukemia

  Yoshimitsu Shimomura; Tomotaka Sobue; Shigeki Hirabayashi; Tadakazu Kondo; Shohei Mizuno; Junya Kanda; Takahiro Fujino; Keisuke Kataoka; Naoyuki Uchida; Tetsuya Eto; Shigesaburo Miyakoshi; Masatsugu Tanaka; Toshiro Kawakita; Hisayuki Yokoyama; Noriko Doki; Kaito Harada; Atsushi Wake; Shuichi Ota; Satoru Takada; Satoshi Takahashi; Takafumi Kimura; Makoto Onizuka; Takahiro Fukuda; Yoshiko Atsuta; Masamitsu Yanada

  Leukemia, 2021

  
• Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysis.

  Takayoshi Tachibana; Junya Kanda; Takuma Ishizaki; Yuho Najima; Masatsugu Tanaka; Noriko Doki; Shin-Ichiro Fujiwara; Shun-Ichi Kimura; Makoto Onizuka; Satoshi Takahashi; Takeshi Saito; Takehiko Mori; Shin Fujisawa; Emiko Sakaida; Takuya Miyazaki; Nobuyuki Aotsuka; Moritaka Gotoh; Reiko Watanabe; Katsuhiro Shono; Heiwa Kanamori; Yoshinobu Kanda; Shinichiro Okamoto

  Annals of hematology, Nov. 2021

  
• Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma

  Koji Kato; Shinichi Makita; Hideki Goto; Junya Kanda; Nobuharu Fujii; Kazuyuki Shimada; Koichi Akashi; Koji Izutsu; Takanori Teshima; Natsuko Fukuda; Tokuhito Sumitani; Hiroyuki Sumi; Shinji Shimizu; Yasuyuki Kakurai; Kenji Yoshikawa; Kensei Tobinai; Noriko Usui; Kiyohiko Hatake

  International Journal of Clinical Oncology, 01 Oct. 2021

  
• Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysis.

  Shuhei Kurosawa; Shohei Mizuno; Yasuyuki Arai; Masayoshi Masuko; Junya Kanda; Kentaro Kohno; Daishi Onai; Takahiro Fukuda; Yukiyasu Ozawa; Yuta Katayama; Masatsugu Tanaka; Kazuhiro Ikegame; Naoyuki Uchida; Tetsuya Eto; Shuichi Ota; Junji Tanaka; Tatsuo Ichinohe; Yoshiko Atsuta; Masamitsu Yanada

  Blood cancer journal, 24 Sep. 2021

  
• Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis.

  Shuhei Kurosawa; Yoshimitsu Shimomura; Hidehiro Itonaga; Yuho Najima; Takeshi Kobayashi; Yukiyasu Ozawa; Yoshinobu Kanda; Shinichi Kako; Toshiro Kawakita; Ken-Ichi Matsuoka; Yumiko Maruyama; Shuichi Ota; Hideyuki Nakazawa; Kazunori Imada; Junya Kanda; Takahiro Fukuda; Yoshiko Atsuta; Jun Aoki

  Bone marrow transplantation, 07 Sep. 2021

  
• Allogeneic Hematopoietic Cell Transplantation from Alternative Donors in Acute Myeloid Leukemia: A Comparative Analysis.

  Masamitsu Yanada; Takaaki Konuma; Satoshi Yamasaki; Kaito Harada; Makoto Iwasaki; Ayako Kobayashi; Akihiko Nishijima; Masatsugu Tanaka; Naoyuki Uchida; Hirohisa Nakamae; Takahiro Fukuda; Makoto Onizuka; Yukiyasu Ozawa; Masashi Sawa; Yuta Katayama; Satoshi Yoshioka; Takafumi Kimura; Tatsuo Ichinohe; Yoshiko Atsuta; Junya Kanda; Shingo Yano

  Transplantation and cellular therapy, 06 Sep. 2021

  
• Impact of HLA disparity on the risk of overall mortality in patients with grade II-IV acute GVHD on behalf of the HLA Working Group of Japan Society for Hematopoietic Cell Transplantation.

  Shigeo Fuji; Akitoshi Hakoda; Junya Kanda; Makoto Murata; Seitaro Terakura; Yoshihiro Inamoto; Naoyuki Uchida; Takashi Toya; Tetsuya Eto; Hirohisa Nakamae; Kazuhiro Ikegame; Masatsugu Tanaka; Toshiro Kawakita; Tadakazu Kondo; Toshihiro Miyamoto; Takahiro Fukuda; Tatsuo Ichinohe; Takafumi Kimura; Yoshiko Atsuta; Ayumi Shintani; Satoko Morishima

  Bone marrow transplantation, 03 Sep. 2021

  
• Differential Effect of Graft-versus-Host Disease on Survival in Acute Leukemia according to Donor Type.

  Takaaki Konuma; Junya Kanda; Yachiyo Kuwatsuka; Masamitsu Yanada; Tadakazu Kondo; Shigeki Hirabayashi; Shinichi Kako; Yu Akahoshi; Naoyuki Uchida; Noriko Doki; Yukiyasu Ozawa; Masatsugu Tanaka; Tetsuya Eto; Masashi Sawa; Satoshi Yoshioka; Takafumi Kimura; Yoshinobu Kanda; Takahiro Fukuda; Yoshiko Atsuta; Fumihiko Kimura

  Clinical cancer research : an official journal of the American Association for Cancer Research, 01 Sep. 2021

  
• Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia.

  Satoshi Wakita; Masahiro Sakaguchi; Iekuni Oh; Shinichi Kako; Takashi Toya; Yuho Najima; Noriko Doki; Junya Kanda; Junya Kuroda; Shinichiro Mori; Atsushi Satake; Kensuke Usuki; Toshimitsu Ueki; Nobuhiko Uoshima; Yutaka Kobayashi; Eri Kawata; Kenji Tajika; Yuhei Nagao; Katsuhiro Shono; Motoharu Shibusawa; Jiro Tadokoro; Kensuke Kayamori; Masao Hagihara; Hitoji Uchiyama; Naoyuki Uchida; Yasushi Kubota; Shinya Kimura; Hisao Nagoshi; Tatsuo Ichinohe; Saiko Kurosawa; Sayuri Motomura; Akiko Hashimoto; Hideharu Muto; Eriko Sato; Masao Ogata; Kenjiro Mitsuhashi; Jun Ando; Atsushi Marumo; Ikuko Omori; Yusuke Fujiwara; Kazuki Terada; Shunsuke Yui; Kunihito Arai; Tomoaki Kitano; Miho Miyata; Akiyo Kurosawa; Ayumi Mizoguchi; Norio Komatsu; Takahiro Fukuda; Kazuteru Ohashi; Yoshinobu Kanda; Koiti Inokuchi; Hiroki Yamaguchi

  Blood advances, 27 Aug. 2021

  
• Personalized prediction of overall survival in patients with AML in non‐complete remission undergoing allo‐HCT

  Shigeki Hirabayashi; Ryuji Uozumi; Tadakazu Kondo; Yasuyuki Arai; Takahito Kawata; Naoyuki Uchida; Atsushi Marumo; Kazuhiro Ikegame; Takahiro Fukuda; Tetsuya Eto; Masatsugu Tanaka; Atsushi Wake; Junya Kanda; Takafumi Kimura; Ken Tabuchi; Tatsuo Ichinohe; Yoshiko Atsuta; Masamitsu Yanada; Shingo Yano

  Cancer Medicine, 16 Jun. 2021

  Access this paper :

  
• Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation.

  Sachiko Seo; Yoshiaki Usui; Keitaro Matsuo; Yoshiko Atsuta; Aiko Igarashi; Takahiro Fukuda; Yukiyasu Ozawa; Yuta Katayama; Shuro Yoshida; Naoyuki Uchida; Tadakazu Kondo; Shinichi Kako; Nobuhiro Tsukada; Shunichi Kato; Makoto Onizuka; Tatsuo Ichinohe; Fumihiko Kimura; Yoshinobu Kanda; Koichi Miyamura; Junya Kanda

  Bone marrow transplantation, 14 May 2021

  
• Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia with high hyperdiploidy: a retrospective nationwide study.

  Shuhei Kurosawa; Satoshi Kaito; Naoyuki Uchida; Takahiro Fukuda; Noriko Doki; Takehiko Mori; Yuichi Hasegawa; Satoru Takada; Emiko Sakaida; Masatsugu Tanaka; Kazuhiro Ikegame; Junya Kanda; Yoshiko Atsuta; Shinichi Kako

  Leukemia & lymphoma, 12 May 2021

  
• Detection of adenovirus hepatitis and acute liver failure in allogeneic hematopoietic stem cell transplant patients

  Yoshiyuki Onda; Junya Kanda; Soichiro Sakamoto; Mutsumi Okada; Naoyuki Anzai; Hiroshi Umadome; Masaro Tashima; Hironori Haga; Chihiro Watanabe; Nozomu Hanaoka; Tsuguto Fujimoto; Akifumi Takaori‐Kondo

  Transplant Infectious Disease, 04 Apr. 2021

  Access this paper :

  
• Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantation.

  Harada K; Kimura SI; Fuji S; Najima Y; Yakushijin K; Uchida N; Onizuka M; Ikegame K; Yano S; Shingai N; Matsuoka KI; Onishi Y; Sawa M; Takada S; Nakasone H

  Bone marrow transplantation, Apr. 2021

  
• Multiple thrombosis during eltrombopag therapy

  Yutaka Shimazu; Junya Kanda

  eJHaem, 13 Mar. 2021

  
• Possible nosocomial transmission of virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation

  Yoshiyuki Onda; Junya Kanda; Nozomu Hanaoka; Mizuki Watanabe; Yasuyuki Arai; Masakatsu Hishizawa; Tadakazu Kondo; Kouhei Yamashita; Miki Nagao; Tsuguto Fujimoto; Akifumi Takaori-Kondo

  Annals of Hematology, 13 Mar. 2021

  Access this paper :

  
• Does one model fit all? Predicting non-relapse mortality after allogeneic hematopoietic cell transplantation

  Masamitsu Yanada; Naoyuki Uchida; Tatsuo Ichinohe; Takahiro Fukuda; Junya Kanda; Yoshinobu Kanda; Yoshiko Atsuta; Hideki Nakasone

  Bone Marrow Transplantation, 03 Mar. 2021

  
• Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma

  Teruhito Takakuwa; Kensuke Ohta; Eiji Nakatani; Tomoki Ito; Hitomi Kaneko; Shin-Ichi Fuchida; Yuji Shimura; Hideo Yagi; Hirohiko Shibayama; Junya Kanda; Hitoji Uchiyama; Satoru Kosugi; Hirokazu Tanaka; Eri Kawata; Nobuhiko Uoshima; Jun Ishikawa; Masaru Shibano; Takahiro Karasuno; Maki Shindo; Yoshifumi Shimizu; Kazunori Imada; Yuzuru Kanakura; Junya Kuroda; Masayuki Hino; Shosaku Nomura; Akifumi Takaori-Kondo; Chihiro Shimazaki; Itaru Matsumura

  HEMATOLOGICAL ONCOLOGY, Mar. 2021

  
• CD19 CAR-T細胞療法における白血球アフェレーシスの経験 国内最多2施設による共同研究

  城 友泰; 吉原 哲; 新井 康之; 池本 純子; 小野本 仁美; 杉山 寛貴; 吉原 享子; 松井 恵子; 丹羽 紀実; 中川 陽子; 北脇 年雄; 諫田 淳也; 高折 晃史; 長尾 美紀

  臨床血液, Mar. 2021

  
• Impact of event-free survival status after stem cell transplantation on subsequent survival of patients with lymphoma.

  Fujimoto A; Anzai T; Fukuda T; Uchida N; Ohta T; Mori T; Sawa M; Yoshioka S; Miyamoto T; Uchiyama H; Katayama Y; Matsuoka KI; Shiratori S; Suzuki R

  Blood advances, Mar. 2021

  
• Higher exercise tolerance early after allogeneic hematopoietic stem cell transplantation is the predictive marker for higher probability of later social reintegration.

  Hamada R; Arai Y; Kondo T; Harada K; Murao M; Miyasaka J; Yoshida M; Yonezawa H; Nankaku M; Ouchi S; Kitakubo W; Wadayama T; Kanda J; Matsuda S

  Scientific reports, Mar. 2021

  Access this paper :

  
• Favorable Outcomes after Single Cord Blood Transplantation for Patients with High-Risk Hematologic Diseases: A Single-Institute Retrospective Analysis.

  Wada F; Kanda J; Watanabe M; Arai Y; Hishizawa M; Kondo T; Yamashita K; Takaori-Kondo A

  Transplantation and cellular therapy, Feb. 2021

  Access this paper :

  
• Reduced leukemia relapse through cytomegalovirus reactivation in killer cell immunoglobulin-like receptor-ligand-mismatched cord blood transplantation

  Hisayuki Yokoyama; Junya Kanda; Yuta Kawahara; Naoyuki Uchida; Masatsugu Tanaka; Satoshi Takahashi; Makoto Onizuka; Yuma Noguchi; Yukiyasu Ozawa; Yuna Katsuoka; Shuichi Ota; Takanori Ohta; Takafumi Kimura; Yoshinobu Kanda; Tatsuo Ichinohe; Yoshiko Atsuta; Hideki Nakasone; Satoko Morishima

  Bone Marrow Transplantation, 08 Jan. 2021

  
• Analysis of factors associated with patient-reported physical functioning scores at discharge of allogeneic hematopoietic stem cell transplantation patients: a cross-sectional study

  Masanobu Murao; Ryota Hamada; Tadakazu Kondo; Junsuke Miyasaka; Michiko Yoshida; Honami Yonezawa; Yasuyuki Arai; Junya Kanda; Manabu Nankaku; Ryosuke Ikeguchi; Akifumi Takaori-Kondo; Shuichi Matsuda

  Supportive Care in Cancer, 2021

  Access this paper :

  
• [Clinical experience of leukapheresis for CD19 CAR-T cell therapy].

  Jo T; Yoshihara S; Arai Y; Ikemoto J; Onomoto H; Sugiyama H; Yoshihara K; Matsui K; Niwa N; Nakagawa Y; Kitawaki T; Kanda J; Takaori-Kondo A; Nagao M

  [Rinsho ketsueki] The Japanese journal of clinical hematology, Jan. 2021

  
• Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission.

  Konuma T; Kanda J; Yamasaki S; Harada K; Shimomura Y; Terakura S; Mizuno S; Uchida N; Tanaka M; Doki N; Ozawa Y; Nakamae H; Sawa M; Matsuoka KI; Yanada M

  Transplantation and cellular therapy, Jan. 2021

  
• Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis.

  Takakuwa T; Yamamura R; Ohta K; Kaneko H; Imada K; Nakaya A; Fuchida SI; Shibayama H; Matsuda M; Shimazu Y; Adachi Y; Kosugi S; Uchiyama H; Tanaka H; Nomura S

  European journal of haematology, Jan. 2021

  
• Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation.

  Sakurai M; Mori T; Kato K; Kanaya M; Mizuno S; Shiratori S; Wakayama T; Uchida N; Kobayashi H; Kubo K; Amano I; Ohta T; Miyazaki Y; Kanda J; Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

  Bone marrow transplantation, Jan. 2021

  
• Impact of HLA class I allele-level mismatch on viral infection within 100 days after cord blood transplantation.

  Iemura T; Arai Y; Kanda J; Kitawaki T; Hishizawa M; Kondo T; Yamashita K; Takaori-Kondo A

  Scientific reports, Dec. 2020

  
• Indication and benefit of upfront hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma in the era of ALL-type induction therapies.

  Morita-Fujita M; Arai Y; Yoshioka S; Ishikawa T; Kanda J; Kondo T; Akasaka T; Ueda Y; Imada K; Moriguchi T; Yago K; Kitano T; Yonezawa A; Nohgawa M; Kyoto Stem Cell Transplantation Group (KSCTG)

  Scientific reports, Dec. 2020

  Access this paper :

  
• Portal vein thrombosis due to essential thrombocythemia with limited cutaneous systemic sclerosis.

  Iwaki K; Ueda Y; Mishima M; Narukami S; Shiokawa M; Sawada K; Kanda J; Takahashi K; Seno H

  Clinical journal of gastroenterology, Nov. 2020

  
• Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors.

  Morishima S; Fukuda T; Doki N; Mori T; Onizuka M; Kawakita T; Kato C; Ozawa Y; Tanaka M; Kurokawa M; Kamimura T; Inoue M; Tanaka J; Ichinohe T; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation

  Bone marrow transplantation, Oct. 2020

  
• Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation

  Kaito Harada; Shigeo Fuji; Sachiko Seo; Junya Kanda; Toshimitsu Ueki; Fumihiko Kimura; Koji Kato; Naoyuki Uchida; Kazuhiro Ikegame; Makoto Onizuka; Ken-ichi Matsuoka; Noriko Doki; Toshiro Kawakita; Yasushi Onishi; Shingo Yano; Takahiro Fukuda; Minoko Takanashi; Yoshinobu Kanda; Yoshiko Atsuta; Masao Ogata

  Bone Marrow Transplantation, 12 Sep. 2020, Peer-reviewed

  
• Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCT.

  Yamasaki S; Mori J; Kanda J; Imahashi N; Uchida N; Doki N; Tanaka M; Katayama Y; Eto T; Ozawa Y; Takada S; Onizuka M; Hino M; Kanda Y; Fukuda T; Atsuta Y; Yanada M

  Annals of hematology, Sep. 2020

  
• Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry.

  Nakaya A; Kohara T; Shibayama H; Onda Y; Kanda J; Kaneko H; Imada K; Kida T; Kosugi S; Ishikawa J; Yamamura R; Shimazu Y; Tanaka H; Fuchida SI; Kansai Myeloma Forum Investigators

  International journal of hematology, Sep. 2020

  
• Clinical Benefits of Preconditioning Intervention in Patients with Relapsed or Refractory Acute Myelogenous Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A Kanto Study of Group for Cell Therapy Multicenter Analysis.

  Tachibana T; Kanda J; Ishizaki T; Najima Y; Tanaka M; Doki N; Fujiwara SI; Kimura SI; Onizuka M; Takahashi S; Saito T; Mori T; Fujisawa S; Sakaida E; Kanto Study Group for Cell Therapy (KSGCT)

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Sep. 2020

  
• Allogeneic stem cell transplantation for patients with aggressive NK-cell leukemia.

  Fujimoto A; Ishida F; Izutsu K; Yamasaki S; Chihara D; Suzumiya J; Mitsui T; Doki N; Sakai H; Kobayashi H; Kanda J; Fukuda T; Atsuta Y; Suzuki R

  Bone marrow transplantation, Aug. 2020

  
• Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.

  Nakaya A; Tanaka H; Yagi H; Ohta K; Shibayama H; Kohara T; Kanda J; Shindo M; Shimura Y; Kosugi S; Kida T; Kaneko H; Imada K; Karasuno T; Matsuda M; Kansai Myeloma Forum Investigators

  International journal of hematology, Aug. 2020

  
• Predicting non-relapse mortality following allogeneic hematopoietic cell transplantation during first remission of acute myeloid leukemia.

  Yanada M; Konuma T; Mizuno S; Saburi M; Shinohara A; Tanaka M; Marumo A; Sawa M; Uchida N; Ozawa Y; Onizuka M; Yoshioka S; Nakamae H; Kondo T; Yano S

  Bone marrow transplantation, Aug. 2020

  
• Updated Comparison of 7/8 HLA Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Umbilical Cord Blood Transplantation as Alternative Donors in Adults with Acute Leukemia.

  Miyao K; Terakura S; Kimura F; Konuma T; Miyamura K; Yanada M; Kako S; Morhishima S; Uchida N; Toya T; Ozawa Y; Fukuda T; Tanaka M; Sawa M; Takada S; Donor/Source Working Group of the Japan Society for Hematopoietic Cell Transplantation

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Aug. 2020, Peer-reviewed

  
• Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders

  Mizuki Watanabe; Junya Kanda; Masakatsu Hishizawa; Momoko Nishikori; Tadakazu Kondo; Kouhei Yamashita; Akifumi Takaori-Kondo

  Annals of Hematology, 20 Jul. 2020, Peer-reviewed

  Access this paper :

  
• Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT

  Hiroyuki Matsui; Yasuyuki Arai; Hiroharu Imoto; Takaya Mitsuyoshi; Naoki Tamura; Tadakazu Kondo; Junya Kanda; Takayuki Ishikawa; Kazunori Imada; Yasunori Ueda; Yusuke Toda; Naoyuki Anzai; Kazuhiro Yago; Masaharu Nohgawa; Akihito Yonezawa; Hiroko Tsunemine; Mitsuru Itoh; Kazuyo Yamamoto; Masaaki Tsuji; Toshinori Moriguchi; Akifumi Takaori-Kondo

  Blood Advances, 14 Jul. 2020

  Access this paper :

  
• Effect of graft-versus-host disease on outcomes after pediatric single cord blood transplantation

  Junya Kanda; Katsutsugu Umeda; Koji Kato; Makoto Murata; Junichi Sugita; Souichi Adachi; Katsuyoshi Koh; Maiko Noguchi; Hiroaki Goto; Nao Yoshida; Maho Sato; Yuhki Koga; Tsukasa Hori; Yuko Cho; Atsushi Ogawa; Masami Inoue; Yoshiko Hashii; Yoshiko Atsuta; Takanori Teshima

  Bone Marrow Transplantation, 11 Jul. 2020, Peer-reviewed

  
• Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation for Mature T Cell and Natural Killer Cell Neoplasms in the Kyoto Stem Cell Transplantation Group.

  Watanabe M; Kanda J; Arai Y; Hishizawa M; Nishikori M; Ishikawa T; Imada K; Ueda Y; Akasaka T; Yonezawa A; Nohgawa M; Kitano T; Itoh M; Takeoka T; Kyoto Stem Cell Transplantation Group (KSCTG)

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Jul. 2020

  
• The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse.

  Kurosawa S; Yamaguchi H; Yamaguchi T; Fukunaga K; Yui S; Kanamori H; Usuki K; Uoshima N; Yanada M; Takeuchi J; Mizuno I; Kanda J; Okamura H; Yano S; Fukuda T

  International journal of hematology, Jun. 2020, Peer-reviewed

  
• Comparison of reduced-intensity/toxicity conditioning regimens for umbilical cord blood transplantation for lymphoid malignancies.

  Imahashi N; Terakura S; Kondo E; Kako S; Uchida N; Kobayashi H; Inamoto Y; Sakai H; Tanaka M; Ishikawa J; Kozai Y; Matsuoka KI; Kimura T; Fukuda T; Donor/Source Working Group of the Japan Society for Hematopoietic Cell Transplantation

  Bone marrow transplantation, May 2020

  
• Drug monitoring for mycophenolic acid in graft-vs-host disease prophylaxis in cord blood transplantation.

  Muranushi H; Kanda J; Arai Y; Shindo T; Hishizawa M; Yamamoto T; Kondo T; Yamashita K; Matsubara K; Takaori-Kondo A

  British journal of clinical pharmacology, May 2020, Peer-reviewed

  Access this paper :

  
• Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic/Myeloproliferative Neoplasms-Unclassifiable: A Retrospective Nationwide Study of the Japan Society for Hematopoietic Cell Transplantation.

  Kurosawa S; Shimomura Y; Tachibana T; Ishiyama K; Ota S; Kobayashi T; Uchida N; Fukushima K; Ashida T; Matsuoka KI; Kanda J; Ichinohe T; Atsuta Y; Aoki J

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, May 2020, Peer-reviewed

  
• Wide availability of HLA-matched or a few loci-mismatched donors in the graft-vs-host direction among nonsibling first-degree relatives.

  Watanabe M; Kanda J; Kojima H; Ikeda N; Fuji S; Kanda Y; Saji H; Tanaka H

  HLA, Apr. 2020

  
• Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study.

  Ikeda K; Ohto H; Yamada-Fujiwara M; Okuyama Y; Fujiwara SI; Muroi K; Mori T; Kasama K; Kanamori H; Iseki T; Nagamura-Inoue T; Kameda K; Kanda J; Tanosaki R

  Transfusion, Apr. 2020, Peer-reviewed

  
• Favorable Effect of Cytomegalovirus Reactivation on Outcomes in Cord Blood Transplant and Its Differences Among Disease Risk or Type.

  Yokoyama H; Takenaka K; Nishida T; Seo S; Shinohara A; Uchida N; Tanaka M; Takahashi S; Onizuka M; Kozai Y; Yasuhiro S; Ozawa Y; Katsuoka Y; Doki N; Japan Society for Hematopoietic Cell Transplantation Transplantation-Related Complication Working Group

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Apr. 2020, Peer-reviewed

  
• Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan.

  Yamashita T; Takami A; Uchida N; Fukuda T; Eto T; Shiratori S; Ota S; Akasaka T; Miyakoshi S; Kondo T; Hidaka M; Kanda J; Atsuta Y; Yano S

  Bone marrow transplantation, Mar. 2020

  
• Influence of HLA 1-3-locus mismatch and antithymocyte globulin administration in unrelated bone marrow transplantation.

  Kawamura K; Kanda J; Ohashi K; Fukuda T; Iwato K; Eto T; Fujiwara SI; Mori T; Fukushima K; Ozawa Y; Uchida N; Ashida T; Ichinohe T; Atsuta Y; Kanda Y

  Annals of hematology, Mar. 2020, Peer-reviewed

  
• Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation.

  Kaito S; Nakajima Y; Hara K; Toya T; Nishida T; Uchida N; Mukae J; Fukuda T; Ozawa Y; Tanaka M; Ikegame K; Katayama Y; Kuriyama T; Kanda J; Atsuta Y; Ohashi K

  Blood advances, Mar. 2020, Peer-reviewed

  
• Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT collaborative study

  Junya Kanda; Hiromi Hayashi; Annalisa Ruggeri; Fumihiko Kimura; Fernanda Volt; Satoshi Takahashi; Myriam Labopin; Shinichi Kako; Karina Tozatto-Maio; Shingo Yano; Guillermo Sanz; Naoyuki Uchida; Maria Teresa Van Lint; Seiko Kato; Mohamad Mohty; Edouard Forcade; Heiwa Kanamori; Jorge Sierra; Yuju Ohno; Riccardo Saccardi; Takahiro Fukuda; Tatsuo Ichinohe; Minoko Takanashi; Vanderson Rocha; Shinichiro Okamoto; Arnon Nagler; Yoshiko Atsuta; Eliane Gluckman

  Leukemia, 14 Jan. 2020, Peer-reviewed

  
• Hematopoietic Stem Cell Transplantation From a Related Donor with Human Leukocyte Antigen 1-Antigen Mismatch in the Graft-Versus-Host Direction Using Low-dose Anti-thymocyte Globulin

  Junya Kanda; Toshihiko Ando; Shun-ichi Kimura; Shin-ichiro Fujiwara; Kazunori Imada; Shin Fujisawa; Takayoshi Tachibana; Yoshiko Atsuta; Yoshinobu Kanda

  Cell Transplantation, 01 Jan. 2020

  
• Outcomes and Prognostic Factors for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A KSGCT Multicenter Analysis.

  Tachibana T; Kanda J; Ishizaki T; Najima Y; Tanaka M; Doki N; Fujiwara SI; Kimura SI; Onizuka M; Takahashi S; Saito T; Mori T; Fujisawa S; Sakaida E; Kanto Study Group for Cell Therapy (KSGCT)

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Jan. 2020, Peer-reviewed

  
• Outcomes of allogeneic stem cell transplantation for DLBCL: a multi-center study from the Kyoto Stem Cell Transplantation Group

  Kiyotaka Izumi; Junya Kanda; Momoko Nishikori; Yasuyuki Arai; Takayuki Ishikawa; Satoshi Yoshioka; Yasunori Ueda; Takeshi Maeda; Akihito Yonezawa; Naoyuki Anzai; Toshinori Moriguchi; Kazunori Imada; Takashi Akasaka; Masaharu Nohgawa; Mitsuru Itoh; Akiko Aiba; Hiroko Tsunemine; Mitsumasa Watanabe; Tadakazu Kondo; Akifumi Takaori-Kondo

  Annals of Hematology, 12 Dec. 2019, Peer-reviewed

  
• Improvement of early mortality in single-unit cord blood transplantation for Japanese adults from 1998 to 2017.

  Konuma T; Kanda J; Inamoto Y; Hayashi H; Kobayashi S; Uchida N; Sugio Y; Tanaka M; Kobayashi H; Kouzai Y; Takahashi S; Eto T; Mukae J; Matsuhashi Y; Kimura F

  American journal of hematology, Dec. 2019, Peer-reviewed

  
• Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis

  Takayoshi Tachibana; Junya Kanda; Takuma Ishizaki; Yuho Najima; Masatsugu Tanaka; Noriko Doki; Shin-ichiro Fujiwara; Shun-ichi Kimura; Makoto Onizuka; Satoshi Takahashi; Takeshi Saito; Takehiko Mori; Shin Fujisawa; Emiko Sakaida; Kenji Matsumoto; Nobuyuki Aotsuka; Moritaka Goto; Reiko Watanabe; Katsuhiro Shono; Kensuke Usuki; Nobuhiro Tsukada; Heiwa Kanamori; Yoshinobu Kanda; Shinichiro Okamoto

  Leukemia, 30 Nov. 2019, Peer-reviewed

  
• Recent progress in haploidentical transplantation: is this the optimal choice for alternative donor transplantation?

  Watanabe M; Kanda J

  Current opinion in hematology, Nov. 2019

  
• Effect of the severity of acute graft-versus-host disease on physical function after allogeneic hematopoietic stem cell transplantation.

  Hamada R; Kondo T; Murao M; Miyasaka J; Yoshida M; Nankaku M; Kanda J; Takaori-Kondo A; Ikeguchi R; Matsuda S

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, Nov. 2019, Peer-reviewed

  
• Impact of HLA Allele Mismatch at HLA-A, -B, -C, and -DRB1 in Single Cord Blood Transplantation.

  Yokoyama H; Morishima Y; Fuji S; Uchida N; Takahashi S; Onizuka M; Tanaka M; Yuju O; Eto T; Ozawa Y; Takada S; Takanashi M; Kato K; Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Nov. 2019, Peer-reviewed

  
• Increased Relapse Risk of Acute Lymphoid Leukemia in Homozygous HLA-C1 Patients after HLA-Matched Allogeneic Transplantation: A Japanese National Registry Study.

  Arima N; Kanda J; Yabe T; Morishima Y; Tanaka J; Kako S; Sakaguchi H; Kato M; Ohashi K; Ozawa Y; Fukuda T; Ota S; Tachibana T; Onizuka M; Ichinohe T; Kanda Y

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Nov. 2019, Peer-reviewed

  
• ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation

  Fumihiko Kimura; Junya Kanda; Ken Ishiyama; Toshio Yabe; Kota Yoshifuji; Takahiro Fukuda; Yukiyasu Ozawa; Koji Iwato; Tetsuya Eto; Takehiko Mori; Naoyuki Uchida; Shuichi Ota; Toru Sakura; Tatsuo Ichinohe; Yoshiko Atsuta; Yoshinobu Kanda

  Bone Marrow Transplantation, 13 Oct. 2019, Peer-reviewed

  
• Effects of Haplotype Matching on Outcomes after Adult Single-Cord Blood Transplantation.

  Kanda J; Kawase T; Tanaka H; Kojima H; Morishima Y; Uchida N; Nagafuji K; Matsuhashi Y; Ohta T; Onizuka M; Sakura T; Takahashi S; Miyakoshi S; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Oct. 2019, Peer-reviewed

  
• Time-Varying Effects of Graft Type on Outcomes for Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.

  Yanada M; Konuma T; Yamasaki S; Kuwatsuka Y; Masuko M; Tanaka M; Ozawa Y; Toya T; Fukuda T; Ota S; Sawa M; Uchida N; Nakamae H; Eto T; Kanda J; Yano S

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Oct. 2019, Peer-reviewed

  
• Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia: a KSGCT multicenter retrospective analysis.

  Tachibana T; Ishizaki T; Takahashi S; Najima Y; Kimura SI; Sakaida E; Onizuka M; Mori T; Fujisawa S; Fujiwara SI; Saito T; Hagihara M; Aotsuka N; Kanto Study Group for Cell Therapy (KSGCT)

  Bone marrow transplantation, Sep. 2019, Peer-reviewed

  
• Impact of Homozygous Conserved Extended HLA Haplotype on Single Cord Blood Transplantation: Lessons for Induced Pluripotent Stem Cell Banking and Transplantation in Allogeneic Settings.

  Morishima Y; Morishima S; Murata M; Arima N; Uchida N; Sugio Y; Takahashi S; Matsuhashi Y; Onizuka M; Eto T; Nagafuji K; Onishi Y; Inoue M; Atsuta Y; Kanda J

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Sep. 2019, Peer-reviewed

  
• Conditioning Intensity for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Poor-Prognosis Cytogenetics in First Complete Remission.

  Konuma T; Kondo T; Mizuno S; Doki N; Aoki J; Fukuda T; Tanaka M; Sawa M; Katayama Y; Uchida N; Ozawa Y; Morishige S; Matsuoka KI; Ichinohe T; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Sep. 2019, Peer-reviewed

  
• Clinical significance of low-dose total body irradiation in HLA-mismatched reduced-intensity stem cell transplantation

  Shin-ichiro Fujiwara; Junya Kanda; Raine Tatara; Hiroyasu Ogawa; Takahiro Fukuda; Hirokazu Okumura; Kazuteru Ohashi; Koji Iwato; Yasunori Ueda; Ken Ishiyama; Tetsuya Eto; Ken-ichi Matsuoka; Hirohisa Nakamae; Makoto Onizuka; Yoshiko Atsuta; Yoshinobu Kanda

  Bone Marrow Transplantation, 22 Aug. 2019, Peer-reviewed

  
• Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia.

  Sakaguchi M; Yamaguchi H; Kuboyama M; Najima Y; Usuki K; Ueki T; Oh I; Mori S; Kawata E; Uoshima N; Kobayashi Y; Kako S; Tajika K; Shono K; Inokuchi K

  International journal of hematology, Aug. 2019, Peer-reviewed

  
• Impact of High-Frequency HLA Haplotypes on Clinical Cytomegalovirus Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation.

  Kawase T; Tanaka H; Kojima H; Uchida N; Ohashi K; Fukuda T; Ozawa Y; Ikegame K; Eto T; Mori T; Miyamoto T; Hidaka M; Shiratori S; Takanashi M; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Aug. 2019, Peer-reviewed

  
• Guest Editorial: Are “alternative” stem cell sources still alternative in the new era?

  Junya K; a

  International Journal of Hematology, 28 Jul. 2019, Peer-reviewed

  
• Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation

  Hisayuki Yokoyama; Junya Kanda; Shunichi Kato; Eisei Kondo; Yoshinobu Maeda; Hiroo Saji; Satoshi Takahashi; Makoto Onizuka; Yasushi Onishi; Yukiyasu Ozawa; Heiwa Kanamori; Jun Ishikawa; Yuju Ohno; Tatsuo Ichinohe; Minoko Takanashi; Koji Kato; Yoshiko Atsuta; Yoshinobu Kanda

  Bone Marrow Transplantation, 06 Jul. 2019, Peer-reviewed

  
• Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromes.

  Kawabata H; Usuki K; Shindo-Ueda M; Kanda J; Tohyama K; Matsuda A; Araseki K; Hata T; Suzuki T; Kayano H; Shimbo K; Chiba S; Ishikawa T; Arima N; Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes

  International journal of hematology, Jul. 2019, Peer-reviewed

  
• 造血細胞輸注に伴う有害事象に関する前向き研究 小児および低体重症例解析

  皆川 敬治; 大戸 斉; 奥山 美樹; 藤原 実名美; 金森 平和; 藤原 慎一郎; 室井 一男; 森 毅彦; 笠間 絹代; 井関 徹; 長村 登紀子; 藤井 伸治; 芦田 隆司; 亀田 和明; 諫田 淳也; 廣瀬 朝生; 高橋 勉; 長井 一浩; 田野崎 隆二; 池田 和彦

  日本輸血細胞治療学会誌, Jun. 2019

  
• Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemia.

  Yanada M; Mori J; Aoki J; Masuko M; Harada K; Uchida N; Doki N; Fukuda T; Sakura T; Kanamori H; Sawa M; Kondo T; Katayama Y; Kanda J; Ichinohe T; Atsuta Y; Yano S

  Annals of hematology, Jun. 2019

  
• BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient.

  Nakasone H; Kawamura K; Yakushijin K; Shinohara A; Tanaka M; Ohashi K; Ota S; Uchida N; Fukuda T; Nakamae H; Matsuoka KI; Kanda J; Ichinohe T; Ogata M

  Blood advances, Jun. 2019, Peer-reviewed

  
• 侵攻性ナチュラルキラー細胞白血病患者に対する同種異系造血幹細胞移植 日本における全国多施設共同研究(Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Aggressive Natural Killer Cell Leukemia: A Nationwide Multicenter Analysis in Japan)

  藤本 亜弓; 石田 文宏; 伊豆津 宏二; 山崎 聡; 千原 大; 鈴宮 淳司; 三井 哲夫; 大橋 一輝; 中澤 英之; 小林 光; 諫田 淳也; 福田 隆浩; 熱田 由子; 鈴木 律朗

  日本リンパ網内系学会会誌, May 2019

  
• Unit selection for umbilical cord blood transplantation for adults with acute myeloid leukemia in complete remission: a Japanese experience.

  Yanada M; Konuma T; Kuwatsuka Y; Kondo T; Kawata T; Takahashi S; Uchida N; Miyakoshi S; Tanaka M; Ozawa Y; Sawa M; Nakamae H; Aotsuka N; Kanda J; Yano S

  Bone marrow transplantation, May 2019, Peer-reviewed

  
• Impact of cumulative steroid dose on infectious diseases after allogenic hematopoietic stem cell transplantation

  Mizuki Watanabe; Junya Kanda; Masakatsu Hishizawa; Tadakazu Kondo; Kouhei Yamashita; Akifumi Takaori‐Kondo

  Transplant Infectious Disease, 06 Apr. 2019, Peer-reviewed

  Access this paper :

  
• 造血細胞輸注に伴う有害事象に関する前向き研究 小児・低体重患者についての解析

  藤原 実名美; 池田 和彦; 大戸 斉; 奥山 美樹; 金森 平和; 藤原 慎一郎; 室井 一男; 森 毅彦; 笠間 絹代; 井関 徹; 長村 登紀子; 藤井 伸治; 芦田 隆司; 亀田 和明; 諫田 淳也; 廣瀬 朝生; 高橋 勉; 長井 一浩; 皆川 敬治; 田野崎 隆二

  日本輸血細胞治療学会誌, Apr. 2019

  
• Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndrome.

  Shimomura Y; Hara M; Tachibana T; Ohashi K; Sakura T; Fukuda T; Nakazawa H; Iwato K; Kanda Y; Ikeda T; Eto T; Kanda J; Ichinohe T; Atsuta Y; Ishikawa T; Ishiyama K

  British journal of haematology, Apr. 2019, Peer-reviewed

  
• Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma.

  Sawayama Y; Itonaga H; Fukushima T; Nakano N; Fujiwara H; Utsunomiya A; Fukuda T; Miyamoto T; Eto T; Miyashita K; Nakamae H; Ogata M; Yamanoha A; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation

  American journal of hematology, Mar. 2019, Peer-reviewed

  
• Lymphocyte Area Under the Curve as a Predictive Factor for Viral Infection after Allogenic Hematopoietic Stem Cell Transplantation

  Mizuki Watanabe; Junya Kanda; Masakatsu Hishizawa; Tadakazu Kondo; Kouhei Yamashita; Akifumi Takaori-Kondo

  Biology of Blood and Marrow Transplantation, Mar. 2019, Peer-reviewed

  Access this paper :

  
• Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT.

  Fuji S; Miyamura K; Kanda Y; Fukuda T; Kobayashi T; Ozawa Y; Iwato K; Uchida N; Eto T; Ashida T; Mori T; Sawa M; Ichinohe T; Atsuta Y; Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation

  International journal of hematology, Mar. 2019, Peer-reviewed

  
• Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia

  Motohiro Kato; Mio Kurata; Junya Kanda; Koji Kato; Daisuke Tomizawa; Kazuko Kudo; Nao Yoshida; Kenichiro Watanabe; Hiroyuki Shimada; Jiro Inagaki; Katsuyoshi Koh; Hiroaki Goto; Keisuke Kato; Yuko Cho; Yuki Yuza; Atsushi Ogawa; Keiko Okada; Masami Inoue; Yoshiko Hashii; Takanori Teshima; Makoto Murata; Yoshiko Atsuta

  Bone Marrow Transplantation, 24 Jan. 2019, Peer-reviewed

  
• Haploidentical transplantation using low-dose alemtuzumab: Comparison with haploidentical transplantation using low-dose thymoglobulin.

  Kako S; Gomyo A; Akahoshi Y; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Kanda Y

  European journal of haematology, Jan. 2019

  
• Effect of laminar air flow and building construction on aspergillosis in acute leukemia patients: a retrospective cohort study.

  Iwasaki M; Kanda J; Hishizawa M; Kitano T; Kondo T; Yamashita K; Takaori-Kondo A

  BMC infectious diseases, Jan. 2019, Peer-reviewed

  Access this paper :

  
• HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome.

  Maeda Y; Ugai T; Kondo E; Ikegame K; Murata M; Uchida N; Miyamoto T; Takahashi S; Ohashi K; Nakamae H; Fukuda T; Onizuka M; Eto T; Ota S; Hirokawa M; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation

  Haematologica, Dec. 2018, Peer-reviewed

  
• A Prospective, Multicenter Surveillance Study for Adverse Events Associated with Hematopoietic Stem Cell Infusion: Analysis of Pediatric and Low Body-Weight Recipients

  Ikeda Kazuhiko; Ohto Hitoshi; Okuyama Yoshiki; Yamada-Fujiwara Minami; Kanamori Heiwa; Fujiwara Shin-ichiro; Muroi Kazuo; Mori Takehiko; Kasama Kinuyo; Iseki Tohru; Nagamura-Inoue Tokiko; Fujii Nobuharu; Ashida Takashi; Kameda Kazuaki; Kanda Junya; Hirose Asao; Takahashi Tsutomu; Nagai Kazuhiro; Minakawa Keiji; Tanosaki Ryuji

  BLOOD, 29 Nov. 2018, Peer-reviewed

  
• Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma.

  Yamasaki S; Chihara D; Kim SW; Kawata T; Mizuta S; Ago H; Chou T; Yamane T; Uchiyama H; Oyake T; Miura K; Saito B; Taji H; Nakamae H; Miyamoto T; Suzuki R

  International journal of hematology, Nov. 2018

  
• Impact of the Use and Type of Antibiotics on Acute Graft-versus-Host Disease.

  Nishi K; Kanda J; Hishizawa M; Kitano T; Kondo T; Yamashita K; Takaori-Kondo A

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Nov. 2018, Peer-reviewed

  
• Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).

  Konuma T; Mizuno S; Kondo T; Yamaguchi H; Fukuda T; Uchida N; Najima Y; Kanamori H; Ota S; Nakamae H; Nakamae M; Mizuno I; Sugita J; Onishi Y; Yokota A; Takahashi S; Kanda Y; Ichinohe T; Atsuta Y; Yano S; Adult Acute; Myeloid; Leukemia Working; Group of; the Japan; Society for; Hematopoietic Cell Transplantation

  Annals of hematology, Nov. 2018, Peer-reviewed

  
• Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning.

  Harada K; Yanada M; Machida S; Kanamori H; Onizuka M; Ozawa Y; Kobayashi H; Sawa M; Katayama Y; Ohashi K; Kanda J; Ichinohe T; Atsuta Y; Yano S

  Leukemia & lymphoma, Nov. 2018, Peer-reviewed

  
• Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.

  Alousi A; Wang T; Hemmer MT; Spellman SR; Arora M; Couriel DR; Pidala J; Anderlini P; Boyiadzis M; Bredeson CN; Cahn JY; Cairo MS; Gadalla SM; Weisdorf DJ

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Oct. 2018, Peer-reviewed

  
• Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia.

  Sakaguchi M; Yamaguchi H; Najima Y; Usuki K; Ueki T; Oh I; Mori S; Kawata E; Uoshima N; Kobayashi Y; Kako S; Tajika K; Gomi S; Shono K; Kayamori K; Inokuchi K

  Blood advances, Oct. 2018, Peer-reviewed

  
• Outcome of gastrointestinal graft-versus-host disease according to the treatment response.

  Tamaki M; Nakasone H; Misaki Y; Yoshimura K; Gomyo A; Hayakawa J; Kusuda M; Akahoshi Y; Ishihara Y; Kawamura K; Tanihara A; Sato M; Terasako-Saito K; Kameda K; Wada H; Kikuchi M; Kimura SI; Kako S; Kanda Y

  Annals of hematology, Oct. 2018, Peer-reviewed

  
• Comparison of HLA Allele Mismatch and Antigen Mismatch in Unrelated Bone Marrow Transplantation in Patients with Leukemia.

  Atsuta Y; Kato S; Morishima Y; Ohashi K; Fukuda T; Ozawa Y; Eto T; Iwato K; Uchida N; Ota S; Onizuka M; Ichinohe T; Kanda J; Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Oct. 2018, Peer-reviewed

  
• Upfront allogeneic HCT vs remission induction chemotherapy followed by allogeneic HCT for acute myeloid leukemia with multilineage dysplasia: a propensity score matched analysis.

  Konuma T; Harada K; Yamasaki S; Mizuno S; Uchida N; Takahashi S; Onizuka M; Nakamae H; Hidaka M; Fukuda T; Ohashi K; Kohno A; Matsushita A; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation

  American journal of hematology, Oct. 2018, Peer-reviewed

  
• Lower glomerular filtration rate predicts increased hepatic and mucosal toxicity in myeloma patients treated with high-dose melphalan.

  Tamaki M; Nakasone H; Gomyo A; Hayakawa J; Akahoshi Y; Harada N; Kusuda M; Ishihara Y; Kawamura K; Tanihara A; Sato M; Terasako-Saito K; Kameda K; Wada H; Kikuchi M; Kimura SI; Kako S; Kanda Y

  International journal of hematology, Oct. 2018, Peer-reviewed

  
• 症候性骨髄腫1414例の後方視的解析 関西骨髄腫フォーラムからの最新報告(Retrospective analyses of 1,414 symptomatic multiple myeloma cases: update from Kansai Myeloma Forum)

  田中 宏和; 芹澤 憲太郎; 中谷 綾; 金子 仁臣; 太田 健介; 小杉 智; 八木 秀男; 花本 仁; 淵田 真一; 志村 勇司; 柴山 浩彦; 小原 尚恵; 中谷 英仁; 諫田 淳也; 魚嶋 伸彦; 和田 勝也; 烏野 隆博; 松井 利充; 内山 人二; 松田 光弘; 足立 陽子; 高折 晃史; 黒田 純也; 谷脇 雅史; 島崎 千尋; 日野 雅之; 今田 和典; 野村 昌作; 金倉 譲; 松村 到

  臨床血液, Sep. 2018

  
• Successful engraftment after cord blood transplantation from an HLA-homozygous donor (homo-to-hetero cord blood transplantation) in a primary myelofibrosis patient with broad HLA antibodies.

  Iemura T; Itoh M; Mano C; Oba A; Kawabata N; Horisawa Y; Matsui M; Miyahara Y; Kanda J

  Transfusion, Sep. 2018, Peer-reviewed

  
• 形質細胞腫の後方視的多施設共同研究(関西骨髄腫フォーラム)(Retrospective multi-centers study of plasmacytoma)

  中谷 綾; 田中 宏和; 八木 秀男; 太田 健介; 柴山 浩彦; 諫田 淳也; 新堂 真紀; 志村 勇司; 小杉 智; 木田 亨; 金子 仁臣; 今田 和典; 烏野 隆博; 松田 光弘; 飯田 正人; 足立 陽子; 淵田 真一; 魚嶋 伸彦; 内山 人二; 高橋 良一; 松井 利充; 和田 勝也; 清田 実希; 島崎 千尋; 日野 雅之; 黒田 純也; 金倉 譲; 高折 晃史; 野村 昌作; 松村 到

  臨床血液, Sep. 2018, Peer-reviewed

  
• Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation.

  Wada H; Kanda J; Akahoshi Y; Nakano H; Ugai T; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kimura SI; Kanda Y

  Hematology (Amsterdam, Netherlands), Jun. 2018, Peer-reviewed

  
• Adverse Events Associated with Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study

  Kazuhiko Ikeda; Hitoshi Ohto; Yoshiki Okuyama; Minami Yamada-Fujiwara; Heiwa Kanamori; Shin-ichiro Fujiwara; Kazuo Muroi; Takehiko Mori; Kinuyo Kasama; Tohru Iseki; Tokiko Nagamura-Inoue; Nobuharu Fujii; Takashi Ashida; Kazuaki Kameda; Junya Kanda; Asao Hirose; Tsutomu Takahashi; Kazuhiro Nagai; Keiji Minakawa; Ryuji Tanosaki

  Transfusion Medicine Reviews, Jun. 2018, Peer-reviewed

  
• 同種造血幹細胞移植後の急性移植片対宿主病の重症度が身体機能の回復に及ぼす影響

  濱田 涼太; 吉田 路子; 宮坂 淳介; 村尾 昌信; 南角 学; 諫田 淳也; 近藤 忠一; 高折 晃史; 池口 良輔; 松田 秀一

  The Japanese Journal of Rehabilitation Medicine, May 2018, Peer-reviewed

  
• Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302).

  Tachibana T; Kanda J; Machida S; Saito T; Tanaka M; Najima Y; Koyama S; Miyazaki T; Yamamoto E; Takeuchi M; Morita S; Kanda Y; Kanamori H; Okamoto S; Kanto Study Group for Cell Therapy (KSGCT)

  International journal of hematology, May 2018, Peer-reviewed

  
• Allogeneic haematopoietic cell transplantation for adult acute myeloid leukaemia in second remission: a retrospective study of the Adult Acute Myeloid Leukaemia Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT).

  Konuma T; Yanada M; Yamasaki S; Kuwatsuka Y; Fukuda T; Kobayashi T; Ozawa Y; Uchida N; Ota S; Hoshino T; Takahashi S; Kanda Y; Ueda Y; Takanashi M; Yano S

  British journal of haematology, May 2018, Peer-reviewed

  
• Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia.

  Arima N; Kanda J; Tanaka J; Yabe T; Morishima Y; Kim SW; Najima Y; Ozawa Y; Eto T; Kanamori H; Mori T; Kobayashi N; Kondo T; Nakamae H; Uchida N; Kanda Y

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Apr. 2018, Peer-reviewed

  
• Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data.

  Yoshinaga N; Kanda J; Aisa Y; Hagiwara S; Mori T; Fukuda T; Ishida Y; Hashimoto H; Iwato K; Kanda Y; Kurokawa M; Nakazawa H; Ota S; Uchida N; Takaori-Kondo A

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Mar. 2018, Peer-reviewed

  
• Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome

  Yu Akahoshi; Shun-Ichi Kimura; Ayumi Gomyo; Jin Hayakawa; Masaharu Tamaki; Naonori Harada; Machiko Kusuda; Kazuaki Kameda; Tomotaka Ugai; Hidenori Wada; Yuko Ishihara; Koji Kawamura; Kana Sakamoto; Miki Sato; Kiriko Terasako-Saito; Misato Kikuchi; Hideki Nakasone; Shinichi Kako; Yoshinobu Kanda

  Hematological Oncology, 01 Feb. 2018, Peer-reviewed

  
• Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study).

  Nakasone H; Terasako-Saito K; Hirano T; Wake A; Shimizu S; Kurita N; Yamazaki E; Usuki K; Akazawa K; Kanda J; Minauchi K; Yamamoto G; Tanimoto S; Kanda Y

  Hematological oncology, Feb. 2018, Peer-reviewed

  
• Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin.

  Kameda K; Kako S; Hayakawa J; Akahoshi Y; Komiya Y; Harada N; Ugai T; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Kanda J; Tanihara A; Wada H; Kanda Y

  Annals of hematology, Jan. 2018, Peer-reviewed

  
• Comparison of Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Allogeneic Transplantation Recipients 50 Years or Older.

  Koji Kawamura; Shinichi Kako; Shuichi Mizuta; Ken Ishiyama; Jun Aoki; Shingo Yano; Takahiro Fukuda; Naoyuki Uchida; Yukiyasu Ozawa; Tetsuya Eto; Koji Iwato; Heiwa Kanamori; Kaoru Kahata; Tadakazu Kondo; Masashi Sawa; Tatsuo Ichinohe; Yoshiko Atsuta; Yoshinobu Kanda

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Dec. 2017, Peer-reviewed

  
• Positive Cytotoxic Crossmatch Predicts Delayed Neutrophil Engraftment in Allogeneic Hematopoietic Cell Transplantation from HLA-Mismatched Related Donors.

  Kameda K; Nakasone H; Komiya Y; Kanda J; Gomyo A; Hayakawa J; Akahoshi Y; Tamaki M; Harada N; Kusuda M; Ugai T; Ishihara Y; Kawamura K; Sakamoto K; Kanda Y

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Nov. 2017, Peer-reviewed

  
• Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation

  K Kawamura; J Kanda; S Fuji; M Murata; K Ikegame; K Yoshioka; T Fukuda; Y Ozawa; N Uchida; K Iwato; T Sakura; M Hidaka; H Hashimoto; T Ichinohe; Y Atsuta; Y Kanda

  Bone Marrow Transplantation, 17 Oct. 2017, Peer-reviewed

  
• D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations.

  Yui S; Kurosawa S; Yamaguchi H; Kanamori H; Ueki T; Uoshima N; Mizuno I; Shono K; Usuki K; Chiba S; Nakamura Y; Yanada M; Kanda J; Tajika K; Gomi S; Inokuchi K

  Annals of hematology, Oct. 2017, Peer-reviewed

  
• GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia

  S Terakura; Y Kuwatsuka; S Yamasaki; A Wake; J Kanda; Y Inamoto; S Mizuta; T Yamaguchi; N Uchida; Y Kouzai; N Aotsuka; H Ogawa; H Kanamori; K Nishiwaki; S Miyakoshi; M Onizuka; I Amano; T Fukuda; T Ichinohe; Y Atsuta; M Murata; T Teshima

  Bone Marrow Transplantation, 12 Sep. 2017, Peer-reviewed

  
• Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia.

  Yamasaki R; Kanda J; Akahoshi Y; Nakano H; Ugai T; Wada H; Kawamura K; Ishihara Y; Sakamoto K; Sato M; Ashizawa M; Machishima T; Terasako-Saito K; Kimura SI; Kikuchi M; Nakasone H; Yamazaki R; Kako S; Nishida J; Kanda Y

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Jun. 2017, Peer-reviewed

  
• Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.

  Hayakawa J; Kanda J; Akahoshi Y; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Yamazaki R; Kako S; Kanda Y

  INTERNATIONAL JOURNAL OF HEMATOLOGY, May 2017, Peer-reviewed

  
• HLA-mismatched haploidentical transplantation using low-dose anti-thymocyte globulin (ATG: thymoglobulin).

  Kako S; Akahoshi Y; Harada N; Nakano H; Kameda K; Ugai T; Yamasaki R; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Ashizawa M; Terasako-Saito K; Kimura SI; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kanda Y

  HEMATOLOGY, Apr. 2017, Peer-reviewed

  
• Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation.

  Kanda J; Morishima Y; Terakura S; Wake A; Uchida N; Takahashi S; Ono Y; Onishi Y; Kanamori H; Aotsuka N; Ozawa Y; Ogawa H; Sakura T; Ohashi K; Ichinohe T; Kato K; Atsuta Y; Teshima T; Murata M

  LEUKEMIA, Mar. 2017, Peer-reviewed

  
• Clinical characteristics and predictive factors for mortality in coryneform bacteria bloodstream infection in hematological patients.

  Kimura SI; Gomyo A; Hayakawa J; Akahoshi Y; Harada N; Ugai T; Komiya Y; Kameda K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kanda J; Kako S; Tanihara A; Kanda Y

  JOURNAL OF INFECTION AND CHEMOTHERAPY, Mar. 2017, Peer-reviewed

  
• Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion.

  Akahoshi Y; Kanda J; Ohno A; Komiya Y; Gomyo A; Hayakawa J; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Nakasone H; Kako S; Shiraki K; Kanda Y

  JOURNAL OF INFECTION AND CHEMOTHERAPY, Mar. 2017, Peer-reviewed

  
• Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial

  Takehiko Mori; Yoshinobu Kanda; Katsuto Takenaka; Shinichiro Okamoto; Jun Kato; Junya Kanda; Goichi Yoshimoto; Hisashi Gondo; Sayaka Doi; Masaki Inaba; Yoshihisa Kodera

  International Journal of Hematology, 01 Feb. 2017

  
• Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial.

  Mori T; Kanda Y; Takenaka K; Okamoto S; Kato J; Kanda J; Yoshimoto G; Gondo H; Doi S; Inaba M; Kodera Y

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Feb. 2017, Peer-reviewed

  
• Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia.

  Yamasaki S; Hirakawa A; Aoki J; Uchida N; Fukuda T; Ogawa H; Ohashi K; Kondo T; Eto T; Kanamori H; Okumura H; Iwato K; Ichinohe T; Kanda J; Onizuka M; Kuwatsuka Y; Yanada M; Atsuta Y; Takami A; Yano S

  ANNALS OF HEMATOLOGY, Feb. 2017, Peer-reviewed

  
• Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen.

  Yokoyama H; Kanda J; Fuji S; Kim SW; Fukuda T; Najima Y; Ohno H; Uchida N; Ueda Y; Eto T; Iwato K; Kobayashi H; Ozawa Y; Kondo T; Ichinohe T; Atsuta Y; Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Feb. 2017, Peer-reviewed

  
• [Impact of HLA mismatch on transplant outcomes].

  K; a J

  [Rinsho ketsueki] The Japanese journal of clinical hematology, 2017, Peer-reviewed

  
• High pretransplant hepcidin levels are associated with poor overall survival and delayed platelet engraftment after allogeneic hematopoietic stem cell transplantation.

  Sakamoto S; Kawabata H; Kanda J; Uchiyama T; Mizumoto C; Kitano T; Kondo T; Hishizawa M; Tomosugi N; Takaori-Kondo A

  CANCER MEDICINE, Jan. 2017, Peer-reviewed

  Access this paper :

  
• The Prognostic Impact of KIT D816 Mutations in Core Binding Factor Acute Myeloid Leukemia

  Shunsuke Yui; Saiko Kurosawa; Hiroki Yamaguchi; Heiwa Kanamori; Toshimitsu Ueki; Nobuhiko Uoshima; Ishikazu Mizuno; Katsuhiro Shono; Kensuke Usuki; Yasushi Okoshi; Yukinori Nakamura; Masamitsu Yanada; Junya Kanda; Kenji Tajika; Seiji Gomi; Keiko Fukunaga; Satoshi Wakita; Takeshi Ryotokuji; Takahiro Fukuda; Koiti Inokuchi

  BLOOD, Dec. 2016, Peer-reviewed

  
• Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.

  Inamoto Y; Kimura F; Kanda J; Sugita J; Ikegame K; Nakasone H; Nannya Y; Uchida N; Fukuda T; Yoshioka K; Ozawa Y; Kawano I; Atsuta Y; Kato K; Ichinohe T; Inoue M; Teshima T; JSHCT GVHD Working Group

  HAEMATOLOGICA, Dec. 2016, Peer-reviewed

  
• 小児とAYA世代ホジキンリンパ腫に対する造血幹細胞移植成績の比較 TRUMPデータを用いた解析(Comparison of outcomes of hematopoietic transplantation for children and AYAs with Hodgkin lymphoma)

  古賀 友紀; 小林 良二; 鈴木 律朗; 鈴宮 淳司; 賀古 真一; 福田 隆浩; 小林 直樹; 今田 和典; 内田 直之; 富田 直人; 小川 啓恭; 井上 雅美; 加藤 剛二; 諫田 淳也; 熱田 由子; 三井 哲夫

  日本小児血液・がん学会雑誌, Nov. 2016

  
• Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes

  Junya Kanda; Kazuhiro Ikegame; Shigeo Fuji; Mineo Kurokawa; Heiwa Kanamori; Takahiro Fukuda; Kazuteru Ohashi; Jun Ishikawa; Hiroyasu Ogawa; Masami Inoue; Tatsuo Ichinohe; Yoshiko Atsuta; Yoshinobu Kanda

  Biology of Blood and Marrow Transplantation, Nov. 2016, Peer-reviewed

  
• Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations.

  Ryotokuji T; Yamaguchi H; Ueki T; Usuki K; Kurosawa S; Kobayashi Y; Kawata E; Tajika K; Gomi S; Kanda J; Kobayashi A; Omori I; Marumo A; Fujiwara Y; Yui S; Terada K; Fukunaga K; Hirakawa T; Arai K; Inokuchi K

  HAEMATOLOGICA, Sep. 2016, Peer-reviewed

  
• Risk Factors and Impact of Secondary Failure of Platelet Recovery After Allogeneic Stem Cell Transplantation.

  Akahoshi Y; Kanda J; Gomyo A; Hayakawa J; Komiya Y; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kimura S; Kikuchi M; Nakasone H; Kako S; Kanda Y

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Sep. 2016, Peer-reviewed

  
• Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes.

  Kanda J; Ikegame K; Fuji S; Kurokawa M; Kanamori H; Fukuda T; Ohashi K; Ishikawa J; Ogawa H; Inoue M; Ichinohe T; Atsuta Y; Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Aug. 2016, Peer-reviewed

  
• A Comparison of Outcomes for Cord Blood Transplant and Unrelated Bone Marrow Transplant in Adult Aplastic Anemia.

  Kuwatsuka Y; Kanda J; Yamazaki H; Mori T; Miyamura K; Kako S; Uchida N; Ohashi K; Ozawa Y; Takahashi Y; Kato C; Iwato K; Ishiyama K; Kobayashi H; Eto T; Kahata K; Kato J; Miyamoto T; Kato K; Mori S

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Jul. 2016, Peer-reviewed

  
• MTX中止後に消失し、TAC・アバタセプト投与で再燃、TAC中止で縮小したMTX関連リンパ増殖性疾患

  後明 晃由美; 賀古 真一; 早川 仁; 小宮 佑介; 原田 尚憲; 亀田 和明; 鵜飼 知嵩; 和田 英則; 石原 優子; 河村 浩二; 坂本 佳奈; 佐藤 美樹; 斎藤 桐子; 木村 俊一; 菊地 美里; 仲宗根 秀樹; 諫田 淳也; 森口 正人; 神田 善伸

  臨床血液, Jun. 2016

  
• Decision Analysis of Postremission Therapy in Cytogenetically Intermediate-Risk Acute Myeloid Leukemia: The Impact of FLT3 Internal Tandem Duplication, Nucleophosmin, and CCAAT/Enhancer Binding Protein Alpha.

  Kurosawa S; Yamaguchi H; Yamaguchi T; Fukunaga K; Yui S; Wakita S; Kanamori H; Usuki K; Uoshima N; Yanada M; Shono K; Ueki T; Mizuno I; Yano S; Takeuchi J; Kanda J; Okamura H; Inamoto Y; Inokuchi K; Fukuda T

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Jun. 2016, Peer-reviewed

  
• Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.

  Konuma T; Tsukada N; Kanda J; Uchida N; Ohno Y; Miyakoshi S; Kanamori H; Hidaka M; Sakura T; Onizuka M; Kobayashi N; Sawa M; Eto T; Matsuhashi Y; Kato K; Ichinohe T; Atsuta Y; Miyamura K; Donor/Source Working Group of the Japan Society for Hematopoietic Cell Transplantation

  AMERICAN JOURNAL OF HEMATOLOGY, May 2016, Peer-reviewed

  
• Development tuberculous meningitis during chemotherapy for CD5-positive diffuse large B-cell lymphoma.

  Teramura Y; Kameda K; Kanda J; Gomyo A; Hayakawa J; Akahoshi Y; Komiya Y; Harada N; Ugai T; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Wada H; Terasako-Saito K; Kimura S; Kikuchi M; Nakasone H; Kako S; Kanda Y

  [Rinsho ketsueki] The Japanese journal of clinical hematology, May 2016, Peer-reviewed

  
• Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations

  Junya Kanda; Ruta Brazauskas; Zhen-Huan Hu; Yachiyo Kuwatsuka; Koji Nagafuji; Heiwa Kanamori; Yoshinobu Kanda; Koichi Miyamura; Makoto Murata; Takahiro Fukuda; Hisashi Sakamaki; Fumihiko Kimura; Sachiko Seo; Mahmoud Aljurf; Ayami Yoshimi; Giuseppe Milone; William A. Wood; Celalettin Ustun; Shahrukh Hashimi; Marcelo Pasquini; Carmem Bonfim; Jignesh Dalal; Theresa Hahn; Yoshiko Atsuta; Wael Saber

  Biology of Blood and Marrow Transplantation, Apr. 2016, Peer-reviewed

  
• Assessment of the ovarian reserve with anti-Mullerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding.

  Nakano H; Ashizawa M; Akahoshi Y; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Nakasone H; Kako S; Kanda J; Yamazaki R; Tanihara A; Nishida J; Kanda Y

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Apr. 2016, Peer-reviewed

  
• Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation.

  Akahoshi Y; Kimura SI; Nakano H; Harada N; Kameda K; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Nakasone H; Kikuchi M; Yamazaki R; Kanda J; Kako S; Nishida J

  CLINICAL TRANSPLANTATION, Mar. 2016, Peer-reviewed

  
• High Incidence of Afebrile Bloodstream Infection Detected by Surveillance Blood Culture in Patients on Corticosteroid Therapy after Allogeneic Hematopoietic Stem Cell Transplantation.

  Kameda K; Kimura S; Akahoshi Y; Nakano H; Harada N; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Nakasone H; Kikuchi M; Yamazaki R; Kanda J; Kako S; Tanihara A

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Feb. 2016, Peer-reviewed

  
• Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia.

  Terakura S; Atsuta Y; Tsukada N; Kobayashi T; Tanaka M; Kanda J; Najima Y; Fukuda T; Uchida N; Takahashi S; Nagamura-Inoue T; Morishima Y; Miyamura K; Japan Society for Hematopoietic Cell Transplantation

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Feb. 2016, Peer-reviewed

  
• Impact of D-index and L-index on pulmonary infection in induction chemotherapy for acute lymphoblastic leukemia and lymphoblastic lymphoma.

  Ishihara Y; Kimura S; Akahoshi Y; Harada N; Nakano H; Kameda K; Ugai T; Wada H; Yamasaki R; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A

  HEMATOLOGY, Jan. 2016, Peer-reviewed

  
• Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation.

  Arai Y; Kanda J; Nakasone H; Kondo T; Uchida N; Fukuda T; Ohashi K; Kaida K; Iwato K; Eto T; Kanda Y; Nakamae H; Nagamura-Inoue T; Morishima Y; Hirokawa M; Atsuta Y; Murata M; GVHD working group of the Japan Society for Hematopoietic Cell Transplantation

  BONE MARROW TRANSPLANTATION, Jan. 2016, Peer-reviewed

  
• Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, L-asparaginase, and/or methotrexate may improve the outcome of T-lineage ALL.

  Kako S; Akahoshi Y; Harada N; Nakano H; Kameda K; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Nishida J

  ANNALS OF HEMATOLOGY, Jan. 2016, Peer-reviewed

  
• Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation.

  Junya Kanda

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Jan. 2016, Peer-reviewed

  
• A retrospective analysis of computed tomography findings in patients with pulmonary complications after allogeneic hematopoietic stem cell transplantation.

  Ugai T; Hamamoto K; Kimura S; Akahoshi Y; Nakano H; Harada N; Kameda K; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Nakasone H; Kikuchi M; Yamazaki R; Okochi T; Kanda J

  EUROPEAN JOURNAL OF RADIOLOGY, Dec. 2015, Peer-reviewed

  
• Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remission.

  Yanada M; Kanda J; Ohtake S; Fukuda T; Sakamaki H; Miyamura K; Miyawaki S; Uchida N; Maeda T; Nagamura-Inoue T; Asou N; Morishima Y; Atsuta Y; Miyazaki Y; Kimura F; Kobayashi Y; Takami A; Naoe T; Kanda Y

  EUROPEAN JOURNAL OF HAEMATOLOGY, Dec. 2015, Peer-reviewed

  
• ウサギおよびウマ抗胸腺細胞globulinによる再生不良性貧血の治療のメタアナリシス(Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia)

  Hayakawa Jin; Kanda Junya; Akahoshi Yu; Harada Naonori; Kameda Kazuaki; Ugai Tomotaka; Wada Hidenori; Ishihara Yuko; Kawamura Koji; Sakamoto Kana; Ashizawa Masahiro; Sato Miki; Terasako-Saito Kiriko; Kimura Shun-ichi; Kikuchi Misato; Yamazaki Rie; Kako Shinichi; Kanda Yoshinobu

  臨床血液, Sep. 2015

  
• Effect of the duration between total body irradiation and stem cell infusion on the outcome of allogeneic transplantation with myeloablative conditioning.

  Akahoshi Y; Kako S; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Nishida J; Kanda Y

  HEMATOLOGY, Aug. 2015, Peer-reviewed

  
• Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus and varicella zoster virus diseases after autologous hematopoietic stem cell transplantation.

  Kawamura K; Hayakawa J; Akahoshi Y; Harada N; Nakano H; Kameda K; Ugai T; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kimura S; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Aug. 2015, Peer-reviewed

  
• A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch.

  Fuji S; Kanda J; Kato S; Ikegame K; Morishima S; Miyamoto T; Hidaka M; Kubo K; Miyamura K; Tsudo M; Kobayashi H; Maesako Y; Eto T; Adachi S; Ichinohe T; Atsuta Y; Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation

  AMERICAN JOURNAL OF HEMATOLOGY, Jul. 2015, Peer-reviewed

  
• Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases.

  Kimura SI; Murata T; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Nakasone H; Kikuchi M; Yamazaki R; Kako S; Kanda J; Tanihara A; Nishida J

  EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, May 2015, Peer-reviewed

  
• A HAMP promoter bioassay system for identifying chemical compounds that modulate hepcidin expression.

  Kawabata H; Uchiyama T; Sakamoto S; Kanda J; Oishi S; Fujii N; Tomosugi N; Kadowaki N; Takaori-Kondo A

  EXPERIMENTAL HEMATOLOGY, May 2015, Peer-reviewed

  
• Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantation.

  Sato M; Kako S; Matsumoto K; Oshima K; Akahoshi Y; Nakano H; Ugai T; Yamasaki R; Wada H; Ishihara Y; Sakamoto K; Kawamura K; Ashizawa M; Terasako-Saito K; Kimura S; Nakasone H; Kikuchi M; Tanihara A; Yamazaki R; Tanaka Y

  INTERNATIONAL JOURNAL OF HEMATOLOGY, May 2015, Peer-reviewed

  
• False-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantation.

  Kimura S; Akahoshi Y; Nakano H; Harada N; Kameda K; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Nakasone H; Kikuchi M; Yamazaki R; Kanda J; Kako S; Tanihara A

  JOURNAL OF INFECTION, May 2015, Peer-reviewed

  
• Unrelated cord blood transplantation vs. related transplantation with HLA 1-antigen mismatch in the GVH direction.

  Junya Kanda

  [Rinsho ketsueki] The Japanese journal of clinical hematology, May 2015, Peer-reviewed

  
• Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation

  H. Nakasone; T. Fukuda; J. Kanda; T. Mori; S. Yano; T. Kobayashi; K. Miyamura; T. Eto; H. Kanamori; K. Iwato; N. Uchida; S. Mori; T. Nagamura-Inoue; T. Ichinohe; Y. Atsuta; T. Teshima; M. Murata

  Bone Marrow Transplantation, 04 Apr. 2015

  
• Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation.

  Nakasone H; Fukuda T; Kanda J; Mori T; Yano S; Kobayashi T; Miyamura K; Eto T; Kanamori H; Iwato K; Uchida N; Mori S; Nagamura-Inoue T; Ichinohe T; Atsuta Y; Teshima T; Murata M; GVHD working group of the Japan Society of Hematopoietic Cell Transplantation

  BONE MARROW TRANSPLANTATION, Apr. 2015, Peer-reviewed

  
• Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients.

  Kawamura K; Yamazaki R; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kimura S; Kikuchi M; Nakasone H; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y

  HEMATOLOGY, Mar. 2015, Peer-reviewed

  
• Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma.

  Kikuchi M; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Sakamoto K; Kawamura K; Ishihara Y; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Yamazaki R; Kako S; Kanda J; Nishida J; Sekiguchi N; Noto S

  JOURNAL OF CHEMOTHERAPY, Feb. 2015, Peer-reviewed

  
• An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions.

  Kanda J; Mori K; Kawabata H; Kuwabara T; Mori KP; Imamaki H; Kasahara M; Yokoi H; Mizumoto C; Thoennissen NH; Koeffler HP; Barasch J; Takaori-Kondo A; Mukoyama M; Nakao K

  CLINICAL AND EXPERIMENTAL NEPHROLOGY, Feb. 2015, Peer-reviewed

  Access this paper :

  
• Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma

  Misato Kikuchi; Hideki Nakasone; Yu Akahoshi; Hirofumi Nakano; Tomotaka Ugai; Hidenori Wada; Ryoko Yamasaki; Kana Sakamoto; Koji Kawamura; Yuko Ishihara; Miki Sato; Masahiro Ashizawa; Kiriko Terasako-Saito; Shun-ichi Kimura; Rie Yamazaki; Shinichi Kako; Junya Kanda; Junji Nishida; Naohiro Sekiguchi; Satoshi Noto; Michiko Kida; Akira Hangaishi; Kensuke Usuki; Yoshinobu Kanda

  JOURNAL OF CHEMOTHERAPY, Feb. 2015, Peer-reviewed

  
• Impact of HLA Mismatch Direction on the Outcome of Unrelated Bone Marrow Transplantation: A Retrospective Analysis from the Japan Society for Hematopoietic Cell Transplantation

  Junya Kanda

  Biology of Blood and Marrow Transplantation, Feb. 2015, Peer-reviewed

  
• Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.

  Kikuchi M; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Sakamoto K; Kawamura K; Ishihara Y; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y

  TRANSPLANT INFECTIOUS DISEASE, Feb. 2015, Peer-reviewed

  
• The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study

  Kanda, Junya; Ikegame, Kazuhiro; Fuji, Shigeo; Fukuda, Takahiro; Kurokawa, Mineo; Ogawa, Hiroyasu; Ohashi, Kazuteru; Kanamori, Heiwa; Ishikawa, Jun; Inoue, Masami; Ichinohe, Tatsuo; Atsuta, Yoshiko; Kanda, Yoshinobu

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015

  
• Age influences post-graft-versus-host disease non-relapse mortality in adults with acute graft-versus-host disease of varying severity following allogeneic hematopoietic cell transplant.

  Nakane T; Fukuda T; Kanda J; Taniguchi S; Eto T; Ohashi K; Nakamae H; Kurokawa M; Mori T; Morishima Y; Nagamura-Inoue T; Sakamaki H; Atsuta Y; Murata M

  LEUKEMIA & LYMPHOMA, 2015, Peer-reviewed

  
• Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation

  K. Terasako-Saito; H. Nakasone; Y. Tanaka; R. Yamazaki; M. Sato; K. Sakamoto; Y. Ishihara; K. Kawamura; Y. Akahoshi; J. Hayakawa; H. Wada; N. Harada; H. Nakano; K. Kameda; T. Ugai; R. Yamasaki; M. Ashizawa; S. I. Kimura; M. Kikuchi; A. Tanihara; J. Kanda; S. Kako; J. Nishida; Y. Kanda

  Transplant Infectious Disease, 01 Dec. 2014, Peer-reviewed

  
• Allotype analysis to determine the origin of cytomegalovirus immunoglobulin-G after allogeneic stem cell transplantation

  R. Yamazaki; Y. Tanaka; H. Nakasone; M. Sato; K. Terasako-Saito; K. Sakamoto; Y. Akahoshi; H. Nakano; T. Ugai; R. Yamasaki; H. Wada; Y. Ishihara; K. Kawamura; M. Ashizawa; S. I. Kimura; M. Kikuchi; S. Kako; J. Kanda; A. Tanihara; J. Nishida; Y. Kanda

  Transplant Infectious Disease, 01 Dec. 2014, Peer-reviewed

  
• Severe oral infection due to Lactobacillus rhamnosus during induction chemotherapy for acute myeloid leukemia.

  Ishihara Y; Kanda J; Tanaka K; Nakano H; Ugai T; Wada H; Yamasaki R; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kimura S; Kikuchi M; Nakasone H; Yamazaki R; Kako S; Nishida J; Watanabe K; Kanda Y

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Dec. 2014, Peer-reviewed

  
• Allotype analysis to determine the origin of cytomegalovirus immunoglobulin-G after allogeneic stem cell transplantation.

  Yamazaki R; Tanaka Y; Nakasone H; Sato M; Terasako-Saito K; Sakamoto K; Akahoshi Y; Nakano H; Ugai T; Yamasaki R; Wada H; Ishihara Y; Kawamura K; Ashizawa M; Kimura SI; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J

  TRANSPLANT INFECTIOUS DISEASE, Dec. 2014, Peer-reviewed

  
• Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation.

  Terasako-Saito K; Nakasone H; Tanaka Y; Yamazaki R; Sato M; Sakamoto K; Ishihara Y; Kawamura K; Akahoshi Y; Hayakawa J; Wada H; Harada N; Nakano H; Kameda K; Ugai T; Yamasaki R; Ashizawa M; Kimura SI; Kikuchi M; Tanihara A

  TRANSPLANT INFECTIOUS DISEASE, Dec. 2014, Peer-reviewed

  
• Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT.

  Fuji S; Kanda J; Kato S; Ikegame K; Morishima S; Miyamoto T; Hidaka M; Kubo K; Miyamura K; Ohashi K; Kobayashi H; Maesako Y; Adachi S; Ichinohe T; Atsuta Y; Kanda Y; HLA Working Group of Japan Society for Hematopoietic Cell Transplantation

  BONE MARROW TRANSPLANTATION, Sep. 2014, Peer-reviewed

  
• Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials.

  Kimura S; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Nakasone H; Kikuchi M; Yamazaki R; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y

  JOURNAL OF INFECTION, Jul. 2014, Peer-reviewed

  
• Graft-Versus-Host Disease and Survival after Cord Blood Transplantation for Acute Leukemia: A Comparison of Japanese versus White Populations

  Junya Kanda

  Biology of Blood and Marrow Transplantation, May 2014, Peer-reviewed

  
• Impact of high-/middle-molecular-weight adiponectin on the synthesis and regulation of extracellular matrix in dermal fibroblasts.

  Nakasone H; Terasako-Saito K; Yamazaki R; Sato M; Tanaka Y; Sakamoto K; Kurita M; Yamasaki R; Wada H; Ishihara Y; Kawamura K; Machishima T; Ashizawa M; Kimura S; Kikuchi M; Tanihara A; Kanda J; Kako S; Nishida J; Yamada S

  EXPERIMENTAL HEMATOLOGY, Apr. 2014, Peer-reviewed

  
• Changes in the clinical impact of high-risk human leukocyte antigen allele mismatch combinations on the outcome of unrelated bone marrow transplantation.

  Kanda Y; Kanda J; Atsuta Y; Fuji S; Maeda Y; Ichinohe T; Takanashi M; Ohashi K; Fukuda T; Miyamura K; Mori T; Sao H; Kobayashi N; Iwato K; Sawada A; Mori S; HLA working group of the Japan Society for Hematopoietic Cell Transplantation

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Apr. 2014, Peer-reviewed

  
• Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation.

  Sato M; Nakasone H; Terasako-Saito K; Sakamoto K; Yamazaki R; Tanaka Y; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Ashizawa M; Kimura SI; Kikuchi M; Tanihara A; Kanda J; Kako S; Nishida J

  BONE MARROW TRANSPLANTATION, Apr. 2014, Peer-reviewed

  
• D-index dose not predict the development of pulmonary infection in acute myeloid leukemia patients undergoing consolidation chemotherapy with high-dose cytarabine.

  Kimura S; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Yamasaki R; Ashizawa M; Machishima T; Sato M; Terasako K; Nakasone H; Kikuchi M; Okuda S; Kako S; Kanda J; Yamazaki R; Tanihara A; Nishida J; Kanda Y

  HEMATOLOGY, Mar. 2014, Peer-reviewed

  
• A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia.

  Ashizawa M; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako K; Kimura S; Kikuchi M; Nakasone H; Kako S; Kanda J; Yamazaki R; Tanihara A; Nishida J; Kanda Y

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Mar. 2014, Peer-reviewed

  
• Protection of ovarian function by two distinct methods of ovarian shielding for young female patients who receive total body irradiation.

  Kanda Y; Wada H; Yamasaki R; Kawamura K; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako-Saito K; Kimura S; Nakasone H; Kikuchi M; Yamazaki R; Kanda J; Kako S; Nishida J; Tsunoda H; Omori Y; Nakazawa M

  ANNALS OF HEMATOLOGY, Feb. 2014, Peer-reviewed

  
• Risk factors and organ involvement of chronic GVHD in Japan.

  Kanda J; Nakasone H; Atsuta Y; Toubai T; Yokoyama H; Fukuda T; Taniguchi S; Ohashi K; Ogawa H; Eto T; Miyamura K; Morishima Y; Nagamura-Inoue T; Sakamaki H; Murata M

  BONE MARROW TRANSPLANTATION, Feb. 2014, Peer-reviewed

  
• Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation.

  Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura S; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y

  INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, Feb. 2014, Peer-reviewed

  
• Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab from HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients with Hematologic Malignancies

  Junya Kanda

  Biology of Blood and Marrow Transplantation, Feb. 2014, Peer-reviewed

  
• Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation

  M. Sato; H. Nakasone; K. Terasako-Saito; K. Sakamoto; R. Yamazaki; Y. Tanaka; Y. Akahoshi; H. Nakano; T. Ugai; H. Wada; R. Yamasaki; Y. Ishihara; K. Kawamura; M. Ashizawa; S. I. Kimura; M. Kikuchi; A. Tanihara; J. Kanda; S. Kako; J. Nishida; Y. Kanda

  Bone Marrow Transplantation, 2014, Peer-reviewed

  
• Impact of Conditioning Intensity with or without Total Body Irradiation on Acute Graft-Versus-Host Disease and Clinical Outcomes

  Nakasone, Hideki; Fukuda, Takahiro; Kanda, Junya; Mori, Takehiko; Teshima, Takanori; Yano, Shingo; Uchida, Naoyuki; Kakihana, Kazuhiko; Eto, Tetsuya; Mori, Shin-Ichiro; Nagamura, Tokiko; Ichinohe, Tatsuo; Atsuta, Yoshiko; Murata, Makoto

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014

  
• Donor selection in hematopoietic stem cell transplantation

  Junya K; a

  Journal of Hematopoietic Cell Transplantation, 2014, Peer-reviewed

  
• Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.

  Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J

  IMMUNOLOGY LETTERS, 2014, Peer-reviewed

  
• Single-cell T-cell receptor-β analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT.

  Nakasone H; Tanaka Y; Yamazaki R; Terasako K; Sato M; Sakamoto K; Yamasaki R; Wada H; Ishihara Y; Kawamura K; Machishima T; Ashizawa M; Kimura SI; Kikuchi M; Tanihara A; Kanda J; Kako S; Nishida J; Kanda Y

  BONE MARROW TRANSPLANTATION, Jan. 2014, Peer-reviewed

  
• Decision analysis for donor selection in stem cell transplantation-HLA-8/8 allele-matched unrelated donor vs HLA-1 AG mismatched related donor.

  Kanda J; Fuji S; Kato S; Takami A; Tanaka J; Miyamura K; Ohashi K; Fukuda T; Ozawa Y; Kanamori H; Eto T; Kobayashi N; Iwato K; Morishima Y; Sakamaki H; Atsuta Y; Kanda Y; HLA Working Group; Donor/Source Working Group; Adult AML Working Group

  BLOOD CANCER JOURNAL, 2014, Peer-reviewed

  
• Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone.

  Sung AD; Grima DT; Bernard LM; Brown S; Carrum G; Holmberg L; Horwitz ME; Liesveld JL; Kanda J; McClune B; Shaughnessy P; Tricot GJ; Chao NJ

  BONE MARROW TRANSPLANTATION, Nov. 2013, Peer-reviewed

  
• Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies.

  Kawamura K; Kikuchi M; Terasako K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Kimura S; Nakasone H; Okuda S; Yamazaki R; Kanda J; Kako S; Tanaka Y; Tanihara A; Nishida J; Kanda Y

  TRANSFUSION AND APHERESIS SCIENCE, Oct. 2013, Peer-reviewed

  
• Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation.

  Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura SI; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y

  TRANSPLANT INFECTIOUS DISEASE, Oct. 2013, Peer-reviewed

  
• 好中球減少症における抗菌薬予防としてのgarenoxacinとlevofloxacinの比較(Comparison of garenoxacin and levofloxacin as antibacterial prophylaxis during neutropenia)

  Yamasaki Ryoko; Kanda Junya; Akahoshi Yu; Nakano Hirofumi; Ugai Tomotaka; Wada Hidenori; Kawamura Koji; Ishihara Yuko; Sakamoto Kana; Sato Miki; Ashizawa Masahiro; Machishima Tomohito; Terasako Kiriko; Kimura Shun-ichi; Kikuchi Misato; Nakasone Hideki; Kako Shinichi; Yamazaki Rie; Nishida Junji; Kanda Yoshinobu

  臨床血液, Sep. 2013

  
• T細胞系とB細胞系ALL間の強化レジメンの効果の違い メタ解析(Different effect of intensive regimen between T- and B-lineage ALL: A meta-analysis)

  Kako Shinichi; Akahoshi Yu; Nakano Hiroshi; Ugai Tomotaka; Wada Hidenori; Yamasaki Ryoko; Ishihara Yuko; Kawamura Koji; Sakamoto Kana; Sato Miki; Ashizawa Masahiro; Machishima Tomohito; Terasako Kiriko; Kimura Shun-ichi; Kikuchi Misato; Nakasone Hideki; Yamazaki Rie; Kanda Junya; Nishida Junji; Kanda Yoshinobu

  臨床血液, Sep. 2013

  
• Effect of HLA mismatch on acute graft-versus-host disease.

  Junya Kanda

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Sep. 2013, Peer-reviewed

  
• Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: an analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation.

  Murata M; Nakasone H; Kanda J; Nakane T; Furukawa T; Fukuda T; Mori T; Taniguchi S; Eto T; Ohashi K; Hino M; Inoue M; Ogawa H; Atsuta Y; Nagamura-Inoue T; Yabe H; Morishima Y; Sakamaki H; Suzuki R

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Aug. 2013, Peer-reviewed

  
• Prediction of infectious events by the high-sensitivity C-reactive protein level before autologous hematopoietic cell transplantation for lymphoma and multiple myeloma

  M. Sato; H. Nakasone; H. Wada; R. Yamasaki; Y. Ishihara; K. Sakamoto; K. Kawamura; M. Ashizawa; T. Machishima; K. Terasako; S. I. Kimura; M. Kikuchi; A. Tanihara; R. Yamazaki; Y. Tanaka; J. Kanda; S. Kako; J. Nishida; Y. Kanda

  Transplant Infectious Disease, Aug. 2013, Peer-reviewed

  
• Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment.

  Kanda J; Kaynar L; Kanda Y; Prasad VK; Parikh SH; Lan L; Shen T; Rizzieri DA; Long GD; Sullivan KM; Gasparetto C; Chute JP; Morris A; Winkel S; McPherson J; Kurtzberg J; Chao NJ; Horwitz ME

  BONE MARROW TRANSPLANTATION, Jul. 2013, Peer-reviewed

  
• Allotype analysis to distinguish the origin of varicella-zoster virus immunoglobulin G after allogeneic stem cell transplantation.

  Yamazaki R; Nakasone H; Tanaka Y; Sato M; Terasako K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Machishima T; Kimura S; Kikuchi M; Okuda S; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Jul. 2013, Peer-reviewed

  
• A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation.

  Nakasone H; Kanda J; Yano S; Atsuta Y; Ago H; Fukuda T; Kakihana K; Adachi T; Yujiri T; Taniguchi S; Taguchi J; Morishima Y; Nagamura T; Sakamaki H; Mori T; Murata M; GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation

  TRANSPLANT INTERNATIONAL, Jun. 2013, Peer-reviewed

  
• Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT.

  Sato M; Nakasone H; Oshima K; Ishihara Y; Wada H; Sakamoto K; Kawamura K; Ashizawa M; Machishima T; Terasako K; Kimura S; Kikuchi M; Okuda S; Tanihara A; Yamazaki R; Tanaka Y; Kanda J; Kako S; Nishida J; Kanda Y

  BONE MARROW TRANSPLANTATION, May 2013, Peer-reviewed

  
• Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia.

  Atsuta Y; Kanda J; Takanashi M; Morishima Y; Taniguchi S; Takahashi S; Ogawa H; Ohashi K; Ohno Y; Onishi Y; Aotsuka N; Nagamura-Inoue T; Kato K; Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation

  HAEMATOLOGICA, May 2013, Peer-reviewed

  
• Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation.

  Kanda Y; Kanda J; Atsuta Y; Maeda Y; Ichinohe T; Ohashi K; Fukuda T; Miyamura K; Iida H; Mori T; Iwato K; Eto T; Kawa K; Morita S; Morishima Y

  BRITISH JOURNAL OF HAEMATOLOGY, May 2013, Peer-reviewed

  
• Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction.

  Kanda J; Ichinohe T; Kato S; Uchida N; Terakura S; Fukuda T; Hidaka M; Ueda Y; Kondo T; Taniguchi S; Takahashi S; Nagamura-Inoue T; Tanaka J; Atsuta Y; Miyamura K; Kanda Y; Donor/Source Working Group and HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation

  LEUKEMIA, Feb. 2013, Peer-reviewed

  
• Impact of the direction of HLA mismatch on transplantation outcomes in single unrelated cord blood transplantation.

  Kanda J; Atsuta Y; Wake A; Ichinohe T; Takanashi M; Morishima Y; Taniguchi S; Takahashi S; Ogawa H; Ohashi K; Ohno Y; Aotsuka N; Onishi Y; Kato K; Nagamura-Inoue T; Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Feb. 2013, Peer-reviewed

  
• Decision Analysis of Donor Selection in Allogeneic Stem Cell Transplantation for Patients with Acute Leukemia in First Remission-Related Donor with HLA-1 Antigen Mismatch in the GVH Direction vs. HLA-8/8 Allele-Matched Unrelated Donor

  Kanda Junya; Takami Akiyoshi; Tanaka Junji; Miyamura Koichi; Ohashi Kazuteru; Fukuda Takahiro; Ozawa Yukiyasu; Morishima Yasuo; Sakamaki Hisashi; Atsuta Yoshiko; Kanda; Yoshinobu

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, Peer-reviewed

  
• Hyperbilirubinemia in the early phase after allogeneic HSCT: Prognostic significance of the alkaline phosphatase/total bilirubin ratio

  M. Ashizawa; K. Oshima; H. Wada; Y. Ishihara; K. Kawamura; K. Sakamoto; M. Sato; K. Terasako; T. Machishima; S. Kimura; M. Kikuchi; H. Nakasone; S. Okuda; S. Kako; J. Kanda; R. Yamazaki; A. Tanihara; J. Nishida; Y. Kanda

  Bone Marrow Transplantation, Jan. 2013, Peer-reviewed

  
• Differing impacts of pretransplant serum ferritin and C-reactive protein levels on the incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

  Sakamoto S; Kawabata H; Kanda J; Uchiyama T; Mizumoto C; Kondo T; Yamashita K; Ichinohe T; Ishikawa T; Kadowaki N; Takaori-Kondo A

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Jan. 2013, Peer-reviewed

  
• The safety and efficacy of acute graft-versus-host disease prophylaxis with a higher target blood concentration of cyclosporine around 500 ng/mL.

  Machishima T; Kako S; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Ashizawa M; Terasako K; Kimura S; Kikuchi M; Nakasone H; Kanda J; Yamazaki R; Nishida J; Kanda Y

  CLINICAL TRANSPLANTATION, 2013, Peer-reviewed

  
• Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides.

  Sakamoto K; Nakasone H; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Ashizawa M; Sato M; Terasako-Saito K; Machishima T; Kimura S; Kikuchi M; Kako S; Kanda J; Yamazaki R; Tanihara A; Nishida J; Kanda Y

  PLOS ONE, 2013, Peer-reviewed

  
• Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation.

  Tanaka Y; Nakasone H; Yamazaki R; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Machishima T; Sato M; Terasako K; Kimura S; Kikuchi M; Okuda S; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y

  JOURNAL OF CLINICAL IMMUNOLOGY, Dec. 2012, Peer-reviewed

  
• Acidic milieu augments the expression of hepcidin, the central regulator of iron homeostasis.

  Mizumoto C; Kawabata H; Uchiyama T; Sakamoto S; Kanda J; Tomosugi N; Takaori-Kondo A

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Dec. 2012, Peer-reviewed

  
• Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.

  Kanda J; Chiou LW; Szabolcs P; Sempowski GD; Rizzieri DA; Long GD; Sullivan KM; Gasparetto C; Chute JP; Morris A; McPherson J; Hale J; Livingston JA; Broadwater G; Niedzwiecki D; Chao NJ; Horwitz ME

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Nov. 2012, Peer-reviewed

  
• 多発性骨髄腫症例におけるlenalidomideの有効性と毒性に及ぼす体重の効果(Effect of body weight on efficacy and toxicity of lenalidomide in patients with multiple myeloma)

  Wada Hidenori; Ishihara Yuko; Kawamura Koji; Sakamoto Kana; Sato Miki; Ashizawa Masahiro; Machishima Tomohito; Terasako Kiriko; Kimura Shun-ichi; Kikuchi Misato; Nakasone Hideki; Okuda Shinya; Kanda Junya; Kako Shinichi; Yamazaki Rie; Nishida Junji; Kanda Yoshinobu

  臨床血液, Sep. 2012

  
• 同種異系幹細胞移植後のVZV-IgGの起源を識別するためのアロタイプ分析(Allotype analysis to distinguish the origin of VZV-IgG after allogeneic stem cell transplantation)

  Yamazaki Rie; Nakasone Hideki; Tanaka Yukie; Sato Miki; Terasako Kiriko; Wada Hidenori; Ishihara Yuko; Kawamura Koji; Sakamoto Kana; Ashizawa Masahiro; Machishima Tomohito; Kimura Shun-ichi; Kikuchi Misato; Okuda Shinya; Kako Shinichi; Kanda Junya; Nishida Junji; Kanda Yoshinobu

  臨床血液, Sep. 2012

  
• Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation.

  Kanda J; Horwitz ME; Long GD; Gasparetto C; Sullivan KM; Chute JP; Morris A; Hennig T; Li Z; Chao NJ; Rizzieri DA

  BONE MARROW TRANSPLANTATION, May 2012, Peer-reviewed

  
• Inverse association between soy intake and non-Hodgkin lymphoma risk among women: a case-control study in Japan.

  Chihara D; Matsuo K; Kanda J; Hosono S; Ito H; Nakamura S; Seto M; Morishima Y; Tajima K; Tanaka H

  ANNALS OF ONCOLOGY, Apr. 2012, Peer-reviewed

  
• Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study.

  Kanda J; Saji H; Fukuda T; Kobayashi T; Miyamura K; Eto T; Kurokawa M; Kanamori H; Mori T; Hidaka M; Iwato K; Yoshida T; Sakamaki H; Tanaka J; Kawa K; Morishima Y; Suzuki R; Atsuta Y; Kanda Y

  BLOOD, Mar. 2012, Peer-reviewed

  
• Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study.

  Kanda J; Hishizawa M; Utsunomiya A; Taniguchi S; Eto T; Moriuchi Y; Tanosaki R; Kawano F; Miyazaki Y; Masuda M; Nagafuji K; Hara M; Takanashi M; Kai S; Atsuta Y; Suzuki R; Kawase T; Matsuo K; Nagamura-Inoue T; Kato S

  BLOOD, Mar. 2012, Peer-reviewed

  
• Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.

  Kanda J; Rizzieri DA; Gasparetto C; Long GD; Chute JP; Sullivan KM; Morris A; Smith CA; Hogge DE; Nitta J; Song K; Niedzwiecki D; Chao NJ; Horwitz ME

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Jun. 2011, Peer-reviewed

  
• Alemtuzumab for the prevention and treatment of graft-versus-host disease.

  Kanda J; Lopez RD; Rizzieri DA

  INTERNATIONAL JOURNAL OF HEMATOLOGY, May 2011, Peer-reviewed

  
• Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria.

  Sato T; Ichinohe T; Kanda J; Yamashita K; Kondo T; Ishikawa T; Uchiyama T; Takaori-Kondo A

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Apr. 2011, Peer-reviewed

  
• Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation.

  Kanda J; Mizumoto C; Ichinohe T; Kawabata H; Saito T; Yamashita K; Kondo T; Takakura S; Ichiyama S; Uchiyama T; Ishikawa T

  BONE MARROW TRANSPLANTATION, Feb. 2011, Peer-reviewed

  Access this paper :

  
• Iron overload and allogeneic hematopoietic stem-cell transplantation.

  Kanda J; Kawabata H; Chao NJ

  EXPERT REVIEW OF HEMATOLOGY, Feb. 2011, Peer-reviewed

  
• Haploidentical transplantation for leukemia.

  Kanda J; Chao NJ; Rizzieri DA

  CURRENT ONCOLOGY REPORTS, Sep. 2010, Peer-reviewed

  
• Impact of discontinuing fluoroquinolone prophylaxis on early mortality after allogeneic marrow or peripheral blood SCT with myeloablative conditioning.

  Kanda J; Ichinohe T; Saito T; Yamashita K; Kondo T; Ishikawa T; Ichiyama S; Uchiyama T

  BONE MARROW TRANSPLANTATION, Aug. 2010, Peer-reviewed

  
• Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study.

  Hishizawa M; Kanda J; Utsunomiya A; Taniguchi S; Eto T; Moriuchi Y; Tanosaki R; Kawano F; Miyazaki Y; Masuda M; Nagafuji K; Hara M; Takanashi M; Kai S; Atsuta Y; Suzuki R; Kawase T; Matsuo K; Nagamura-Inoue T; Kato S

  BLOOD, Aug. 2010, Peer-reviewed

  
• Association of anthropometric characteristics with the risk of malignant lymphoma and plasma cell myeloma in a Japanese population: a population-based cohort study.

  Kanda J; Matsuo K; Inoue M; Iwasaki M; Sawada N; Shimazu T; Yamaji T; Sasazuki S; Tsugane S; Japan Public Health Center-based Prospective Study Group

  CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, Jun. 2010, Peer-reviewed

  
• ヒト急性腎障害バイオマーカーNgalの産生部位としての好中球と腎臓

  森 潔; 向山 政志; 諫田 淳也; 川端 浩; 横井 秀基; 笠原 正登; 桑原 孝成; 水本 智咲; 内山 卓; 中尾 一和

  日本腎臓学会誌, May 2010

  
• Association between obesity and the risk of malignant lymphoma in Japanese: a case-control study.

  Kanda J; Matsuo K; Suzuki T; Hosono S; Ito H; Ichinohe T; Seto M; Morishima Y; Tajima K; Tanaka H

  INTERNATIONAL JOURNAL OF CANCER, May 2010, Peer-reviewed

  
• Association of alcohol intake with the risk of malignant lymphoma and plasma cell myeloma in Japanese: a population-based cohort study (Japan Public Health Center-based Prospective Study).

  Kanda J; Matsuo K; Inoue M; Iwasaki M; Sawada N; Shimazu T; Yamaji T; Sasazuki S; Tsugane S; Japan Public Health Center-based Prospective Study Group

  CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, Feb. 2010, Peer-reviewed

  
• Insomnia and depression during protective isolation in patients with hematological disorders.

  Kunitomi A; Iida H; Kamiya Y; Hayashi M; Suwa T; Kanda J; Sao H

  INTERNAL MEDICINE, 2010, Peer-reviewed

  
• Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines.

  Kanda J; Uchiyama T; Tomosugi N; Higuchi M; Uchiyama T; Kawabata H

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Dec. 2009, Peer-reviewed

  
• Long-term survival after HLA-haploidentical SCT from noninherited maternal antigen-mismatched family donors: impact of chronic GVHD.

  Kanda J; Ichinohe T; Shimazaki C; Hamaguchi M; Watanabe A; Ishida H; Yoshihara T; Morimoto A; Uoshima N; Adachi S; Inukai T; Sawada A; Oka K; Itoh M; Hino M; Maruya E; Saji H; Uchiyama T; Kodera Y

  BONE MARROW TRANSPLANTATION, Sep. 2009, Peer-reviewed

  
• Association of alcohol intake and smoking with malignant lymphoma risk in Japanese: a hospital-based case-control study at Aichi Cancer Center.

  Kanda J; Matsuo K; Kawase T; Suzuki T; Ichinohe T; Seto M; Morishima Y; Tajima K; Tanaka H

  CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, Sep. 2009, Peer-reviewed

  
• HLA不適合血縁者間移植 (特集 造血幹細胞移植の多様性に迫る--質の高い治癒を目指したアプローチ) -- (造血幹細胞移植の方法論)

  諌田 淳也; 一戸 辰夫

  内科, Aug. 2009

  
• Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation.

  Kanda J; Mizumoto C; Kawabata H; Ichinohe T; Tsuchida H; Tomosugi N; Matsuo K; Yamashita K; Kondo T; Ishikawa T; Uchiyama T

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Aug. 2009, Peer-reviewed

  Access this paper :

  
• Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning.

  Mizumoto C; Kanda J; Ichinohe T; Ishikawa T; Matsui M; Kadowaki N; Kondo T; Imada K; Hishizawa M; Kawabata H; Nishikori M; Yamashita K; Takaori-Kondo A; Hori T; Uchiyama T

  INTERNATIONAL JOURNAL OF HEMATOLOGY, May 2009, Peer-reviewed

  
• Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies.

  Kanda J; Ichinohe T; Matsuo K; Benjamin RJ; Klumpp TR; Rozman P; Blumberg N; Mehta J; Sohn SK; Uchiyama T

  TRANSFUSION, Apr. 2009, Peer-reviewed

  
• Impact of alcohol consumption with polymorphisms in alcohol-metabolizing enzymes on pancreatic cancer risk in Japanese.

  Kanda J; Matsuo K; Suzuki T; Kawase T; Hiraki A; Watanabe M; Mizuno N; Sawaki A; Yamao K; Tajima K; Tanaka H

  CANCER SCIENCE, Feb. 2009, Peer-reviewed

  
• Clinical Significance of Severity and Subcategory of Chronic GVHD Evaluated by NIH Consensus Criteria

  Sato, Takayuki; Ichinohe, Tatsuo; Kanda, Junya; Yamashita, Kouhei; Kondo, Tadakazu; Ishikawa, Takayuki; Uchiyama, Takashi

  BLOOD, 2009

  
• Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation.

  Kanda J; Mizumoto C; Kawabata H; Tsuchida H; Tomosugi N; Matsuo K; Uchiyama T

  HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, Oct. 2008, Peer-reviewed

  
• [Epstein-Barr virus-associated B cell lymphoproliferative disorder complicated in adult T-cell leukemia].

  Tanaka Y; Kondo T; Kishimoto W; Kanda J; Tashima M; Mizumoto C; Ichinohe T; Ishikawa T; Uchiyama T; Haga H; Manabe T

  [Rinsho ketsueki] The Japanese journal of clinical hematology, Apr. 2008, Peer-reviewed

  
• Durable remission of large B-cell lymphoma transformed from lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia successfully treated with sequential immunochemotherapy followed by reduced-intensity allogeneic stem cell transplantation.

  Yamamoto R; Takaori-Kondo A; Kanda J; Imada K; Ichinohe T; Ishikawa T; Ohmori K; Uchiyama T

  BONE MARROW TRANSPLANTATION, Mar. 2008, Peer-reviewed

  
• Clinical Significance of Serum Hepcidin-25 Levels on Early Treatment-Related Complications after Hematopoietic Stem Cell Transplantation

  Kanda, Junya; Mizumoto, Chisaki; Kawabata, Hiroshi; Ichinohe, Tatsuo; Tsuchida, Hideyuki; Tomosugi, Naohisa; Matsuo, Keitaro; Kondo, Tadakazu; Ishikawa, Takayuki; Uchiyama, Takashi

  BLOOD, 2008

  
• Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease.

  Kawabata H; Tomosugi N; Kanda J; Tanaka Y; Yoshizaki K; Uchiyama T

  HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, Jun. 2007, Peer-reviewed

  
• Reversible cardiomyopathy associated with Multicentric Castleman disease: successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody.

  Kanda J; Kawabata H; Yamaji Y; Ichinohe T; Ishikawa T; Tamura T; Furukawa Y; Kimura T; Kita T; Uchiyama T

  INTERNATIONAL JOURNAL OF HEMATOLOGY, Apr. 2007, Peer-reviewed

  
• Long-term survival after HLA-haploidentical stem cell transplantation, from non-inherited maternal antigen-mismatched family donors: Impact of chronic graft-versus-host disease

  Ichinohe, Tatsuo; Shimazaki, Chihiro; Hamaguchi, Motohiro; Watanabe, Arata; Ishida, Hiroyuki; Yoshihara, Takao; Morimoto, Akira; Uoshima, Nobuhiko; Adachi, Souichi; Inukai, Takeshi; Sawada, Akihisa; Oka, Koji; Itoh, Mitsuru; Hino, Masayuki; Kanda, Junya; Uchiyama, Takashi; Kodera, Yoshihisa

  BLOOD, 2007

  
• Similar background of graft-versus-host disease (GVHD) following allogeneic blood and marrow transplantation (Tx) in Korean and Japanese populations allows a uniform foundation to perform large-scale clinical studies in the region

  Kim, Sung-Won; Lee, Jong-Wook; Kim, Hyeoung-Joon; Fukuda, Takahiro; Kanda, Yoshinobu; Kim, Hee-Je; Min, Woo-Sung; Mori, Shin-ichiro; Tanosaki, Ryuji; Lee, Je-Hwan; Lee, Kyoo-Hyung; Yamashita, Takuya; Sakamaki, Hisashi; Sohn, Sang-Kyun; Chae, Yee-Soo; Ohshima, Kumi; Ichinohe, Tatsuo; Kanda, Junya; Kasai, Masaharu; Kobayashi, Naoki; Ando, Kiyoshi; Onizuka, Masahito; Taniguchi, Shuichi; Seo, Sachiko; Yang, Deok-Hwan; Kim, Yeo-Kyeoung; Shin, Ho-Jin; Takaue, Yoichi; Kim, Chun-Choo

  BLOOD, 2007

  
• Monitoring of serum hepcidin-25 in multicentric Castleman's disease patients treated with tocilizumab, an anti-interleukin-6 receptor antibody

  Kawabata, Hiroshi; Tomosugi, Naohisa; Kanda, Junya; Mizumoto, Chisaki; Tanaka, Yasuhiro; Ichinohe, Tatsuo; Kadowaki, Norimitsu; Yoshizaki, Kazuyuki; Ishikawa, Takayuki; Uchiyama, Takashi

  BLOOD, 2007

  
• [Successful treatment with cyclosporine of sodium valproate-induced pure red cell aplasia].

  Kanda J; Chonabayashi K; Watanabe M; Arima N; Tsudo M

  [Rinsho ketsueki] The Japanese journal of clinical hematology, Oct. 2005, Peer-reviewed

  

Misc.

• Assessment and Intervention Strategies for Sarcopenia in Transplantation

  濱田涼太; 村尾昌信; 松下路子; 宮坂淳介; 太田垣あゆみ; 浅野伝美; 小林亜海; 福田裕子; 諫田淳也; 新井康之; 新井康之; 池口良輔; 松田秀一; 高折晃史; 高折晃史

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2024

  
• Actionable mutations in AML and novel therapeutic strategies.

  CHI Sunggi; 新井宏典; 宇津欣和; 池田大輔; 上田智朗; 福島健太郎; 小山大輔; 池添隆之; 細野奈穂子; 山内高弘; 吉本五一; 小林敬宏; 高橋直人; 堀口拓人; 井山諭; 諫田淳也; 近藤健; 伊豆津宏二; 湯田淳一朗; 南陽介

  日本臨床腫瘍学会学術集会(CD-ROM), 2023

  
• 家族性血球貪食性リンパ組織球症3型における発症年齢とNK細胞およびCTLの脱顆粒能の関連性の検討

  宮本 尚幸; 吉永 則良; 秋山 大介; 諫田 淳也; 加藤 健太郎; 東口 素子; 前田 由可子; 西谷 真彦; 仁平 寛士; 日衛嶋 栄太郎; 井澤 和司; 滝田 順子; 八角 高裕

  日本免疫不全・自己炎症学会雑誌, Sep. 2022

  
• PBSCT using haploidentical donor with PTCy versus matched sibling donor for lymphoma

  中舎洋輔; 中前博久; 西久保雅司; 近藤英生; 福田隆浩; 平本展大; 森康雄; 長藤宏司; 衛藤徹也; 諫田淳也; 一戸辰夫; 熱田由子; 熱田由子; 賀古真一

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2024

  
• ATG could potentially overcome an adverse effect of acute GVHD in matched-related PBSCT

  宮尾康太郎; 鍬塚八千代; 村田誠; 長藤宏司; 豊嶋崇徳; 竹内裕貴; 白鳥聡一; 名島悠峰; 内田直之; 田中正嗣; 澤正史; 太田秀一; 福田隆浩; 小澤幸泰; 賀古真一; 河北敏弘; 荒隆英; 田中淳司; 神田善伸; 熱田由子; 諫田淳也; 寺倉精太郎

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2022

  
• Effect of conditioning regimens and GVHD prophylaxis on UCBT performed with CY/TBI-based regimens

  今橋伸彦; 栗田尚樹; 小沼貴晶; 高橋聡; 西田徹也; 田中正嗣; 中前博久; 河北敏郎; 太田秀一; 土岐典子; 大西康; 澤正史; 尾関和貴; 平本展大; 鬼塚真仁; 石丸文彦; 一戸辰夫; 熱田由子; 熱田由子; 諫田淳也

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2024

  
• HSCT from haploidentical offspring using PTCY versus matched sibling in older patients with MDS

  下村良充; 下村良充; 北村哲久; 小沼貴晶; 中舎洋輔; 土岐典子; 澤正史; 中前博久; 衛藤徹也; 西田徹也; 大東寛幸; 太田秀一; 鬼塚真仁; 平本展大; 河北敏郎; 諫田淳也; 一戸辰夫; 熱田由子; 熱田由子; 糸永英弘

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2024

  
• The Comparison between BM and PBSC for the Patients with Pre-Transplant Pulmonary Dysfunction in HLA-Matched Allo-HCT: Subgroup Analysis Exploring the Impact Based on HCT Factors

  Shunto Kawamura; Masaharu Tamaki; Takaaki Konuma; Makoto Onizuka; Emiko Sakaida; Hiromi Hayashi; Noriko Doki; Tetsuya Nishida; Masashi Sawa; Hiroyuki Ohigashi; Takahiro Fukuda; Jun Ishikawa; Ken-Ichi Matsuoka; Toshiro Kawakita; Masatsugu Tanaka; Fumihiko Ishimaru; Tatsuo Ichinohe; Yoshiko Atsuta; Yoshinobu Kanda; Kimikazu Yakushijin; Junya Kanda; Hideki Nakasone

  BLOOD, 02 Nov. 2023

  
• Ideal body weight is useful to predict engraftment for overweight and obese recipients in CBT

  岡田陽介; 岡田陽介; 仲宗根秀樹; 小沼貴晶; 内田直之; 田中正嗣; 杉尾康浩; 青墳信之; 土岐典子; 勝岡優奈; 木村貴文; 福田隆浩; 熱田由子; 諫田淳也; 木村文彦

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2022

  
• Association between classification combining muscle mass and water and muscle strength in allo-HSCT

  浅野伝美; 濱田涼太; 村尾昌信; 松下路子; 宮坂淳介; 太田垣あゆみ; 諫田淳也; 新井康之; 新井康之; 池口良輔; 高折晃史; 高折晃史; 松田秀一

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2024

  
• Investigation of risk factors contributing to reduced exercise tolerance after CAR-T cell therapy

  濱田涼太; 新井康之; 新井康之; 北脇年雄; 村尾昌信; 松下路子; 宮坂淳介; 太田垣あゆみ; 浅野伝美; 福田裕子; 錦織桃子; 諫田淳也; 水本智咲; 池口良輔; 松田秀一; 高折晃史; 高折晃史

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2024

  
• Prognosis factors during lung transplantation waiting in patients with LONIPCs after allo-HSCT

  濱田涼太; 大島洋平; 佐藤晋; 吉岡佑二; 村尾昌信; 松下路子; 宮坂淳介; 太田垣あゆみ; 浅野伝美; 堀江賢; 田村真悠; 田辺直也; 諫田淳也; 近藤忠一; 新井康之; 近藤忠一; 新井康之; 池口良輔; 高折晃史; 高折晃史; 伊達洋至; 松田秀一

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2024

  
• Body compositions of BIA are related to serum IGF-1 level in patients after allo-HSCT

  村尾昌信; 濱田涼太; 諫田淳也; 近藤忠一; 近藤忠一; 松下路子; 宮坂淳介; 太田垣あゆみ; 浅野伝美; 新井康之; 新井康之; 池口良輔; 高折晃史; 高折晃史; 松田秀一

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2024

  
• 同種造血幹細胞移植後の膝関節伸展筋力は血清中IGF-1レベルと相関する

  村尾昌信; 濱田涼太; 諫田淳也; 近藤忠一; 近藤忠一; 松下路子; 宮坂淳介; 太田垣あゆみ; 浅野伝美; 新井康之; 新井康之; 池口良輔; 高折晃史; 高折晃史; 松田秀一

  近畿理学療法学術大会抄録集(CD-ROM), 2024

  
• Donor NK cell education by KIR3DL1/S1 and HLA-B associates with reduced relapse in unrelated bone marrow transplantation for adult T-cell leukemia

  森田真梨; 森田真梨; 進藤岳郎; 川口修治; 諫田淳也; 加藤光次; 中野伸亮; 衛藤徹也; 宮崎泰彦; 今田和典; 一戸辰夫; 福田隆浩; 鬼塚真仁; 松田文彦; 高折晃史

  日本HTLV-1学会学術集会, 2023

  
• 特発性造血障害に関する調査研究 再生不良性貧血/骨髄異形成症候群の前方視的症例登録・セントラルレビュー・追跡調査研究・遺伝子研究

  高折晃史; 通山薫; 松田晃; 川端浩; 諫田淳也

  特発性造血障害に関する調査研究 令和4年度 総括・分担研究報告書(Web), 2023

  
• アグレッシブ非ホジキンリンパ腫および多発性骨髄腫に対する自家移植後に起こる血小板生着遅延の影響

  岡田 陽介; 木村 文彦; 栗田 尚樹; 高橋 寛行; 島津 裕; 水野 昌平; 内田 直之; 片岡 圭亮; 平本 展大; 太田 秀一; 賀古 真一; 塚田 信弘; 神田 善伸; 倉橋 信悟; 土岐 典子; 西川 彰則; 金 成元; 半下石 明; 諫田 淳也; 福田 隆浩; 熱田 由子; 近藤 英生; 河村 浩二; 仲宗根 秀樹

  日本血液学会学術集会, Oct. 2023

  
• Efficacy of Foscarnet in Preventing HHV6 Encephalitis in Adult Cord Blood Transplantation

  鈴木光太郎; 諫田淳也; 家村知樹; 新井康之; 渡邊瑞希; 島津裕; 北脇年雄; 水本智咲; 山下浩平; 高折晃史

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2024

  
• Trends of allogeneic transplant outcomes for adult myelodysplastic syndrome in Japan

  小沼貴晶; 糸永英弘; 石山謙; 土岐典子; 内田直之; 小澤幸泰; 片山雄太; 片岡圭亮; 上田恭典; 松岡賢市; 河北敏郎; 衛藤徹也; 荒隆英; 諫田淳也; 鬼塚真仁; 福田隆浩; 熱田由子; 熱田由子

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2022

  
• Impact of early CMV reactivation on relapse in adult patients with MDS after allogeneic HSCT

  小西達矢; 松田健佑; 糸永英弘; 土岐典子; 小澤幸泰; 松岡賢市; 池田宇次; 神田善伸; 福田隆浩; 諫田淳也; 中前博久; 一戸辰夫; 熱田由子; 石山謙

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2022

  
• Impact of melphalan dose in patients with MDS undergoing allo-HSCT with RIC

  黒澤修兵; 下村良充; 下村良充; 糸永英弘; 片山雄太; 鬼塚真仁; 田中正嗣; 小林光; 小澤幸泰; 澤正史; 諫田淳也; 土岐典子; 藤澤信; 内田直之; 福田隆浩; 熱田由子; 熱田由子; 石山謙

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2022

  
• Personalized transplant strategy guided by machine learning in allogeneic stem cell transplantation

  岡村浩史; 岡村浩史; 中前博久; 中前美佳; 中前美佳; 加葉田大志朗; 吉田寿子; 新谷歩; 内田直之; 土岐典子; 福田隆浩; 小澤幸泰; 田中正嗣; 池亀和博; 衛藤徹也; 澤正史; 木村貴文; 諫田淳也; 熱田由子; 日野雅之; 日野雅之

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2022

  
• Comparing Single Cord Blood Transplantation and Matched Related Donor Transplantation in Non-Remission Acute Myeloid Leukemia

  Yoshimitsu Shimomura; Tomotaka Sobue; Shigeki Hirabayashi; Tadakazu Kondo; Shohei Mizuno; Junya Kanda; Takahiro Fujino; Keisuke Kataoka; Naoyuki Uchida; Tetsuya Eto; Shigesaburo Miyakoshi; Masatsugu Tanaka; Toshiro Kawakita; Hisayuki Yokoyama; Noriko Doki; Kaito Harada; Atsushi Wake; Shuichi Ota; Satoru Takada; Satoshi Takahashi; Takafumi Kimura; Makoto Onizuka; Takahiro Fukuda; Yoshiko Atsuta; Masamitsu Yanada

  BLOOD, Nov. 2021

  
• Peripheral-blood stem cells versus bone marrow from unrelated donors for adult AML patients

  城友泰; 新井康之; 近藤忠一; 水野昌平; 平林茂樹; 稲本賢弘; 諫田淳也; 土岐典子; 福田隆浩; 小澤幸泰; 片山雄太; 神田善伸; 鬼塚真仁; 一戸辰夫; 熱田由子; 柳田正光

  日本血液学会学術集会抄録(Web), 2021

  
• MTX大量療法,自家末梢血幹細胞移植により完全寛解に至った脳原発および脳内再発悪性リンパ腫の2症例

  諌田淳也; 蝶名林和久; 渡辺光正; 赤坂浩司; 有馬靖佳; 通堂満

  日本リンパ網内系学会会誌, 10 Jun. 2004

  
• Outcomes of allo-HSCT for therapy-related MDS compared to de novo MDS by propensity-score matching

  糸永英弘; 木田理子; 土岐典子; 内田直之; 小澤幸泰; 福田隆浩; 上田恭典; 片山雄太; 諫田淳也; 一戸辰夫; 熱田由子; 宮崎泰司; 宮崎泰司; 石山謙

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2022

  
• Comparison of Myeloablative Versus Reduced-Intensity Fludarabine/Busulfan Regimen in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

  Shuhei Kurosawa; Yoshimitsu Shimomura; Hidehiro Itonaga; Yuho Najima; Takeshi Kobayashi; Yukiyasu Ozawa; Yoshinobu Kanda; Shinichi Kako; Toshiro Kawakita; Ken-Ichi Matsuoka; Yumiko Maruyama; Shuichi Ota; Hideyuki Nakazawa; Kazunori Imada; Takafumi Kimura; Junya Kanda; Takahiro Fukuda; Yoshiko Atsuta; Ken Ishiyama

  BLOOD, Nov. 2021

  
• 傾向スコアマッチングを用いたATLと急性白血病との移植合併症の比較検討

  友利昌平; 友利昌平; 森島聡子; 加藤光次; 仲宗根秀樹; 福田隆浩; 中野伸亮; 衛藤徹也; 内田直之; 末廣陽子; 澤山靖; 河北敏郎; 諫田淳也; 熱田由子; 吉満誠

  日本血液学会学術集会抄録(Web), 2020

  
• Haploidentical transplantation versus cord blood transplantation for AML in non-remission

  松田健佑; 小沼貴晶; 布施香子; 増子正義; 河村浩二; 平山雅浩; 内田直之; 池亀和博; 和氣敦; 衛藤徹也; 土岐典子; 宮腰重三郎; 田中正嗣; 高橋聡; 鬼塚真仁; 加藤光次; 木村貴文; 一戸辰夫; 熱田由子; 諫田淳也; 柳田正光

  日本造血・免疫細胞療法学会総会プログラム・抄録集, 2022

  
• HLA class I抗体エピトープは、非血縁者間骨髄移植後における重症急性GVHD発症の増加と関連する

  岩崎 惇; 諫田 淳也; 田中 秀則; 進藤 岳郎; 土岐 典子; 福田 隆浩; 小澤 幸泰; 衛藤 徹也; 内田 直之; 片山 雄太; 片岡 圭亮; 鬼塚 真仁; 神田 善伸; 一戸 辰夫; 熱田 由子; 森島 聡子

  MHC: Major Histocompatibility Complex, Sep. 2021

  
• 複数のHLA座不適合が単一臍帯血移植後の成績に与える影響 JSTCT HLA WG研究

  諫田 淳也; 平林 茂樹; 横山 寿行; 川瀬 孝和; 田中 秀則; 内田 直之; 谷口 修一; 高橋 聡; 鬼塚 真仁; 田中 正嗣; 杉尾 康浩; 衛藤 徹也; 神田 善伸; 木村 貴文; 一戸 辰夫; 熱田 由子; 森島 聡子

  MHC: Major Histocompatibility Complex, Sep. 2021

  
• Net survival and conditional survival after allogeneic HSCT: Japanese transplant registry analysis

  鍬塚八千代; 伊藤秀美; 田渕健; 小沼貴晶; 内田直之; 土岐典子; 小澤幸泰; 池亀和博; 福田隆浩; 一戸辰夫; 木村文彦; 諫田淳也; 熱田由子; 熱田由子; 松尾恵太郎

  日本造血細胞移植学会総会プログラム・抄録集, 2021

  
• 7/8アリル一致非血縁骨髄移植と臍帯血移植治療成績の最新の比較検討

  宮尾康太郎; 寺倉精太郎; 木村文彦; 小沼貴晶; 宮村耕一; 柳田正光; 賀古真一; 森島聡子; 内田直之; 土岐典子; 小澤幸泰; 福田隆浩; 田中正嗣; 澤正史; 高田覚; 衛藤徹也; 木村貴文; 一戸辰夫; 熱田由子; 諫田淳也

  日本血液学会学術集会抄録(Web), 2020

  
• 症例 Lemierre症候群の1例

  諫田 淳也; 蝶名林 和久; 渡邊 光正

  内科, Aug. 2005

  
• 複数のHLA座不適合が単一臍帯血移植後の成績に与える影響:JSTCT HLA WG研究

  諫田淳也; 平林茂樹; 横山寿行; 川瀬孝和; 田中秀則; 内田直之; 谷口修一; 高橋聡; 鬼塚真仁; 田中正嗣; 杉尾康浩; 衛藤徹也; 神田善伸; 木村貴文; 一戸辰夫; 熱田由子; 熱田由子; 森島聡子

  MHC (Web), 2021

  
• Retrospective Multi-center Study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum Registry

  Aya Nakaya; Takae Kohara; Hirohiko Shibayama; Yoshiyuki Onda; Junya Kanda; Hitomi Kaneko; Kazunori Imada; Toru Kida; Satoru Kosugi; Jun Ishikawa; Ryosuke Yamamura; Yutaka Shimazu; Hirokazu Tanaka; Shin-Ichi Fuchida; Yuji Shimura; Miki Kiyota; Katsuya Wada; Tomoki Ito; Nobuhiko Uoshima; Hideo Yagi; Satoshi Yoshihara; Kensuke Ohta; Chihiro Shimazaki; Masayuki Hino; Akifumi Takaori-Kondo; Junya Kuroda; Itaru Matsumura; Yuzuru Kanakura; Shosaku Nomura

  BONE MARROW TRANSPLANTATION, Dec. 2020

  
• The clinical importance of DNMT3A, NPM1, and FLT3-ITD triple-mutation in Japanese AML

  板橋佳子; 阪口正洋; 由井俊輔; 翁家国; 賀古真一; 土岐典子; 諫田淳也; 森慎一郎; 佐竹敦志; 臼杵憲祐; 植木俊充; 魚嶋伸彦; 田近賢二; 鐘野勝洋; 田所治朗; 萩原政夫; 内山人二; 久保田寧; 黒田純也; 黒澤彩子; 橋本朗子; 本村小百合; 河田英里; 佐藤恵理子; 緒方正男; 三橋健次郎; 安藤純; 福田隆浩; 神田善伸; 山口博樹

  日本血液学会学術集会抄録(Web), 2021

  
• Examination of the usefulness of translocation-type gene abnormality detection using i-densy IS-5320

  由井俊輔; 岡本宗雄; 脇田知志; 永田安伸; 栗林泰子; 朝山敏夫; 藤原裕介; 阪口正洋; 山中聡; 丸毛淳史; 大森郁子; 木下量介; 尾内大志; 砂川実香; 海渡裕太; 稲井一貴; 土蔵太一朗; 竹吉敦志; 保田駿一; 本間俊佑; 荒井邦仁; 北野智章; 宮田美保; 土岐典子; 諫田淳也; 平井光春; 木寺一喜; 猪口孝一; 山口博樹

  日本血液学会学術集会抄録(Web), 2021

  
• FLT3-ITD陽性急性骨髄性白血病におけるDNAメチル化制御遺伝子変異とそのアレル比の臨床的意義

  神田真志; 脇田知志; 新井悠; 溝口歩; 黒沢明世; 阪口正洋; 由井俊輔; 臼杵憲祐; 植木俊充; 翁家国; 森慎一郎; 魚嶋伸彦; 小林裕; 賀古真一; 田近賢二; 鐘野勝洋; 萩原政夫; 諫田淳也; 内山人二; 黒田純也; 内田直之; 久保田寧; 黒澤彩子; 北野智章; 荒井邦仁; 荒井邦仁; 神田善伸; 大橋一輝; 福田隆浩; 山口博樹; 猪口孝一

  日本血液学会学術集会抄録(Web), 2020

  
• 日本人急性骨髄性白血病コホートにおけるASXL1遺伝子変異の臨床的意義

  新井悠; 脇田知志; 神田真志; 溝口歩; 黒沢明世; 阪口正洋; 由井俊輔; 臼杵憲祐; 植木俊充; 翁家国; 森慎一郎; 魚嶋伸彦; 小林裕; 賀古真一; 田近賢二; 鐘野勝洋; 萩原政夫; 諫田淳也; 内山人二; 黒田純也; 内田直之; 久保田寧; 黒澤彩子; 北野智章; 荒井邦仁; 神田善伸; 大橋一輝; 福田隆浩; 山口博樹; 猪口孝一

  日本血液学会学術集会抄録(Web), 2020

  
• 日本人急性骨髄性白血病コホートにおけるCEBPA遺伝子変異の臨床的意義

  黒沢明世; 脇田知志; 溝口歩; 新井悠; 神田真志; 阪口正洋; 由井俊輔; 臼杵憲祐; 植木俊充; 翁家国; 森慎一郎; 魚嶋伸彦; 小林裕; 賀古真一; 田近賢二; 鐘野勝洋; 萩原政夫; 諫田淳也; 内山人二; 黒田純也; 内田直之; 久保田寧; 黒澤彩子; 北野智章; 荒井邦仁; 神田善伸; 大橋一輝; 福田隆浩; 山口博樹; 猪口孝一

  日本血液学会学術集会抄録(Web), 2020

  
• FLT3-ITD陽性急性骨髄性白血病におけるDNAメチル化制御遺伝子変異とそのアレル比の臨床的意義

  神田真志; 脇田知志; 新井悠; 溝口歩; 黒沢明世; 阪口正洋; 由井俊輔; 臼杵憲祐; 植木俊充; 翁家国; 森慎一郎; 魚嶋伸彦; 小林裕; 賀古真一; 田近賢二; 鐘野勝洋; 萩原政夫; 諫田淳也; 内山人二; 黒田純也; 内田直之; 久保田寧; 黒澤彩子; 北野智章; 荒井邦仁; 荒井邦仁; 神田善伸; 大橋一輝; 福田隆浩; 山口博樹; 猪口孝一

  日本血液学会学術集会抄録(Web), 2020

  
• 日本人急性骨髄性白血病コホートにおけるCEBPA遺伝子変異の臨床的意義

  黒沢明世; 脇田知志; 溝口歩; 新井悠; 神田真志; 阪口正洋; 由井俊輔; 臼杵憲祐; 植木俊充; 翁家国; 森慎一郎; 魚嶋伸彦; 小林裕; 賀古真一; 田近賢二; 鐘野勝洋; 萩原政夫; 諫田淳也; 内山人二; 黒田純也; 内田直之; 久保田寧; 黒澤彩子; 北野智章; 荒井邦仁; 神田善伸; 大橋一輝; 福田隆浩; 山口博樹; 猪口孝一

  日本血液学会学術集会抄録(Web), 2020

  
• CEBPA遺伝子変異陽性AMLにおける併存遺伝子変異の臨床的意義

  溝口歩; 脇田知志; 黒沢明世; 新井悠; 神田真志; 阪口正洋; 由井俊輔; 臼杵憲祐; 植木俊充; 翁家国; 森慎一郎; 魚嶋伸彦; 小林裕; 賀古真一; 田近賢二; 鐘野勝洋; 萩原政夫; 諫田淳也; 内山人二; 黒田純也; 内田直之; 久保田寧; 黒澤彩子; 北野智章; 荒井邦仁; 神田善伸; 大橋一輝; 福田隆浩; 山口博樹; 猪口孝一

  日本血液学会学術集会抄録(Web), 2020

  
• Effect of graft-versus-host disease on outcomes after cord blood transplantation

  諫田 淳也

  血液内科 = Hematology, Sep. 2017

  
• Prognostic scoring system for patients undergoing salvage transplantation for graft failure

  原田介斗; 藤重夫; 木村俊一; 名島悠峰; 薬師神公和; 内田直之; 鬼塚真仁; 池亀和博; 矢野真吾; 土岐典子; 松岡賢市; 大西康; 澤正史; 福田隆浩; 諫田淳也; 熱田由子; 仲宗根秀樹

  日本造血細胞移植学会総会プログラム・抄録集, 2021

  
• Comparative effectiveness of FLU/BU4 conditioning regimen of allo-HSCT for MDS

  黒澤修兵; 下村良充; 糸永英弘; 名島悠峰; 小林武; 小澤幸泰; 神田善伸; 賀古真一; 河北敏郎; 松岡賢市; 丸山ゆみ子; 諫田淳也; 福田隆浩; 熱田由子; 青木淳

  日本造血細胞移植学会総会プログラム・抄録集, 2021

  
• Cost of Hematopoietic Stem Cell Transplantation in the Real World: An Analysis using The Japanese National Database

  Mizuki Watanabe; Shosuke Ohtera; Junya Kanda; Shusuke Hiragi; Tomohide Iwao; Tomohiro Kuroda; Akifumi Takaori-Kondo; Genta Kato

  BONE MARROW TRANSPLANTATION, Dec. 2020

  
• 移植非適応MMに対する導入化学療法別の治療成績:KMFにおける547例の後方視的解析

  志村勇司; 柴山浩彦; 中谷綾; 山村亮介; 今田和典; 金子仁臣; 花本仁; 淵田真一; 田中宏和; 小杉智; 清田実希; 松井利充; 諫田淳也; 飯田正人; 松田光弘; 魚嶋伸彦; 柴野賢; 烏野隆博; 濱田常義; 太田健介; 伊藤量基; 八木秀男; 吉原哲; 黒田純也; 島崎千尋; 日野雅之; 高折晃史; 松村到; 金倉譲; 野村昌作

  日本血液学会学術集会抄録(Web), 2020

  
• 移植細胞ソース別の急性白血病に対するGVL効果

  小沼貴晶; 諫田淳也; 鍬塚八千代; 柳田正光; 近藤忠一; 平林茂樹; 賀古真一; 赤星佑; 内田直之; 土岐典子; 小澤幸泰; 田中正嗣; 衛藤徹也; 澤正史; 吉岡聡; 木村貴文; 神田善伸; 福田隆浩; 熱田由子; 熱田由子; 木村文彦

  日本血液学会学術集会抄録(Web), 2020

  
• Outcomes of allogeneic hematopoietic stem cell transplantation in patients with MDS/MPN-U

  黒澤修兵; 下村良充; 立花崇孝; 石山謙; 太田秀一; 小林武; 内田直之; 福島健太郎; 諫田淳也; 一戸辰夫; 熱田由子; 熱田由子; 村田誠; 青木淳

  日本造血細胞移植学会総会プログラム・抄録集, 2020

  
• 同種造血幹細胞移植後早期における骨格筋断面積変化の特徴

  濱田 涼太; 吉田 路子; 宮坂 淳介; 村尾 昌信; 南角 学; 諫田 淳也; 近藤 忠一; 高折 晃史; 佐藤 晋; 池口 良輔; 松田 秀一

  日本造血細胞移植学会雑誌, Apr. 2019

  
• 同種造血幹細胞移植後早期における骨格筋断面積変化の特徴

  濱田 涼太; 吉田 路子; 宮坂 淳介; 村尾 昌信; 南角 学; 諫田 淳也; 近藤 忠一; 高折 晃史; 佐藤 晋; 池口 良輔; 松田 秀一

  日本造血細胞移植学会雑誌, Apr. 2019

  
• NPM1変異陽性かつFLT3-ITD低アレル比の急性骨髄性白血病に対する第一寛解期での同種移植の意義

  阪口正洋; 山口博樹; 名島悠峰; 臼杵憲祐; 植木俊充; 翁家国; 森慎一郎; 河田英里; 魚嶋伸彦; 小林裕; 賀古真一; 田近賢二; 鐘野勝洋; 栢森健介; 萩原政夫; 諫田淳也; 内山人二; 黒田純也; 内田直之; 久保田寧; 木村晋也; 黒澤彩子; 中島菜々; 由井俊輔; 脇田知志; 垣花和彦; 神田善伸; 神田善伸; 大橋一輝; 福田隆浩; 猪口孝一

  日本造血細胞移植学会総会プログラム・抄録集, 2019

  
• Epidemiology of Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed Myelodysplastic Syndrome

  Yoshimitsu Shimomura; Masahiko Hara; Takayoshi Tachibana; Kazuteru Ohashi; Yukiyasu Ozawa; Tetsuya Eto; Naoyuki Uchida; Takehiko Mori; Junya Kanda; Tatsuo Ichinohe; Yoshiko Atsuta; Takayuki Ishikawa; Ken Ishiyama

  BLOOD, Nov. 2018

  
• Comparable Survival Outcomes of Haploidentical Stem Cell Transplantation and Unrelated Bone Marrow Transplantation

  Junichi Sugita; Yoshiko Atsuta; Mio Kurata; Hirohisa Nakamae; Naoki Kurita; Ken Ishiyama; Souichi Shiratori; Takahiro Fukuda; Kazuteru Ohashi; Yukiyasu Ozawa; Junya Kanda; Tatsuo Ichinohe; Takanori Teshima

  BLOOD, Nov. 2018

  
• The evaluation of consolidation and maintenance therapies after HDT/ASCT for symptomatic MM

  Aya Nakaya; Eiji Nakatani; Hitomi Kaneko; Hirohiko Shibayama; Yuji Shimura; Junya Kanda; Maki Shindo; Kensuke Ohta; Satoru Kosugi; Shin-Ichi Fuchida; Hideo Yagi; Hirokazu Tanaka; Yuri Kamitsuji; Takahiro Karasuno; Nobuhiko Uoshima; Eri Kawata; Yoko Adachi; Hitoji Uchiyama; Toshimitsu Matsui; Mitsuhiro Matsuda; Jun Ishikawa; Tsuneyoshi Hamada; Ryoichi Takahashi; Kazunori Imada; Chihiro Shimazaki; Masayuki Hino; Junya Kuroda; Yuzuru Kanakura; Akifumi Takaori-Kondo; Shosaku Nomura; Itaru Matsumura

  BONE MARROW TRANSPLANTATION, Sep. 2018

  
• サリドマイド単剤治療を施行した症候性骨髄腫230例の後方視的解析 関西骨髄腫フォーラム(Analysis of 230 cases of thalidomide monotherapy for symptomatic myeloma registered in KMF)

  金子 仁臣; 柴山 浩彦; 八木 秀男; 諫田 淳也; 中谷 綾; 小杉 智; 木田 亨; 田中 宏和; 志村 勇司; 淵田 真一; 足立 陽子; 和田 勝也; 清田 実希; 魚嶋 伸彦; 太田 健介; 小原 尚恵; 濱田 常義; 小林 正行; 内山 人二; 烏野 隆博; 黒田 純也; 今田 和典; 高折 晃史; 島崎 千尋; 金倉 譲; 日野 雅之; 野村 昌作; 松村 到

  臨床血液, Sep. 2018

  
• RRMM患者に対するKRD療法およびKD療法の後方視的解析(関西骨髄腫フォーラム)(KRD and KD treatment for relapsed/refractory multiple myeloma in Kansai Myeloma Forum study)

  恩田 佳幸; 諫田 淳也; 金子 仁臣; 柴山 浩彦; 志村 勇司; 太田 健介; 田中 宏和; 淵田 真一; 中谷 綾; 魚嶋 伸彦; 小杉 智; 松田 光弘; 足立 陽子; 八木 秀男; 内山 人二; 新堂 真紀; 今田 和典; 日野 雅之; 野村 昌作; 島崎 千尋; 黒田 純也; 金倉 譲; 高折 晃史; 松村 到

  臨床血液, Sep. 2018

  
• 急性骨髄性白血病におけるFLT3-ITD低アレル比とNPM1の予後因子としての重要性(Prognostic impact of acute myeloid leukemia with low allelic ratio FLT3-ITD and NPM1 mutation)

  中島 菜々; 阪口 正洋; 名島 悠峰; 臼杵 憲祐; 植木 俊充; 翁 家国; 森 慎一郎; 河田 英里; 魚嶋 伸彦; 小林 裕; 賀古 真一; 田近 賢二; 五味 聖二; 鐘野 勝洋; 栢森 健介; 萩原 政夫; 諫田 淳也; 内山 人二; 黒田 純也; 内田 直之; 久保田 寧; 木村 晋也; 黒澤 彩子; 荒井 邦仁; 垣花 和彦; 神田 善伸; 大橋 一輝; 福田 隆浩; 山口 博樹; 猪口 孝一

  臨床血液, Sep. 2018

  
• FLT3-TKD遺伝子変異陽性急性骨髄性白血病の臨床的特徴と予後(The clinical features and prognostic impact of acute myeloid leukemia with FLT3-TKD mutation)

  久保山 まりか; 阪口 正洋; 名島 悠峰; 臼杵 憲祐; 植木 俊充; 翁 家国; 森 慎一郎; 河田 英里; 魚嶋 伸彦; 小林 裕; 賀古 真一; 田近 賢二; 五味 聖二; 鐘野 勝洋; 栢森 健介; 萩原 政夫; 諫田 淳也; 内山 人二; 黒田 純也; 内田 直之; 木村 晋也; 黒澤 彩子; 伊達 健太; 脇田 知志; 垣花 和彦; 神田 善伸; 福田 隆浩; 大橋 一輝; 山口 博樹; 猪口 孝一

  臨床血液, Sep. 2018

  
• KMFに登録されたボルテゾミブとIMiDs両剤に抵抗性の再発骨髄腫の予後解析(Clinical outcomes of relapsed myeloma, dual refractory to bortezomib and IMiDs in KMF registry)

  藤原 亮介; 田中 宏和; 芹澤 憲太郎; 金子 仁臣; 志村 勇司; 太田 健介; 淵田 真一; 中谷 綾; 諫田 淳也; 八木 秀男; 和田 勝也; 小杉 智; 魚嶋 伸彦; 柴山 浩彦; 小原 尚恵; 中谷 英仁; 内山 人二; 足立 陽子; 飯田 正人; 濱田 常義; 松田 光弘; 高折 晃史; 野村 昌作; 島崎 千尋; 日野 雅之; 黒田 純也; 谷脇 雅史; 今田 和典; 金倉 譲; 松村 到

  臨床血液, Sep. 2018

  
• KMFに登録されたボルテゾミブとIMiDs両剤に抵抗性の再発骨髄腫の予後解析(Clinical outcomes of relapsed myeloma, dual refractory to bortezomib and IMiDs in KMF registry)

  藤原 亮介; 田中 宏和; 芹澤 憲太郎; 金子 仁臣; 志村 勇司; 太田 健介; 淵田 真一; 中谷 綾; 諫田 淳也; 八木 秀男; 和田 勝也; 小杉 智; 魚嶋 伸彦; 柴山 浩彦; 小原 尚恵; 中谷 英仁; 内山 人二; 足立 陽子; 飯田 正人; 濱田 常義; 松田 光弘; 高折 晃史; 野村 昌作; 島崎 千尋; 日野 雅之; 黒田 純也; 谷脇 雅史; 今田 和典; 金倉 譲; 松村 到

  臨床血液, Sep. 2018

  
• 症候性骨髄腫1414例の後方視的解析 関西骨髄腫フォーラムからの最新報告(Retrospective analyses of 1,414 symptomatic multiple myeloma cases: update from Kansai Myeloma Forum)

  田中 宏和; 芹澤 憲太郎; 中谷 綾; 金子 仁臣; 太田 健介; 小杉 智; 八木 秀男; 花本 仁; 淵田 真一; 志村 勇司; 柴山 浩彦; 小原 尚恵; 中谷 英仁; 諫田 淳也; 魚嶋 伸彦; 和田 勝也; 烏野 隆博; 松井 利充; 内山 人二; 松田 光弘; 足立 陽子; 高折 晃史; 黒田 純也; 谷脇 雅史; 島崎 千尋; 日野 雅之; 今田 和典; 野村 昌作; 金倉 譲; 松村 到

  臨床血液, Sep. 2018

  
• Clinical Significance of Natural Killer Cell-Mediated Alloreactivity in Unrelated Cord Blood Transplantation for Children with Acute Leukemia: A Japanese National Registry Study

  Hirotoshi Sakaguchi; Nobuyoshi Arima; Atsushi Narita; Sae Ishimaru; Daisuke Tomizawa; Daiichiro Hasegawa; Motohiro Kato; Hiroyuki Ishida; Junya Kanda; Masami Inoue; Nao Yoshida; Katsuyoshi Koh; Jiro Inagaki; Atsushi Ogawa; Tsukasa Hori; Yoshiko Hashii; Koji Kato; Yoshiko Atsuta

  BLOOD, Dec. 2017

  
• HLA不適合血縁者間造血幹細胞移植における移植前リンパ球クロスマッチの意義に関する後方視的検討

  亀田和明; 小宮佑介; 諫田淳也; 後明晃由美; 早川仁; 赤星佑; 原田尚憲; 鵜飼知嵩; 石原優子; 河村浩二; 坂本佳奈; 佐藤美樹; 和田英則; 齋藤桐子; 菊地美里; 木村俊一; 仲宗根秀樹; 賀古真一; 神田善伸

  臨床血液, 30 Sep. 2017

  
• 皮膚限局Grade II急性GVHDに対する外用ステロイド単独投与の安全性の検討

  亀田和明; 賀古真一; 早川仁; 赤星佑; 小宮佑介; 原田尚憲; 鵜飼知嵩; 石原優子; 河村浩二; 坂本佳奈; 佐藤美樹; 和田英則; 斎藤桐子; 木村俊一; 菊地美里; 仲宗根秀樹; 諫田淳也; 神田善伸

  日本造血細胞移植学会総会プログラム・抄録集, 15 Feb. 2017

  
• 同種移植後鉄過剰症に対するdeferasiroxの安全性と有効性:第1相臨床試験

  立花崇孝; 立花崇孝; 諫田淳也; 町田真一郎; 斉藤健; 田中正嗣; 名島悠峰; 小山哲; 宮崎拓也; 山本恵理; 武内正博; 森田智視; 神田善伸; 金森平和; 岡本真一郎

  日本造血細胞移植学会総会プログラム・抄録集, 2017

  
• 再発難治急性白血病の非寛解期移植における予後予測Index:KSGCT多施設共同研究

  立花崇孝; 諫田淳也; 諫田淳也; 石埼卓馬; 名島悠峰; 田中正嗣; 土岐典子; 藤原慎一郎; 木村俊一; 鬼塚真仁; 高橋聡; 斎藤健; 森毅彦; 藤澤信; 境田惠美子; 松本憲二; 青墳信之; 後藤守孝; 渡辺玲子; 鐘野勝洋; 臼杵憲祐; 塚田信弘; 神田善伸; 神田善伸; 岡本真一郎

  日本造血細胞移植学会総会プログラム・抄録集, 2017

  
• 骨髄異形成症候群に対する同種造血幹細胞移植後の一次生着不全の検討

  水牧裕希; 水牧裕希; 青木淳; 諫田淳也; 福田隆浩; 神田善伸; 神田善伸; 大橋一輝; 内田直之; 小澤幸泰; 熱田由子; 宮崎泰司; 石山謙

  日本造血細胞移植学会総会プログラム・抄録集, 2017

  
• 再発症例に対する3回目同種造血細胞移植成績

  小林真一; 神田善伸; 稲本賢弘; 小沼貴晶; 松本公一; 小川啓恭; 内田直之; 宮本敏浩; 高橋聡; 鬼塚真仁; 諫田淳也; 福田隆浩; 熱田由子; 木村文彦

  日本造血細胞移植学会総会プログラム・抄録集, 2017

  
• the Safety and Efficacy of Deferasirox for the Transplant Patients with Iron Overload

  Takayoshi Tachibana; Junya Kanda; Shinichiro Machida; Takeshi Saitou; Masatsugu Tanaka; Yuho Najima; Satoshi Koyama; Takuya Miyazaki; Eri Yamamoto; Masahiro Takeuchi; Satoshi Morita; Yoshinobu Kanda; Heiwa Kanamori; Shinichiro Okamoto

  BLOOD, Dec. 2016

  
• Impact of the Presence of HLA 1-Locus Mismatch and the Use of Thymoglobulin in Unrelated Bone Marrow Transplantation

  Koji Kawamura; Junya Kanda; Shigeo Fuji; Kosuke Yoshioka; Yukiyasu Ozawa; Takahiro Fukuda; Naoyuki Uchida; Koji Iwato; Tatsuo Ichinohe; Yoshiko Atsuta; Yoshinobu Kanda

  BLOOD, Dec. 2016

  
• Haploidentical transplantation : current status and future prospects

  諫田 淳也

  血液内科 = Hematology, May 2016

  
• 同種移植前に肺真菌症に対して外科的切除を行った4症例

  原田尚憲; 木村俊一; 後明晃由美; 早川仁; 赤星祐; 小宮祐介; 鵜飼知嵩; 亀田和明; 和田英則; 石原優子; 河村浩二; 坂本佳奈; 佐藤美樹; 斎藤桐子; 菊地美里; 仲宗根秀樹; 諫田淳也; 賀古真一; 坪地宏嘉; 神田善伸

  関東医真菌懇話会プログラム・抄録集, May 2016

  
• 同種造血幹細胞移植後の免疫抑制剤累積量が移植後アスペルギルス症発症に及ぼす影響の検討

  斎藤桐子; 仲宗根秀樹; 後明晃由美; 早川仁; 赤星佑; 小宮祐介; 原田尚憲; 亀田和明; 鵜飼知嵩; 和田英則; 石原優子; 河村浩二; 坂本佳奈; 佐藤美樹; 木村俊一; 菊地美里; 諫田淳也; 賀古真一; 神田善伸

  関東医真菌懇話会プログラム・抄録集, May 2016

  
• Comparison of Graft-Versus-Host Disease-Free, Relapse-Free Survival (GRFS) of Patients with Hematological Malignancy According to Donor Type: JSHCT Working Group Study

  Yoshihiro Inamoto; Fumihiko Kimura; Junya Kanda; Junichi Sugita; Kazuhiro Ikegame; Hideki Nakasone; Yasuhito Nannya; Naoyuki Uchida; Takahiro Fukuda; Kosuke Yoshioka; Yukiyasu Ozawa; Ichiro Kawano; Yoshiko Atsuta; Koji Kato; Tatsuo Ichinohe; Masami Inoue; Takanori Teshima

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Mar. 2016

  
• 同種造血幹細胞移植後における二次性血小板減少のリスク因子と成績への影響

  赤星佑; 諫田淳也; 後明晃由美; 早川仁; 小宮佑介; 原田尚憲; 亀田和明; 鵜飼知嵩; 和田英則; 石原優子; 河村浩二; 坂本佳奈; 佐藤美樹; 寺迫(斎藤; 桐子; 木村俊一; 菊地美里; 仲宗根秀樹; 賀古真一; 神田善伸

  日本造血細胞移植学会総会プログラム・抄録集, 10 Feb. 2016

  
• 血液悪性腫瘍に対する造血幹細胞移植後再発における染色体異常の解析

  石原優子; 仲宗根秀樹; 後明晃由美; 早川仁; 赤星佑; 小宮佑介; 原田尚憲; 亀田和明; 鵜飼知嵩; 和田英則; 河村浩二; 坂本佳奈; 佐藤美樹; 斎藤桐子; 木村俊一; 菊地美里; 諫田淳也; 賀古真一; 神田善伸

  日本造血細胞移植学会総会プログラム・抄録集, 10 Feb. 2016

  
• 低用量アレムツズマブを用いたHLA不適合ハプロアイデンティカル移植:低用量サイモグロブリンを用いたハプロアイデンティカル移植との比較

  賀古真一; 後明晃由美; 赤星佑; 原田尚憲; 亀田和明; 鵜飼知嵩; 和田英則; 石原優子; 河村浩二; 坂本佳奈; 佐藤美樹; 斎藤桐子; 木村俊一; 菊地美里; 仲宗根秀樹; 諫田淳也; 神田善伸

  日本造血細胞移植学会総会プログラム・抄録集, 10 Feb. 2016

  
• The Impact of Donor Age on Outcome after Unrelated Bone Marrow Transplantation: Comparison with Unrelated Cord Blood Transplantation

  Sachiko Seo; Junya Kanda; Yoshiko Atsuta; Naoyuki Uchida; Kazuteru Ohashi; Takahiro Fukuda; Satoshi Takahashi; Yukiyasu Ozawa; Makoto Onizuka; Minoko Takanashi; Nobuhiro Tsukada; Shunichi Kato; Fumihiko Kimura; Yoshinobu Kanda; Koichi Miyamura

  BLOOD, Dec. 2015

  
• CD5+びまん性大細胞型B細胞リンパ腫治療中に発症し,診断に苦慮した結核性髄膜炎

  寺村由希; 亀田和明; 諫田淳也; 後明晃由美; 早川仁; 赤星祐; 小宮佑介; 原田尚憲; 鵜飼知嵩; 石原優子; 河村浩二; 坂本佳奈; 佐藤美樹; 和田英則; 斎藤桐子; 木村俊一; 菊地美里; 仲宗根秀樹; 賀古真一; 神田善伸; 神田善伸

  臨床血液, 30 Nov. 2015

  
• 妊娠中に深部静脈血栓症をきたすもAT製剤の補充により無事出産に至った先天性AT欠損症

  伊藤祥子; 河村浩二; 蘆澤正弘; 菊地美里; 赤星佑; 原田尚憲; 亀田和明; 鵜飼知嵩; 和田英則; 石原優子; 木村俊一; 山崎理絵; 諫田淳也; 賀古真一; 大森司; 山口大介; 森下英理子; 堀内功; 高木健次郎; 神田善伸

  臨床血液, 30 May 2015

  
• 造血細胞輸注時の有害事象観察 多施設共同前向き研究(第2報)

  大戸 斉; 池田 和彦; 田野崎 隆二; 室井 一男; 藤原 実名美; 金森 平和; 藤井 伸治; 奥山 美樹; 芦田 隆司; 諫田 淳也; 長村 登紀子; 竹下 明裕; 田崎 哲典; 笠間 絹代; 日本輸血; 細胞治療学会細胞治療委員会多施設共同前向き研究グループ

  日本輸血細胞治療学会誌, Apr. 2015

  
• TRUMPデータを用いた,肝臓急性移植片対宿主病発症リスク因子の解析

  新井康之; 諫田淳也; 仲宗根秀樹; 近藤忠一; 内田直之; 福田隆浩; 大橋一輝; 小川啓恭; 長村登紀子; 森島泰雄; 廣川誠; 熱田由子; 村田誠

  日本造血細胞移植学会総会プログラム・抄録集, 06 Feb. 2015

  
• 同種移植後,ステロイド使用患者における監視血液培養の有用性

  亀田和明; 木村俊一; 赤星佑; 原田尚徳; 中野裕史; 鵜飼知嵩; 和田英則; 山埼諒子; 石原優子; 河村浩二; 坂本佳奈; 佐藤美樹; 斎藤桐子; 蘆澤正弘; 菊地美里; 山崎理絵; 諫田淳也; 賀古真一; 西田淳二; 神田善伸

  日本造血細胞移植学会総会プログラム・抄録集, 06 Feb. 2015

  
• 自家造血幹細胞移植後の低用量アシクロビルによるHSVおよびVZV再活性化予防の後方視的研究

  河村浩二; 赤星佑; 原田尚憲; 中野裕史; 亀田和明; 鵜飼知嵩; 和田英則; 山崎諒子; 石原優子; 坂本佳奈; 蘆澤正弘; 佐藤美樹; 斎藤桐子; 木村俊一; 菊地美里; 仲宗根秀樹; 山崎理絵; 諫田淳也; 賀古真一; 神田善伸

  日本造血細胞移植学会総会プログラム・抄録集, 06 Feb. 2015

  
• 抗ヒト胸腺細胞免疫グロブリン(ATG:サイモグロブリン)を用いた,進行期造血器腫瘍に対するHLA不適合同種造血幹細胞移植の安全性と有効性に関する後方視的検討

  賀古真一; 赤星佑; 原田尚憲; 中野裕史; 亀田和明; 鵜飼知嵩; 山崎諒子; 和田英則; 石原優子; 河村浩二; 坂本佳奈; 佐藤美樹; 蘆澤正弘; 斎藤桐子; 木村俊一; 菊地美里; 仲宗根秀樹; 山崎理絵; 諫田淳也; 神田善伸

  日本造血細胞移植学会総会プログラム・抄録集, 06 Feb. 2015

  
• Impact of Race on Graft-Versus-Host Disease Rates after HLA-Matched Sibling Bone Marrow or Peripheral Blood Hematopoietic Cell Transplantation: Comparison of North American Caucasian Versus Japanese Populations

  Junya Kanda; Yachiyo Kuwatsuka; Ruta Brazauskas; Zhen-Huan Hu; Koji Nagafuji; Takahiro Fukuda; Hisashi Sakamaki; Carmem Bonfim; Jignesh Dalal; Theresa Hahn; Marcelo C. Pasquini; Yoshiko Atsuta; Wael Saber

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Feb. 2015

  
• Analysis of Risk Factors for Hepatic Acute Graft-Versus-Host Disease By Using Transplant Registry Data in Japan

  Yasuyuki Arai; Junya Kanda; Hideki Nakasone; Tadakazu Kondo; Naoyuki Uchida; Takahiro Fukuda; Kazuteru Ohashi; Hiroyasu Ogawa; Tokiko Nagamura-Inoue; Yasuo Morishima; Makoto Hirokawa; Yoshiko Atsuta; Makoto Murata

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Feb. 2015

  
• Impact of Acute and Chronic Graft-Versus-Host Disease on Outcomes after Single Cord Blood Transplantation: A Retrospective Analysis By the JSHCT Gvhd Working Group

  Junya Kanda; Yasuo Morishima; Atsushi Wake; Seitaro Terakura; Naoyuki Uchida; Satoshi Takahashi; Yuju Ono; Yasushi Onishi; Heiwa Kanamori; Nobuyuki Aotsuka; Koji Kato; Yoshiko Atsuta; Makoto Murata

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Feb. 2015

  
• Decision Analysis of Allogeneic Hematopoietic Stem Cell Transplantation Versus Chemotherapy in Cytogenetically Standard-Risk Acute Myeloid Leukemia in First Complete Remission: The Impact of FLT3-ITD Profile

  Saiko Kurosawa; Hiroki Yamaguchi; Takuhiro Yamaguchi; Keiko Fukunaga; Shunsuke Yui; Heiwa Kanamori; Kensuke Usuki; Nobuhiko Uoshima; Masamitsu Yanada; Katsuhiro Shono; Toshimitsu Ueki; Ishikazu Mizuno; Shingo Yano; Jin Takeuchi; Junya Kanda; Hiroshi Okamura; Kinuko Tajima; Yoshihiro Inamoto; Koiti Inokuchi; Takahiro Fukuda

  BLOOD, Dec. 2014

  
• Comparison of Outcomes of Unrelated BM and CB Transplants in Young Adult Leukemia Patients. Updated Results of Japanese Registration Study

  Seitaro Terakura; Yoshiko Atsuta; Nobuhiro Tsukada; Takeshi Kobayashi; Masatsugu Tanaka; Junya Kanda; Kazuteru Ohashi; Takahiro Fukuda; Naoyuki Uchida; Takahashi Satoshi; Tokiko Nagamura-Inoue; Yasuo Morishima; Koichi Miyamura

  BLOOD, Dec. 2014

  
• MTXによる亜急性脳症から回復後に前処置CY/TBIで同種末梢血幹細胞移植を行ったALLの1例

  山崎諒子; 木村俊一; 赤星佑; 中野裕史; 鵜飼知嵩; 和田英則; 河村浩二; 石原優子; 坂本佳奈; 蘆澤正弘; 佐藤美樹; 斉藤桐子; 菊地美里; 諫田淳也; 賀古真一; 山崎理絵; 西田淳二; 神田善伸; 崎山快夫; 川崎理加; 藤巻克通

  臨床血液, 30 Jul. 2014

  
• SINGLE HIGH-RESOLUTION HLA MISMATCH HAS SIMILAR ADVERSE IMPACT ON THE OUTCOME OF RELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION COMPARED WITH SINGLE LOW-RESOLUTION HLA MISMATCH

  S. Fuji; J. Kanda; K. Miyamura; K. Kubo; M. Hidaka; S. Adachi; T. Ichinohe; Y. Atsuta; Y. Kanda

  BONE MARROW TRANSPLANTATION, Mar. 2014

  
• カルシニューリン・インヒビターの減量及び中止時のプレドニゾロン置換によるGVHD予防の安全性,有効性の検討

  石原優子; 諫田淳也; 中野裕史; 鵜飼知嵩; 和田英則; 山崎諒子; 河村浩二; 坂本佳奈; 佐藤美樹; 蘆澤正弘; 斉藤桐子; 木村俊一; 菊地美里; 仲宗根秀樹; 賀古真一; 山崎理絵; 西田淳二; 神田善伸

  日本造血細胞移植学会総会プログラム・抄録集, 14 Feb. 2014

  
• 同種造血幹細胞移植後のmeasles,mumps,rubellaに対する抗体価についての後方視的検討

  河村浩二; 山崎理絵; 中野裕史; 鵜飼知嵩; 和田英則; 山崎諒子; 石原優子; 坂本佳奈; 蘆澤正弘; 佐藤美樹; 斎藤桐子; 木村俊一; 菊地美里; 仲宗根秀樹; 諫田淳也; 賀古真一; 西田淳二; 神田善伸

  日本造血細胞移植学会総会プログラム・抄録集, 14 Feb. 2014

  
• 全身放射線照射から移植までの日数が移植成績に及ぼす影響

  赤星佑; 賀古真一; 中野裕史; 鵜飼知嵩; 和田英則; 山崎諒子; 石原優子; 河村浩二; 坂本佳奈; 佐藤美樹; 蘆澤正弘; 寺迫桐子; 木村俊一; 菊地美里; 仲宗根秀樹; 山崎理絵; 諫田淳也; 西田淳二; 神田善伸

  日本造血細胞移植学会総会プログラム・抄録集, 14 Feb. 2014

  
• 骨髄非破壊的前処置および卵巣遮蔽全身放射線照射併用骨髄破壊的前処置を施行した症例における同種造血幹細胞移植後の抗ミュラー管ホルモンによる卵巣予備能の評価

  中野裕史; 蘆澤正弘; 赤星佑; 鵜飼知嵩; 和田英則; 山崎諒子; 石原優子; 河村浩二; 坂本佳奈; 佐藤美樹; 斎藤桐子; 木村俊一; 菊地美里; 仲宗根秀樹; 山崎理絵; 諫田淳也; 賀古真一; 西田淳二; 神田善伸

  日本造血細胞移植学会総会プログラム・抄録集, 14 Feb. 2014

  
• 造血幹細胞移植患者におけるシスタチンC血中濃度の有用性

  和田英則; 諫田淳也; 赤星佑; 中野裕史; 鵜飼知嵩; 石原優子; 河村浩二; 坂本佳奈; 山崎諒子; 佐藤美樹; 蘆澤正弘; 斎藤(寺迫; 桐子; 木村俊一; 菊地美里; 山崎理絵; 賀古真一; 西田淳二; 神田善伸

  日本造血細胞移植学会総会プログラム・抄録集, 14 Feb. 2014

  
• 造血幹細胞移植患者における全身性の抗菌薬予防投与の有用性.ランダム化比較試験を対象としたメタ解析

  木村俊一; 赤星佑; 中野裕史; 鵜飼知嵩; 和田英則; 山崎諒子; 石原優子; 河村浩二; 坂本佳奈; 蘆澤正弘; 佐藤美樹; 斎藤桐子; 仲宗根秀樹; 菊地美里; 山崎理絵; 賀古真一; 諫田淳也; 西田淳二; 神田善伸

  日本造血細胞移植学会総会プログラム・抄録集, 14 Feb. 2014

  
• 同種臍帯血移植におけるCMV再活性化に対しHLA不一致が及ぼす影響

  横山寿行; 加藤俊一; 近藤英生; 前田嘉信; 佐治博夫; 西田徹也; 諫田淳也; 内田直之; 藤原実名美; 宮村耕一; 片山義雄; 高橋聡; 長村登紀子; 加藤剛二; 熱田由子; 神田善伸

  日本造血細胞移植学会総会プログラム・抄録集, 14 Feb. 2014

  
• The Impact of HLA-Mismatch Direction on the Outcome of Unrelated Bone Marrow Transplantation: A Retrospective Analysis from the JSHCT HLA Working Group

  Junya Kanda; Yoshinobu Maeda; Kazuteru Ohashi; Takahiro Fukuda; Koichi Miyamura; Shin-Ichiro Mori; Yasuo Morishima; Yoshiko Atsuta; Yoshinobu Kanda

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Feb. 2014

  
• AMLに対する寛解導入療法中に発症したLactobacillus rhamnosusによる口腔内感染

  石原優子; 諫田淳也; 中野裕史; 鵜飼知嵩; 和田英則; 山崎諒子; 河村浩二; 坂本佳奈; 藍澤正弘; 佐藤美樹; 寺迫桐子; 木村俊一; 菊地美里; 賀古真一; 山崎理絵; 西田淳二; 神田善伸; 田中香お里; 渡邉邦友

  臨床血液, 30 Nov. 2013

  
• ヘプシジン・プロモーターのバイオアッセイ

  KAWABATA HIROSHI; UCHIYAMA TATSUKI; SAKAMOTO SOICHIRO; KANDA JUN'YA; OISHI SHIN'YA; FUJII NOBUTAKA; TOMOSUGI NAOHISA; TAKAORI AKIFUMI

  日本鉄バイオサイエンス学会学術集会プログラム・抄録集, Aug. 2013

  
• 片麻痺にて発症しランダム皮膚生検にて診断し得た血管内大細胞B細胞リンパ腫

  宮澤晴久; 町島智人; 菊地美里; 和田英則; 山崎諒子; 河村浩二; 蘆澤正弘; 賀古真一; 諫田淳也; 西田淳二; 神田善伸; 渡辺珠美; 黒田仁; 菅原斉

  臨床血液, 30 May 2013

  
• Graft-versus-host disease rates and survival after cord blood transplantation for acute leukaemia: a comparison of outcomes in the Japanese versus the US populations

  Y. Kuwatsuka; Y. Atsuta; M. Horowitz; J. Inagaki; J. Kanda; K. Kato; K. Koh; M. Zhang; M. Eapen

  BONE MARROW TRANSPLANTATION, Apr. 2013

  
• 同種造血幹細胞移植後の長期低用量ACVによるVZV再活性化予防の後方視的検討

  河村浩二; 和田英則; 山崎諒子; 石原優子; 坂本佳奈; 蘆澤正弘; 佐藤美樹; 寺迫桐子; 町島智人; 木村俊一; 菊地美里; 仲宗根秀樹; 山崎理絵; 諫田淳也; 賀古真一; 西田淳二; 神田善伸

  日本造血細胞移植学会総会プログラム・抄録集, 08 Feb. 2013

  
• 同種造血幹細胞移植後生着前と生着後の血流感染症に関する解析

  菊地美里; 和田英則; 石原優子; 河村浩二; 坂本佳奈; 山崎諒子; 蘆澤正弘; 佐藤美樹; 寺迫桐子; 町島智人; 木村俊一; 仲宗根秀樹; 賀古真一; 諫田淳也; 山崎理絵; 西田淳二; 神田善伸

  日本造血細胞移植学会総会プログラム・抄録集, 08 Feb. 2013

  
• Ph‐ALLに対するHLA不適合移植後早期に生じた腸管急性GVHDからEBV‐PTLDへの急速な病態変化

  久保敬子; 町島智人; 菊地美里; 和田英則; 山崎諒子; 河村浩二; 石原優子; 坂本佳奈; 蘆澤正弘; 木村俊一; 賀古真一; 諫田淳也; 西田淳二; 神田善伸; 浦吉俊輔; 松本吏弘; 野首光弘; 山田茂樹

  臨床血液, 30 Dec. 2012

  
• Older Age Increases Non-Relapse Mortality in Patients with Grade II-IV Acute Gvhd After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the Japanese Trump Database.

  Takahiko Nakane; Takahiro Fukuda; Junya Kanda; Shuichi Taniguchi; Tetsuya Eto; Kazuteru Ohashi; Yasuo Morishima; Tokiko Nagamura; Hisashi Sakamaki; Yoshiko Atsuta; Makoto Murata

  BLOOD, Nov. 2012

  
• Clinical Factors Predicting the Response of Acute Graft-Versus-Host Disease to Corticosteroid Therapy

  Makoto Murata; Hideki Nakasone; Junya Kanda; Takahiko Nakane; Tatsuo Furukawa; Takahiro Fukuda; Shuichi Taniguchi; Takehiko Mori; Tetsuya Eto; Yasuo Morishima; Tokiko Nagamura-Inoue; Hiromasa Yabe; Yoshiko Atsuta; Hisashi Sakamaki; Ritsuro Suzuki

  BLOOD, Nov. 2012

  
• Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia

  諫田 淳也

  血液内科, Aug. 2012

  
• 同種造血幹細胞移植後に肺高血圧症を呈したPulmonary veno‐occlusive disease

  石原優子; 木村俊一; 和田英則; 河村浩二; 坂本佳奈; 蘆澤正弘; 佐藤美樹; 町島智人; 寺迫桐子; 菊地美里; 仲宗根秀樹; 奥田慎也; 賀古真一; 諫田淳也; 山崎理絵; 西田淳二; 神田善伸; 坂倉建一; 和田浩; 阿古潤哉

  臨床血液, 30 May 2012

  
• USE OF CYCLOSPORINE IS ASSOCIATED WITH THE INCREASE IN PRE-ENGRAFTMENT SYNDROME AFTER MYELOABLATIVE DUAL CORD BLOOD TRANSPLANTATION

  J. Kanda; L. Kaynar; Y. Kanda; V. K. Prasad; S. H. Parikh; D. A. Rizzieri; G. D. Long; K. M. Sullivan; C. Gasparetto; J. P. Chute; A. Morris; S. Winkel; J. McPherson; J. Kurtzberg; N. J. Chao; M. E. Horwitz

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Feb. 2012

  
• Grade II以上の急性GVHDに対する治療成績:TRUMPデータを用いた解析

  村田誠; 仲宗根秀樹; 諌田淳也; 中根孝彦; 古川達雄; 福田隆浩; 谷口修一; 森毅彦; 衛藤徹也; 森島泰雄; 長村登紀子; 矢部普正; 熱田由子; 鈴木律朗; 坂巻壽

  日本造血細胞移植学会総会プログラム・抄録集, 01 Feb. 2012

  
• TRUMPデータに基づく同種造血幹細胞移植後の閉塞性細気管支炎の症例対照研究

  仲宗根秀樹; 諌田淳也; 吾郷浩厚; 福田隆浩; 中根孝彦; 小林武; 谷口修一; 森島泰雄; 長村登紀子; 坂巻壽; 熱田由子; 村田誠

  日本造血細胞移植学会総会プログラム・抄録集, 01 Feb. 2012

  
• Chemo-Mobilization Provides Superior Mobilization and Collection in Autologous Stem Cell Transplants but with Less Predictability and At a Higher Cost

  Nelson J. Chao; Daniel T. Grima; George Carrum; Leona Holmberg; Henry C. Fung; Stephen Brown; Mitchell E. Horwitz; Lisa M. Bernard; Junya Kanda; Jane L. Liesveld; Brian McClune; Paul Shaughnessy; Guido J. Tricot

  BLOOD, Nov. 2011

  
• The Impact of Lymphocyte Subset Recovery At 3 Months on Progression-Free Survival After Myeloablative Allogeneic Stem Cell Transplantation

  Junya Kanda; David A. Rizzieri; Gwynn D. Long; Cristina Gasparetto; John P. Chute; Keith M. Sullivan; Ashley Morris; Jacalyn McPherson; J. Andrew Livingston; Gloria Broadwater; Donna Niedzwiecki; Nelson J. Chao; Mitchell E. Horwitz

  BLOOD, Nov. 2011

  
• Differences in Stem Cell Collection Practices and Related Outcomes Between Centers That Conduct and Do Not Conduct Aphaeresis on Weekends

  Nelson J. Chao; Lisa M. Bernard; George Carrum; Henry C. Fung; Daniel T. Grima; Leona Holmberg; Stephen Brown; Mitchell E. Horwitz; Junya Kanda; Jane L. Liesveld; Brian McClune; Paul Shaughnessy; Guido J. Tricot

  BLOOD, Nov. 2011

  
• INVERSE ASSOCIATION BETWEEN SOY INTAKE AND NON-HODGKIN LYMPHOMA RISK: A CASE-CONTROL STUDY IN JAPAN

  D. Chihara; K. Matsuo; J. Kanda; S. Hosono; H. Ito; K. Tajima; H. Tanaka

  ANNALS OF ONCOLOGY, Jun. 2011

  
• OUTCOMES OF A 1-DAY NONMYELOABLATIVE PREPARATIVE REGIMEN FOR PRIMARY GRAFT FAILURE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

  J. Kanda; M. E. Horwitz; G. D. Long; C. Gasparetto; K. M. Sullivan; J. P. Chute; A. Morris; T. Hennig; N. J. Chao; D. A. Rizzieri

  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Feb. 2011

  
• 成人T細胞白血病(ATL)の同種造血幹細胞移植におけるドナーのHTLV‐I感染の影響

  菱澤方勝; 諌田淳也; 宇都宮與; 谷口修一; 衛藤徹也; 森内幸美; 田野崎隆二; 河野文夫; 宮崎泰司; 増田昌人; 長藤宏司; 原雅道; 高梨美乃子; 甲斐俊朗; 熱田由子; 鈴木律朗; 川瀬孝和; 松尾恵太郎; 長村登紀子; 加藤俊一

  日本造血細胞移植学会総会プログラム・抄録集, 2011

  
• Prospective, Biological Randomized Study of T-Cell Depleted Nonmyeloablative Allogeneic Transplantation From HLA-Matched Related, Unrelated or Haploidentical Donors for Patients with Hematologic Malignancies.

  Junya Kanda; Gwynn D. Long; Cristina Gasparetto; Mitchell E. Horwitz; Keith M. Sullivan; John P. Chute; Ashley Morris; Zhiguo Li; Nelson J. Chao; David A. Rizzieri

  BLOOD, Nov. 2010

  
• A Comprehensive Comparison Immune Recovery In Adult Patients Following Allogeneic Umbilical Cord Blood, Matched Sibling and Matched Unrelated Donor Stem Cell Transplantation

  Lun-Wei Chiou; Junya Kanda; Paul Szabolcs; Gregory E. Sempowski; Jeffrey Hale; Donna Niedzwiecki; Gloria Broadwater; Nelson J. Chao; Mitchell E. Horwitz

  BLOOD, Nov. 2010

  
• Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350cGy) and Fludarabine Conditioning

  Junya Kanda; David A. Rizzieri; Cristina Gasparetto; Gwynn D. Long; John P. Chute; Keith M. Sullivan; Ashley Morris; Clayton A. Smith; Donna E. Hogge; Janet Nitta; Kevin Song; Donna Niedzwiecki; Nelson J. Chao; Mitchell E. Horwitz

  BLOOD, Nov. 2010

  
• Impact of Serum Ferritin Levels on the Incidence of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.

  Soichiro Sakamoto; Hiroshi Kawabata; Junya Kanda; Tatsuki Uchiyama; Chisaki Mizumoto; Tadakazu Kondo; Tatsuo Ichinohe; Takayuki Ishikawa; Akifumi Takaori-Kondo

  BLOOD, Nov. 2010

  
• Clinical significance of preformed antibodies against HLA and MICA in recipients of unrelated bone marrow transplantation: a case-control study

  T. Ichinohe; J. Kanda; E. Maruya; F. Ishimaru; Y. Hirata; K. Matsuo; T. Kawase; Y. Morishima; H. Saji

  BONE MARROW TRANSPLANTATION, Mar. 2010

  
• Neutrophils are the predominant source of circulating Ngal in normal conditions and during infection, but not in acute kidney injury

  Kiyoshi Mori; Junya Kanda; Masashi Mukoyama; Hiroshi Kawabata; Masato Kasahara; Hideki Yokoi; Chisaki Mizumoto; Kazuwa Nakao

  ENDOCRINE JOURNAL, Mar. 2010

  
• The Author's Reply: Sleep Complaints in Hospitalized Italian Patients with Hematological Malignancies

  Akane Kunitomi; Hiroatsu Iida; Yoshikazu Kamiya; Mayuko Hayashi; Taro Suwa; Junya Kanda; Hiroshi Sao

  INTERNAL MEDICINE, 2010

  
• 当院における成人T細胞白血病症例の後方視的解析

  内山 達樹; 菱澤 方勝; 諫田 淳也; 一戸 辰夫; 小林 正行; 錦織 桃子; 川端 浩; 門脇 則光; 高折 晃史; 山下 浩平; 近藤 忠一; 石川 隆之; 内山 卓

  臨床血液, Sep. 2009

  
• Effect of alcohol intake and smoking on malignant lymphoma risk in Japanese: A hospital-based case-control study at Aichi Cancer Center

  Junya Kanda; Keitaro Matsuo; Takakazu Kawase; Takeshi Suzuki; Tatsuo Ichinohe; Masao Seto; Yasuo Morishima; Kazuo Tajima; Hideo Tanaka

  CANCER RESEARCH, May 2009

  
• Reappraisal of bacterial prophylaxis in allogeneic marrow or peripheral blood stem cell transplantations after myeloablative conditionings

  J. Kanda; T. Ichinohe; T. Saito; K. Yamashita; T. Kondo; T. Ishikawa; S. Ichiyama; T. Uchiyama

  BONE MARROW TRANSPLANTATION, Mar. 2009

  
• 移植前血清フェリチン値が造血器腫瘍に対する同種造血幹細胞移植の成績に与える影響の検討

  水本 智咲; 諫田 淳也; 川端 浩; 一戸 辰夫; 菱澤 方勝; 錦織 桃子; 高折 晃史; 門脇 則光; 山下 浩平; 近藤 忠一; 石川 隆之; 内山 卓

  臨床血液, Sep. 2008

  
• 非血縁者間骨髄移植後の非感染性肺合併症 緩和な前処置と従来型前処置の比較

  篠原 正信; 諫田 淳也; 一戸 辰夫; 丸山 亙; 山本 和代; 石上 隆宏; 内山 達樹; 阪本 貴士; 藤田 晴之; 小林 正行; 錦織 桃子; 菱澤 方勝; 川端 浩; 門脇 則光; 高折 晃史; 堀 利行; 山下 浩平; 近藤 忠一; 石川 隆之; 内山 卓

  臨床血液, Sep. 2008

  
• Individual patient data-based meta-analysis of cohort studies comparing clinical outcomes of ABO mismatched or matched stem cell transplantation in patients with haematological malignancies

  J. Kanda; T. Ichinohe; K. Matsuo; R. J. Benjamin; T. R. Klumpp; P. Rozman; N. Blumberg; J. Mehta; S. K. Sohn; T. Uchiyama

  BONE MARROW TRANSPLANTATION, Mar. 2008

  
• Allografting for adult T-cell leukemia/lymphoma: A nationwide retrospective analysis

  Masakatsu Hishizawa; Junya Kanda; Atae Utsunomiya; Shuichi Taniguchi; Tetsuya Eto; Yukiyoshi Moriuchi; Fyuji Tanosaki; Fumio Kawano; Yasushi Miyazaki; Koji Nagafuji; Masamichi Hara; Fumiaki Yoshiba; Minoko Takanashi; Shunro Kai; Yoshiko Atsuta; Takakazu Kawase; Tokiko Nagamura Inoue; Keitaro Matsuo; Shunichi Kato; Yasuo Morishima; Jun Okamura; Yoshihisa Kodera; Takashi Uchiyama

  BLOOD, Nov. 2007

  
• Serum level of hepcidin and erythropoietic activity after hematopoietic stem cell transplantation

  Junya Kanda; Chisaki Mizumoto; Hiroshi Kawabata; Hideyuki Tsuchida; Naohisa Tomosugi; Takashi Uchiyama

  BLOOD, Nov. 2007

  
• 緩和な前処置を用いた同種造血幹細胞移植における幹細胞源としての骨髄と末梢血の比較

  松井 道志; 諫田 淳也; 一戸 辰夫; 井尾 克宏; 蝶名林 和久; 石上 隆宏; 菱澤 方勝; 錦織 桃子; 川端 浩; 山下 浩平; 近藤 忠一; 高折 晃史; 堀 利行; 門脇 則光; 石川 隆之; 内山 卓

  臨床血液, Sep. 2007

  
• 急性骨髄性白血病・ハイリスク骨髄異形成症候群に対する同種造血幹細胞移植の成績に急性GVHDが与える影響

  井尾 克宏; 諌田 淳也; 一戸 辰夫; 松井 道志; 蝶名林 和久; 石上 隆宏; 菱澤 方勝; 錦織 桃子; 川端 浩; 山下 浩平; 近藤 忠一; 高折 晃史; 堀 利行; 門脇 則光; 石川 隆之; 内山 卓

  臨床血液, Sep. 2007

  
• Successful treatment of pure red cell aplasia after major ABO-incompatible unrelated bone marrow transplantation for chronic myelocytic leukemia with plasma exchange

  CHONABAYASHI Kazuhisa; WATANABE Mitsumasa; KANDA Junya; ARIMA Nobuyoshi; TSUDO Mitsuru

  The Japanese Red Cross medical journal, 10 Jul. 2007

  
• The serum level of hepcidin after stem cell transplantation

  J. Kanda; C. Mizumoto; H. Kawabata; N. Tomosugi; T. Uchiyama

  AMERICAN JOURNAL OF HEMATOLOGY, Jun. 2007

  
• Anti-interleukin 6 receptor antibody tocilizumab reduces the levels of serum hepcidin in patients with Multicentric Castleman's disease

  H. Kawabata; N. Tomosugi; J. Kanda; Y. Tanaka; N. Kadowaki; T. Ichinohe; T. Ishikawa; T. Uchiyama

  AMERICAN JOURNAL OF HEMATOLOGY, Jun. 2007

  
• Feasibility of T-cell-replete stem cell transplantation from HLA-haplo-identical family members mismatched at a zero or one HLA antigen in graft-versus-host direction: impact of allelic host-versus-graft HLA mismatching

  J. Kanda; T. Ichinohe; T. Ishikawa; T. Kondo; M. Watanabe; M. Tsudo; N. Ochiai; E. Maruya; H. Saji; T. Uchiyama

  BONE MARROW TRANSPLANTATION, Apr. 2007

  
• Castleman病において抗インターロイキン6抗体(MRA)は血清中hepcidin濃度を減少させて貧血を改善する

  川端 浩; 友杉 直久; 諫田 淳也; 田中 康博; 一戸 辰夫; 門脇 則光; 石川 隆之; 内山 卓

  臨床血液, Sep. 2006

  
• T細胞性リンパ腫におけるEBER陽性率と臨床経過・予後についての検討

  田中 康博; 諌田 淳也; 水本 智咲; 田嶌 政治; 錦織 桃子; 山下 浩平; 近藤 忠一; 川端 浩; 一戸 辰夫; 高折 晃文; 門脇 則光; 堀 利行; 石川 隆之; 内山 卓; 橘 充弘; 羽賀 博典

  臨床血液, Sep. 2006

  
• シクロスポリン投与により軽快したバルプロ酸ナトリウムによる赤芽球癆

  諌田 淳也; 蝶名林 和久; 渡邊 光正; 有馬 靖佳; 通堂 満

  臨床血液, Oct. 2005

  
• 非血縁者間骨髄移植後の赤芽球ろうに対し血しょう交換が奏効した慢性骨髄性白血病の一例

  蝶名林和久; 渡辺光正; 諌田淳也; 有馬靖佳; 通堂満

  臨床血液, 30 Aug. 2005

  
• Rituximabが著効したCD5陰性B‐CLLに合併した赤芽球ろうの1例

  渡辺光正; 蝶名林和久; 諌田淳也; 有馬靖佳; 通堂満

  臨床血液, 30 Aug. 2005

  
• 腰椎圧迫骨折,高カルシウム血症で発症した急性巨核芽球性白血病の2症例

  諌田淳也; 蝶名林和久; 渡辺光正; 赤坂浩司; 有馬靖佳; 通堂満

  臨床血液, 30 Aug. 2004

  
• R‐CHOP療法が著効したB‐PLLの1例

  渡辺光正; 蝶名林和久; 諌田淳也; 赤坂浩司; 有馬靖佳; 通堂満

  臨床血液, 30 Aug. 2004

  

Awards

• 28 Aug. 2009

  14th Congress of the Asia-Pacific Blood and Marrow Transplantation, Outstanding Poster Award
• 18 Apr. 2009

  AACR 100th Annual Meeting, AACR-ITO EN, Ltd. Scholar-in-Training Award
• 09 Mar. 2013

  The Japan Society for Hematopoietic Stem Cell Transplantation, Encouragement Prize
• 11 Oct. 2013

  The Japanese Society of Hematology, Encouragement Prize
• 04 Mar. 2017

  JSHCT , JSHCT Working Group Research Award

External funds: Kakenhi

• International prognostic algorithm for allogeneic stem cell transplantation by machine learning of comprehensive HLA and clinical information

  Grant-in-Aid for Scientific Research (C)

  Basic Section 54010:Hematology and medical oncology-related

  Kyoto University

  JUNYA KANDA

  From 01 Apr. 2021, To 31 Mar. 2024, Project Closed

  同種造血幹細胞移植;臍帯血移植;機械学習;同種移植;造血幹細胞移植;HLAエピトープ

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21K08391/
• Establishment of an International Standard Algorithm for Improving Umbilical Cord Blood Transplantation Outcomes through Clinical Data Analysis

  Grant-in-Aid for Scientific Research (C)

  Basic Section 54010:Hematology and medical oncology-related

  Kyoto University

  Junya Kanda

  From 01 Apr. 2018, To 31 Mar. 2021, Project Closed

  臍帯血移植

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-18K08325/
• Investigation of redirected Tax-specific T-cell immunotherapy against adult T-cell leukemia/lymphoma

  Grant-in-Aid for Scientific Research (B)

  Jichi Medical University

  YOSHINOBU KANDA

  From 01 Apr. 2014, To 31 Mar. 2017, Project Closed

  遺伝子導入免疫細胞療法;腫瘍特異的免疫細胞療法;免疫学;細胞免疫療法;成人T細胞性白血病;遺伝子治療

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-26290058/
• Analysis of immune reconstitution after unrelated cord blood transplantation

  Grant-in-Aid for Research Activity Start-up

  Jichi Medical University

  Junya KANDA

  From 31 Aug. 2012, To 31 Mar. 2014, Project Closed

  臍帯血移植;遺伝子再構成;免疫再構築

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-24890220/
• Optimizing immunity in hematopoietic stem cell transplantation focusing on HLA epitopes

  Grant-in-Aid for Scientific Research (C)

  Basic Section 54010:Hematology and medical oncology-related

  Hiroshima University

  進藤 岳郎

  From 01 Apr. 2023, To 31 Mar. 2026, Granted

  組織適合性抗原多型;アロ反応性増殖;細胞内シグナリング;HLAエピトープ;造血幹細胞移植;移植片対宿主病;抗腫瘍免疫;免疫再構築

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23K07811/
• 造血器悪性腫瘍患者を対象とする質問促進プログラムの有効性と社会実装に関する検証

  Grant-in-Aid for Scientific Research (B)

  Basic Section 58060:Clinical nursing-related

  Kyoto University

  白井 由紀

  From 01 Apr. 2023, To 31 Mar. 2027, Granted

  がん;造血器悪性腫瘍;意思決定;コミュニケーション;質問促進プログラム

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23H03195/
• 臍帯血移植の移植後中長期合併症に対する国際標準予測アルゴリズムの確立

  Grant-in-Aid for Scientific Research (C)

  Basic Section 54010:Hematology and medical oncology-related

  Kyoto University

  諫田 淳也

  From 01 Apr. 2024, To 31 Mar. 2027, Granted

  臍帯血移植;移植後中長期合併症;続発性悪性新生物

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-24K11515/
• 造血器悪性腫瘍患者を対象とする質問促進プログラムの有効性と社会実装に関する検証

  Grant-in-Aid for Scientific Research (B)

  Basic Section 58060:Clinical nursing-related

  Kyoto University

  白井 由紀

  From 01 Apr. 2023, To 31 Mar. 2027, Granted

  造血器悪性腫瘍;意思決定;コミュニケーション;質問促進プログラム;社会実装;がん

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23K27885/